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1. INTRODUCTION 
Common mental disorders such as depression and anxiety are a major contributor to Australia’s 
burden of disease (1) and cause enormous distress for patients and their families. The majority 
of people who seek professional help for mental illness present to General Practitioners (GPs) in 
the first instance (2), with services primarily accessed through this gateway to the mental 
health system. Indeed, it is estimated that psychological problems are managed at 
approximately 12% of GP encounters, with almost 11 million annual consultations across 
Australia concerning mental health issues (3). Psychological therapies are preferred to 
pharmacological therapies by most consumers (4) and, when delivered by mental health 
professionals, have been shown to be highly effective in alleviating distress, reducing relapse 
and improving quality of life (5).  
Over the last 15 years there have been substantial reforms to mental health care in Australia, 
(6-8), which have impacted on the way in which psychological treatments are accessed by the 
community. These reforms have been driven by a mix of consumer dissatisfaction (e.g., 9), 
advocacy from the health professions, and political vision (e.g., 10, 11), and these overall 
improvements in access are arguably unrivalled in developed countries around the world. To 
further optimise the Australian workforce in its delivery of psychological treatments requires 
careful consideration of issues such as quality and equity (12), commensurate with the 
principles underlying our mental health policy (13), and an appreciation of the trends in the 
current scientific literature towards the provision of psychological treatment through 
collaborative models. With these perspectives in mind, we have selected two areas for review 
that we hope will make a useful contribution to policy discussions in Australia regarding the 
most effective use of the primary mental health care workforce:  
1. What is the evidence for the effectiveness and cost-effectiveness of generalist versus 
specialist providers of psychological treatments in primary care?  
2. How effective and cost-effective are models of collaboration in providing psychological 
treatments in primary care, and what are the elements of successful models? 
We have limited the scope of the review to emphasise the literature that we, and our 
stakeholders, judge to be most relevant to Australia’s current primary mental health system. In 
doing so, we recognise that we cannot be comprehensive and must therefore make 
assumptions about the types of patients, providers and treatment options to include in the 
review. We have focused exclusively on the depressive and anxiety disorders, for three reasons. 
First, these are high prevalence disorders in the Australian population, with the Australian 
National Survey of Mental Health and Wellbeing (2) indicating that the 12-month prevalence of 
depressive disorders was 7.2% (ICD-10 criteria) and 9.5% of respondents experienced an 
anxiety disorder. Second, these disorders have a high impact on the burden of disease in 
Australia (1). Third, these are the two most commonly managed mental health problems in 
Australian General Practice (3). Therefore, we have not included substance abuse or the low 
prevalence disorders such as psychosis or bipolar disorder in this review. To maximise 
generalisability, we did not include articles where the study population was limited to specific 
medical groups (e.g., post-operative, cardiovascular disease, diabetes), although some patients 
in the primary care populations in the studies may have had depression secondary to medical 
illness.  
This review focuses on care provided by a GP, or by psychologists or other allied health 
providers when the patient is referred by a GP. We have not included nurse-delivered or 
psychiatrist-delivered psychological treatment, as the complex role of these professionals in the 
mental health system is a question beyond the scope of this review. We have emphasised 
psychological treatments provided in the community rather than in hospital-based settings. 
Finally, we have limited the scope to evidence-based psychological treatment approaches, and 
given preference to research regarding those approaches that are recognised in the current 
funding streams for psychological treatments in Australia (14).  
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Therefore, we have limited our review to studies where the intervention consists of 
psychoeducation, cognitive behavioural therapy (CBT), problem solving therapy (PST) or 
interpersonal therapy (IPT), although we acknowledge that significant contributions to mental 
health may be made through other therapeutic approaches (e.g., psychodynamic, gestalt, 
humanistic, narrative, non-directive counseling, .)  
1.1. GENERAL METHOD OF REVIEW 
1.1.1. DESIGN 
This document is based on a systematic review of the research evidence (see Figure 1). We 
have followed typical approaches to conducting the review, with particular attention to quality 
ratings (15-17). The key outcome measures of this review are clinical improvement (depression, 
anxiety) and cost-effectiveness, although other outcome variables are discussed as relevant.  
1.1.2. PROCEDURE 
Relevant search terms were input into major databases of articles (Medline, Web of Science, 
PsycINFO, PubMed, Scopus, Cochrane Database). These terms were based on a combination of 
terms and subject headings relevant to “primary care”, “psychotherapy” and “depression OR 
anxiety” (see Table 1; also see Table 13, Appendix 3). Initially, one reviewer (RM) screened all 
the articles based on the inclusion/exclusion criteria, according to abstracts and titles. As the 
search terms were sensitive but not specific, this allowed removal of the less relevant articles. 
Where there was any doubt, the articles remained in the search database. Following this, full 
articles were examined to determine the final papers to be retained (see  for flow-chart). At this 
time, additional papers not identified in the original review were sourced from reference lists of 
sourced papers, and examined for relevance. Following retention in the review, articles were 
classified into four main areas (GP-provided care, allied health-provided care, collaborative 
models, health economics/cost-effectiveness), although articles were allowed to be in more 
than one category. Data was separately extracted for each category according to relevant 
criteria (see Results). Quality of articles was also graded (see Method below). This process was 
followed for all primary articles discussed in this review. While not primary articles, five recent 
reviews of collaborative approaches were also identified during the review process, and are 
described in Chapter 3. 
A “grey” literature search was also undertaken during the review (May 2007), which included 
sources such as the search engines AustHealth and GoogleNews, hand-searches of relevant 
Australian publications such as Australian Doctor, The Age, The Sydney Morning Herald, The 
Herald Sun, The Australian; examination of relevant websites such as the Australian 
Government Department of Health and Aging, Medicare Australia and websites relevant to the 
professional organizations; and personal communications from our stakeholder interviews. This 
approach primarily led to the sourcing of opinion pieces and commentary regarding the recent 
Medicare initiative, which provided us with further contextual information for the Australian 
system. It is in this modality that such information appears through the document. We did not 
formally extract information from these articles, as we had previously decided to limit our 
review to intervention studies.  
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1.1.3. INCLUSION/EXCLUSION CRITERIA 
The inclusion/exclusion criteria developed for this review are listed in Table 2. 
Table 1: List of Search Terms for MEDLINE (Conducted 2/3/07) 
Database Search Terms  
1. TS="primary health care"/"primary healthcare"/"primary care"/"general practice*" "family practice"/"primary mental health 
care"/"family physician"/"primary nursing care"/"primary medical care"/"GP"/"GPs"/ family medicine/"Delivery of Health 
Care"/"cooperation"/ "interdisciplinary team"/"patient care team"/"mental health services"/"primary health care delivery" 
/"primary medical care delivery"/"general practice delivery" /"comprehensive care"/"coordinated care"/"integrated care"/ 
"continuity of care"/"accessibility of care"/"service planning"/"health service structures"/"health service organization"/"health 
service funding"/ "health service governance" 
2. MH:exp=” Primary Health Care"/"Family Practice"/"Physicians, Family"/"Primary Nursing Care"/"Delivery of Health 
Care"/"Cooperative Behavior"/"Mental Health Services"/ "Comprehensive Health Care"/"Continuity of Patient Care" 
3. TS=psychotherapy/ counsel*/"supportive therapy"/"Behavior therapy" /"Behaviour Therapy"/"Cognitive Behavior 
Therapy"/"Cognitive Behaviour Therapy"/"Cognitive Therapy"/"Behavior Analysis"/"Behavior Modification"/" Exposure 
Techniques"/"Activity Scheduling"/"Cognitive Analysis"/"Cognitive Interventions"/"Thought Challenging"/"Cognitive 
Restructuring"/Relaxation/ "Guided Imagery"/"Problem-Solving"/"Anger Management"/" Stress Management" /"Social 
Skills"/"Motivational Interviewing"/"Interpersonal Therapy" /"Parent Management Training"/Psychoeducation/ "Psychological 
Treatment"/CBT/ Interpersonal Techniques/"Behavior Control"/"Behaviour Control"/"Aversive Therapy"/ "psychological 
desensitization"/"Implosive Therapy"/Bibliotherapy /"self-help"/"family therapy" 
4. MH:exp=Counseling/Psychotherapy/"Behavior Therapy"/"Cognitive Therapy" /("Psychotherapy, Rational-Emotive" AND 
Therapeutics)/ Relaxation/ "Imagery Psychotherapy"/"Behavior Control"/"Aversive Therapy"/"Desensitization, Psychologic" 
/"Relaxation Techniques"/"Implosive Therapy"/Bibliotherapy/ "Psychotherapy, Brief"/"Psychotherapy, Multiple"/ "Psychotherapy
Rational-Emotive" 
5. TS= Depressi*/Dysthymi*/"Seasonal Affective Disorder"/Anxiety/Agoraphobia /"Obsessive-Compulsive Disorder"/ OCD/"Pani
Disorder"/"GAD"/"Generali?ed anxiety Disorder"/Phobi*/ "Stress Disorder*"/PTSD/"Adjustment Disorder*" 
6. MH:exp="Depressive Disorder, Major"/"Depressive Disorder"/"Depression, Postpartum" /"Dysthymic Disorder"/"Seasonal 
Affective Disorder"/"Anxiety Disorders"/ "Agoraphobia" /"Obsessive-Compulsive Disorder"/"Panic Disorder"/"Phobic 
Disorders"/"Stress Disorders, Traumatic"/ "Combat Disorders"/"Stress Disorders, Traumatic, Acute"/"Stress Disorders, Post-
Traumatic"/ "Adjustment Disorders" /"Neurotic Disorders" 
MEDLINE 
7. (1 OR 2) AND (3 OR 4) AND (5 OR 6) 2780
SCOPUS See Appendix 3 for Terms 488 
PsycINFO See Appendix 3 for Terms 867 
Cochrane See Appendix 3 for Terms 279 
Web of Science See Appendix 3 for Terms 1418
PubMed See Appendix 3 for Terms 664 
TOTAL (EXCLUDING DUPLICATES) 4520
Note: Forward slash (/) represents the Boolean operator “OR”. 
Table 2: Inclusion/Exclusion Criteria  
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Inclusion Criteria Exclusion Criteria Justification 
After 1979 Before and including 1979 Development of modern CBT, IPT; trials 
more methodologically rigorous 
Depressive Disorders (Major Depressive 
Disorder, dysthymia), and Anxiety Disorders 
(Panic Disorder, PTSD, OCD, Generalised 
Anxiety Disorder, Specific and Social Phobias).  
Primarily psychotic disorders; eating disorders; 
bipolar disorder; Mental Retardation; Personality 
Disorders, substance use, somatoform disorders 
(hypochondriasis, conversion, pain disorder, body 
dysmorphophobia, somatization); Medical illness. 
High prevalence disorders with high 
disability, which are amenable to 
psychotherapeutic approaches. 
Actively recruited from General Practice Setting. Exclusively secondary/tertiary care. 
Exclusively Hospital Care. 
Focus of review on primary care research. 
Most patients who seek professional care 
for mental illness present to GPs in the first 
instance. 
Must be intervention/program to treat existing 
mental illness 
Preventative approach. 
Purely theoretical paper. 
Review prioritises clinical and health service 
research 
Psychotherapy must be a component Exclusively pharmacological approach. Focus of review on psychological 
treatments 
Psychotherapy using: CBT; PST; IPT; 
Psychoeducation 
Exclusively other psychological approach (e.g., 
psychodynamic; gestalt; generic counselling; .) 
Highly relevant to current Australian focus 
of policy on Focussed Psychological 
Strategies. 
Must have some relevance to Australian Context Purely description of overseas context with no 
transferability 
Report designed for Australian context 
English Language Not English Pragmatic consideration. 
General depression/anxiety population Specific population such as depression in post-
operative cardiac patients  
For relevance to general primary care 
context. 
For Health Economics Papers – Cost and 
Outcome data 
– Comparative Arm 
For Health Economics Papers 
- Absence of cost/outcome data 
- Non-comparative study 
Necessary elements of health economics 
evaluations. 
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Figure 1 Flowchart of Review Process for Primary Articles 
 
 
 
 
 
 
 
 
 
 
 
Note: As three papers appear in more than 1 category, the number of papers does not add to 69. Five review articles  
from the past two years also sourced and discussed in the collaborative models chapter. 
1.1.4. QUALITY 
In addition to extracting data from papers, the reviewers also coded the quality of studies. For 
the trials assessing psychological interventions, quality was based on Cochrane Guidelines (17), 
as applied in a previous review of collaborative primary care trials (18). Assessments of study 
quality were therefore based on four main possible sources of bias: randomisation and 
allocation concealment (19), fidelity to the planned intervention, follow-up rates and analytic 
methods (intention-to-treat analyses)(20, 21), and blinded outcome assessments (22). Based 
on these criteria and following Cochrane guidelines, risk of bias was coded as low (all elements 
met), moderate (one or more elements partially met), and high (one or more elements not 
met). Self-report measures were considered partially blinded, as participants were aware of 
treatment they received but not study hypotheses. Where information was not provided in 
published primary or supplementary articles, we attempted to contact the study authors for 
additional description. Where information was unavailable, the criteria were coded as partially 
met. For the economic evaluation articles, formal criteria of economic evaluation quality have 
been applied to each of the identified studies in order to assess quality (23) (see Appendix 10 
for rating scale). To ensure compatibility in quality ratings, a subset of papers were 
independently cross-reviewed by separate reviewers. 
4520 Abstracts Identified  
using search terms 
Excluded by abstract/title 
4181 
GP-provided 
treatment 
(N=8) 
Allied health 
treatment 
(N=32) 
Collaborative 
Models 
(N=9)
Cost-
effectiveness 
(N=23)
339 Met Criteria for Review 
– Articles Retrieved 
12 Articles Sourced using 
hand search 
281 Excluded 
y results  45 
are intervention for 
anxiety or depression 126 
ological intervention as 
defined in Table 2 71 
on study 37 
 2 
Supplementar
Not primary c
Not psych
Not interventi
Other
69 Articles Primary Included in the Review 
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1.1.5. STRENGTH OF EVIDENCE 
In order to provide a simple but accurate assessment of the findings, we have graded the 
strength of evidence of each major finding. The four categories are:  
 (1) No Studies Identified 
(2) Inconclusive Evidence; where the findings are based on a very small number of studies 
that are either inconsistent or at high risk of bias 
(3) Limited Evidence; where the findings are based on an extrapolation of indirect evidence 
from a large number of studies; from generally consistent findings in two or more studies with a 
high risk of bias; or from one study with moderate risk of bias 
(4) Good Evidence; where the findings are based on generally consistent evidence in two or 
more studies with low to moderate risk of bias. 
1.1.6. STAKEHOLDER CONSULTATIONS 
In addition to the literature review, we also conducted a number of stakeholder consultations. 
These consultations took place during the formulation of our research question, and also 
following the initial synthesis of the findings and drafting of the policy options. The 
consultations were of three main forms: (1) short, confidential semi-structured interviews; (2) 
circulations of iterations of our report; and (3) informal discussions in conference settings. We 
took this approach as we believed it would be an effective way to engage time-poor senior 
policy and research staff in discussions relevant to mental health reform and to what they 
viewed to be the most pressing issues regarding the optimisation of the primary mental health 
care system. In taking this approach we recognise that we have not sought to conduct original 
research such as the thematic coding of interviews, which is beyond the scope of our review. 
Notwithstanding such limitations, we consulted a wide range of stakeholders about our review 
including past and current senior policy advisors, policy evaluators, health economists, divisions 
of general practice (both senior managers and mental health program managers), consumers, 
GPs, psychologists, social workers and occupational therapists. We recognise that consulting 
these individuals does not in any way represent agreement or consensus of the various 
professional colleges, organisations or other stakeholders regarding the focus or conclusions of 
our review. Indeed, recent reforms to the delivery of psychological treatments in Australia have 
been the subject of much debate, discussion and differences of opinion in both the medical and 
lay press. However, our stakeholder consultations have been invaluable in shaping the focus of 
our review and in informing us with respect to the current Australian context.  
1.2. POLICY CONTEXT 
1.2.1. MODELS OF MENTAL HEALTH CARE IN AUSTRALIA 
The question of how to provide psychological treatments must be considered in the context of 
the Australian setting. In our primary care system, patients presenting to GPs with mental 
disorders may be managed by the GP or referred for specialist psychological treatment through 
one of a number of methods: private referral, state-based psychological services, the Better 
Outcomes in Mental Health Care Initiative, the Better Access to Psychiatrists, Psychologists and 
GPs through the Medicare Benefits Schedule (Better Access) Initiative, or a range of referral 
models for rural and Indigenous populations (24-26). A summary of these pathways is shown in 
Figure 2. 
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1.2.2. STATE-BASED MENTAL HEALTH CARE INITIATIVES 
States have traditionally held the greater responsibility for provision of services for mental 
illness in Australia. In the most recent National Mental Health Report (27), it was reported that 
in 2002-2003 the state governments provided $1.98 billion and the Federal government $1.21 
billion for funding on mental health.  
Most of the state-provided funding was for hospital services (29% of state and federal funding) 
and non-hospital or ambulatory services (22.9% of funding), with subsidies for pharmacological 
treatments through the Pharmaceutical Benefit Scheme forming the greatest proportion of 
federal provision (27). State and territory services are not uniform, and most states are further 
divided into particular zones or areas, with regionalised teams responsible for in-patient and 
community health service delivery within such areas. State services include crisis assessment 
services, services for individuals with severe mental disorders (such as acute inpatient and 
extended care inpatient services), and community mental health services for treatment, 
assessment, and case management (e.g., 24). Most states also have additional specialised 
programs that are provided either statewide or regionally, such as the Primary Mental Health 
and Early Intervention Teams for treatment or secondary consultation in Victoria (28), the 
Aboriginal Psychiatric Service located at Graylands Hospital in Western Australia (29), and the 
Mobile Assertive Care Services in South Australia (30). 
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Figure 2 GP Referral Pathways to Psychological Treatments in Australia 
 
Note: Better Outcomes=Better Outcomes in Mental Health Care Initiative; ATAPS=Access to Allied Psychological 
Services; Better Access=Better Access to Psychiatrists, Psychologists and GPs through the Medicare Benefits Schedule 
initiative. 
1.2.3. FEDERAL MENTAL HEALTH CARE INITIATIVES 
Recent policy reforms in Australia have incrementally been widening consumer access to 
psychological treatments through primary care, with generalist or specialist providers1 able to 
administer such treatments. Commencing in 2001, the Federal Government allocated $120.4 
million over four years for the Better Outcomes in Mental Health Care Initiative (31). Through 
this initiative, GPs who have completed the requisite training can claim reimbursement for 
developing structured 3-step mental health care plans with patients, and for conducting 
focussed psychological treatments (CBT, IPT, psychoeducation, relaxation) (32). Alternatively, 
GPs can refer patients to psychologists and other allied health providers (social workers, 
occupational therapists, mental health nurses, Indigenous health workers), who are funded 
through the regionalised Divisions of General Practice to conduct six sessions of evidence-based 
treatment with patients referred by GPs, with six further sessions available on re-referral. The 
program was renewed in 2005, with a further $102 million allocated over four years for 
continuation of the program, and $42.6 million over five years for expansion of the program. 
Contracts with Divisions of General Practice have been renewed until 2009 (31).  
From July 2004, the Enhanced Primary Care items (re-termed Chronic Disease Management in 
2005) of Medicare were expanded to include provision of services for mental health issues, 
along with other chronic diseases covered by the items. In this initiative, GPs can refer 
individuals for a maximum of five sessions per year with registered allied health providers 
(including psychologists, occupational therapists, social workers, mental health nurses, and 
Indigenous health workers), following completion of a multidisciplinary care plan (33, 34).  
                                               
 
 
1 While we acknowledge that disagreement exists over definitions of who and what constitutes a “generalist” or “specialist” provider, 
for the purposes of this report General Practitioners are considered the main generalist providers of psychological treatment in the 
Australian Health Care system, and Allied Health staff that deliver psychological treatments are considered to be specialist providers, 
including psychologists, social workers, mental-health orientated occupational therapists, and other workers as relevant. As noted and 
for reasons mentioned previously, psychiatrist and nurse-provision of psychological treatments is not considered in this document. 
Patient 
Presents to 
GP 
Hospital-
based 
Private psychologist/allied health provider. 
Unlimited sessions or based on private insurance coverage. 
Variable rate/rebate. 
1. Better Outcomes (ATAPS) – Maximum 12 sessions, paid 
for via Divisions of GP. Variable copayment (under $30). 
2. Better Access – Maximum 12 individual sessions (18 in 
exceptional circumstance), Maximum 12 group, 
Medicare rebated. Variable Gap fee. 
3. Others – Chronic Disease Management. Maximum 5 
sessions, Medicare rebated. Variable Gap fee.  
Variable depending on State.  
e.g., Vic – Primary Mental Health/Early Intervention teams. 
 
Variable depending on State. 
Federal 
Private 
State
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In November 2006, a further Federal government initiative commenced as part of broader 
Council of Australian Government (COAG) reforms, termed the Better Access to Psychiatrists, 
Psychologists and GPs through the Medicare Benefits Schedule program (the Better Access 
program; see Table 3)(26). Of the $1.9 billion assigned to the program, $538 million was 
designated for the increased provision of psychological services by GPs, psychiatrists and allied 
health providers. The Better Access program is open to individuals with diagnosed mental 
illnesses, excluding dementia, delirium, tobacco use disorder, and mental retardation, according 
to the International Classification of Diseases-10 (ICD-10, 35). Individuals initially can receive 
six sessions of Medicare-rebated services with allied health providers (psychologists, social 
workers, occupational therapists), with six more sessions available following review and re-
referral by their GP, unless there are exceptional circumstances. Unlike the Better Outcomes 
program, GPs do not have to undergo specific training or to register with Divisions in order to 
access the Medicare items or to refer to psychological treatment by psychologists and allied 
health providers2. Furthermore, the referral process for this program is a more direct system 
where psychologists, specific occupational therapists and social workers are able to access fee-
for-service MBS items rather than applying to the Divisions of General Practice. The Better 
Access and Better Outcomes programs are designed to function as complementary systems, 
with the former program designed to make psychological services more widely available, while 
the latter program has more flexibility and scope for development to suit the needs of particular 
regions. Both these programs require judgement on the part of the individual GPs regarding 
which patients they choose to manage, and which are referred for specialist treatment. 
Table 3: COAG Mental Health Care Reforms (2006-2011) 
Selected Components from the New Federal Measures on Mental Health  
1. $538 million over 5 years to promote a team approach to mental health care, including:  
• Medicare rebate items for GPs to provide early intervention, assessment and management of 
patients with mental disorders as part of a mental health care plan. 
• New Medicare items to encourage psychiatrists to see more patients, including increased 
rebates for initial patient assessment and preparation/review of a management plan with 
GPs. 
• New Medicare items for clinical psychologists to provide up to 12 sessions of psychological 
assessment and therapy services, when clients are referred by GPs. 
• New Medicare items for appropriately trained allied health workers (psychologists, social 
workers and occupational therapists) to provide up to 12 sessions of focussed psychological 
strategies, when clients are referred by GPs. 
2. $51.7 million over 5 years to improve access to mental health services for people in rural and remote 
regions. 
3. $191.6 million over 5 years to enable eligible private psychiatry practices, general practices and other 
appropriate organisations to employ mental health nurses in a coordination role to support mental 
health care.  
4. An additional $56.9 million over 5 years to boost capacity of telephone and web-based counselling 
services, and $2.4 million for expansion of Lifeline. 
5. Provision for 420 extra mental health nursing places and 200 postgraduate clinical psychology 
university places, 75 additional scholarships for nursing and psychology and increased clinical 
exposure for junior medical officers. 
 
The uptake of the new GP and psychological items from the Better Access program has been 
dramatic (see Figure 3, 36), although it has leveled off since May 2007. In the first 11 months, 
GPs claimed MBS items for creating 414,587 mental health plans and for conducting 327,744 
extended mental health consultations, although this contrasts with a limited number of formal 
mental health reviews (73,203).  
                                               
 
 
2 Note that from November 2006-April 30th 2007, the 3-step Mental Health Plan from the Better Outcomes initiative was phased out to 
be replaced by the GP Mental Health Plan Medicare items (2710, 2713), removing the incentive payment at review. Due to these 
changes, GPs do not have to undergo level I training to access the ATAPS component of the Better Outcomes initiative (see Appendix 
1 for more detail regarding the Better Outcomes/Better Access initiatives). The new Medicare items are therefore now used for both 
the Better Outcomes and Better Access initiatives. 
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The uptake of GP-conducted focused psychological strategies has remained fairly constant over 
the same time period, with 32,796 consultations conducted from November 2006-September 
2007. In the same period, Medicare was billed for a total of 1,052,191 sessions with allied 
health providers. These statistics indicate that there has been a far greater use of the Medicare 
items than was expected; indeed the number of mental health care plans developed by GPs has 
already exceeded the 170,000 forecast for the five-year initiative, while the 145,488 
psychological services claimed in September 2007 compares with a five-year forecast of 
960,000 services in total (37). Such uptake statistics have been suggested to reflect the 
substantial unmet need for evidence-based psychological treatments in Australia in the past 
(see 38), which has previously been well-documented (39), where access to psychological 
treatment was beyond the means of most Australians. The uptake of such services highlights 
the need for the examination of the evidence base for the efficacy of such interventions in 
primary care settings.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Uptake of MBS Mental Health Items (Nov 2006-July 2007) 
1.2.4. RELEVANCE OF OVERSEAS MENTAL HEALTH CARE 
RESEARCH TO AUSTRALIA 
Around the world, the structure and functioning of primary mental health systems vary widely. 
The pathways to care, the types of mental health specialists, the care provided, the 
communication protocols, the follow up requirements and the strength of primary care may 
differ between these systems of mental health care. A particular challenge for this review of 
models of mental health care is to decide how applicable the research undertaken in other 
countries is to the current Australian system, as most research into primary care psychology is 
conducted in the US, Canada and the UK. Starfield and Shi (40) rated countries according to 
whether they had system policies that are conducive to primary care, as well as characteristics 
of practice that reflect good primary care. They found that the US had low primary care 
strength; Canada and Australia were intermediate; whereas the UK had the strongest system 
and practice characteristics of the Western countries. More specifically, as shown in Table 4, the 
characteristics of primary care psychological treatment services vary between Australia and the 
US, Canada, and the UK (24, 41-45). The weaker US primary care system raises the possibility 
that US studies utilising GP treatment-as-usual as a control condition may be related to larger 
treatment effects than the equivalent treatment in UK and Australian studies. In general, results 
of US studies may be less transferable to Australian settings than UK studies.  
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Table 4: The Characteristics of Primary Care Mental Health Care in Australia, 
the US, Canada and the UK  
Country Characteristics 
Australia Universal, tax-based insurance scheme. State/Commonwealth with separate health 
responsibilities. Patients insured for 85%-100% of GP fees. GP paid per consultation. Smaller 
primary care teams. Incentives for mental illness consultations via Better Outcomes/Better Access 
programs. 
Canada Primary care is free at point-of-contact. Psychologists are mainly private providers, except in 
hospital settings. Recent shift to promote multidisciplinary teams in primary care (Family Health 
Teams). These occasionally include salaried psychologists, but more often social workers/”mental 
health workers” offering counseling. Administration and delivery varies by province/territory. 
Recent establishment of the Mental Health Commission of Canada, with one task to create a 
national mental health strategy.  
UK Tax-based, national system. Funding held by primary care trusts. Patient registration. GP paid via 
patient list. Free at point-of-contact. GPs generally work in teams of 6-8, assisted by allied health 
workers and support staff. Mental health staff may work in (1) close association of Community 
Mental Health Team (CMHT) with single point of referral from primary care and integration of 
services; (2) out-patients model; (3) attachment of CMHT members to perform clinics in primary 
care; (4) consultation-liaison model 
US Lower ratio of GP/Primary Care Physicians to Specialists, more direct access to specialists, costs 
shared by consumers. Fee-for service and managed care schemes that govern medical care. In 
HMOs, doctors work in group practices that may have mental health workers attached. More 
generally, Primary Care Physicians work as individual providers independent of Community Mental 
Health Teams. Recently, opposing trends towards (1) Integrated settings with increased role for 
primary care physicians to manage mental illness and act as gatekeepers; (2) “Carve-out” 
organisations where non-physicians act as gatekeepers and primary care providers may be 
bypassed altogether. 
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2. GP AND ALLIED HEALTH PROVISION OF 
PSYCHOLOGICAL TREATMENTS 
2.1. INTRODUCTION 
GPs are clearly an important part of Australia’s mental health workforce, and the delivery of 
mental health care by GPs has several potential advantages. GPs are highly accessible to 
consumers; can provide continuous care, manage physical comorbidity and manage 
pharmacological treatments; and have the capacity to assess and manage complex 
presentations such as undifferentiated illness, somatisation and substance abuse (46).  
Psychological treatment by specialist allied health providers has potential advantages over GP-
provided services, including being more intensive and allowing provision of care without the 
time limitations and competing demands on providers such as GPs. Allied health providers also 
have greater specific skills and have access to existing systems of clinical supervision. Clearly, 
allied health providers of psychological treatment are not a homogenous group, with specialist 
workers including clinical psychologists, non-clinical psychologists, social workers, occupational 
therapists and Indigenous mental health workers. The training of each of these professions may 
vary substantially, and there may also be differences in their effectiveness for treating specific 
anxiety and depressive disorders. 
The distinction between GP and allied health-delivered psychological treatments has important 
implications for the mental health system and for health policy. Which patients should be 
receiving less intensive GP-based psychological interventions and which patients should be 
apportioned a share of limited specialist-delivered services? What evidence is there for 
generalist versus specialist provision of psychological treatments? Additionally, what can the 
research tell us about how services can best be delivered in settings with less access to 
specialist care such as rural, remote or Indigenous settings?  
2.2. PSYCHOLOGICAL TREATMENT PARADIGMS AND 
EVIDENCE-BASE 
Psychological interventions can be categorised descriptively along a continuum of complexity, 
from stress-management, through focused psychological strategies, to formal psychotherapies 
(47). Stress-management strategies aim to reduce arousal or anxiety in the present time, and 
include relaxation, meditation and imagery. Focused psychological strategies are specific 
therapeutic strategies that are aimed at discrete aspects of problems (47), and in the definition 
for Medicare-reimbursement, include psychoeducation, CBT, IPT, relaxation strategies, and 
skills training (including PST, anger-management, and social skills training) (14). They usually 
do not require extensive formal training, are well-suited to primary care settings, and are 
frequently used in combination with other therapeutic interventions as a package of treatment 
(47). In contrast, formal psychotherapies are complete therapeutic interventions rather than 
specific therapeutic components, and are usually offered in a set series of sessions according to 
a treatment plan. They require specific and complex training, are usually longer and more 
intensive, and their practitioners are regulated by relevant professional bodies (47). Examples 
of formal psychotherapies include CBT, IPT, psychodynamic and gestalt therapy. 
There is high standard scientific evidence from efficacy studies (i.e., from research trials) for 
CBT and IPT approaches in secondary care (5). In line with this, the description of the 
Medicare-reimbursed items for clinical psychological services (“psychological therapy services”) 
state that, “In addition to psycho-education, it is recommended that CBT be provided. However, 
other evidence-based therapies - such as IPT - may be used if considered clinically relevant.” 
(14). Theoretically, CBT suggests that maladaptive beliefs about the self, others and the future, 
lead to unhelpful interpretations about situations and contribute to the maintenance of 
disorders.  
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IPT focuses on the conflicts and transitions in the patient's relationships, in order to improve 
communication or readjust expectations, and aims to assist patients to build or better utilise 
their social support network, facilitating crisis management.  
Most research trials have taken place in specialised secondary care, with the corollary that the 
evidence for the efficacy of CBT and IPT treatments in primary care populations has not often 
been such a focus of research. Katon and colleagues (48) note four limitations of the 
generalisability of specialist mental health research to primary care populations, based on 
differences in populations attending these services. First, primary care patients are often seen 
at earlier stages of illness and have less severe illnesses, for which treatments may be less 
effective. Second, primary care patients often have comorbid physical illnesses that could 
interfere with or reduce response to treatments. Third, primary care interventions are often 
provided at a lower intensity than the same treatments in specialist care. Fourth, primary care 
patients may be more ambivalent about the need for treatment and less motivated to carry out 
treatments than patients in specialist secondary clinics. While raised as criticisms of 
pharmacological research, these issues are also relevant to psychological treatments. Similar 
comments were noted by Raine et al. (49) who conducted a meta-analysis of trials of 
psychological interventions for somatic conditions in primary and secondary care, finding that 
treatments were more effective in secondary care, perhaps due to there being a greater 
severity of disease, greater intensity of treatment and more closely supervised interventions in 
secondary care. They note: 
Pragmatic studies of the effectiveness of psychological interventions in primary care and on 
unselected patients are needed to provide a basis for decisions about health care provision. 
Studies should identify which elements of an intervention require specialist training and 
which require specialist intervention. They should also measure the effectiveness of 
interventions carried out by primary care staff after a realistic amount of training and with 
the aid of standard manuals for patients and practitioners (49 p. 10). 
These issues lead to this research review focussing specifically on psychological treatments 
within a primary care context or population. 
2.3. FINDINGS 
2.3.1. EFFECTIVENESS OF GP AND ALLIED HEALTH 
PROVISION OF PSYCHOLOGICAL TREATMENTS 
2.3.1.1. EFFECTIVENESS OF GP PROVISION OF PSYCHOLOGICAL 
TREATMENTS 
The most rigorous evaluation of randomised RCTs of GP-provided psychological treatment was 
a recent Cochrane review by Huibers and colleagues (50). They searched the Cochrane Library 
and database for randomised controlled trials, controlled clinical trials and controlled patient 
preference trials where psychological interventions of at least a two-session length were 
delivered by GPs. They reported only two high quality RCTs regarding GP provision of 
psychological treatment for depression, conducted by one research group (51, 52). From these 
trials they concluded that there is high level evidence that problem solving therapy (PST) 
conducted by GPs is effective in the treatment of depression and is no less effective than 
antidepressant medication, and limited evidence that it is more effective than placebo and no 
less effective than PST by a nurse-practitioner or combination therapy. However, they caution 
these findings due to the low number of participants in the studies, that a single research group 
was responsible for both trials, and that experienced research GPs took part in the study. In 
addition to these trials, we identified four other RCTs and two before-after studies through our 
review, and these articles are summarised in Table 5 (for detail, Appendix 4). Thus, eight 
studies were identified using GPs as therapists. These studies dealt with Major Depressive 
Disorder (51-53), depressive or anxiety symptoms (54, 55), social phobia (56) and Panic 
Disorder/Generalised Anxiety Disorder (GAD) (57).  
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The eight studies involved a total of 1094 participants, with a median age of approximately 38 
and a median of 77% female participants. Six of the trials were RCTs.  
Table 5: Summary of Evidence for the Effectiveness of GP Provision of 
Psychological Treatments 
Authors Design 
(Diagnosis) 
Organisation  Interventions Training (Manual) Location and 
Provider 
Primary Outcomes - 
Symptoms 
C. S. Scott 
et al. (53) 
Before-After 
(MDD) 
General 
Practice, 
England, UK 
Brief CBT  
(6 sessions) 
 
Visiting GP with extensive 
training. 
(standard booklet) 
In primary care. 
New GP for CBT; 
regular GP 
continued TAU.  
Post; Mean 54% fall on 
Depression. 6/7 patients 
no longer met criteria for 
depression.  
Mynors-
Wallace et 
al. (52) 
RCT 
(MDD) 
General 
Practice, 
England UK  
PST (6 sessions) 
Medication 
Placebo (PL) 
2 GPs, 1 psychiatrist. Reading, 
role plays, training video, 
supervised practice for 5 
patients. (Manualised) 
Treatment by 
new GP. Patient’s 
home or local 
health care 
centre.  
At 12 weeks on 
depression; PST<PL; 
PST=Med. No difference 
by provider. 
 
Mynors-
Wallace et 
al. (51); 
RCT  
(MDD) 
General 
Practice, 
England UK  
PST (6 sessions) 
PST (nurse; 6 
sessions) 
Medication 
PST(nurse)+ 
Medication(GP) 
3 GPs, 2 nurses. GPs received 
theoretical training and 
supervised practice for 5 
patients. Supervised by 
therapist. (Manualised) 
Treatment by 
new GP. Patient’s 
home or local 
health care 
centre.  
At 12 and 52 wks; All 
groups improved on 
depression.  
PST(GP)= PST(nurse) 
=PST +Med=Med 
Blomhoff et 
al. (56) 
RCT 
(Soc Ph) 
Primary Care 
Centres, 
Norway/ 
Sweden 
BT(8 sessions)+ 
Placebo 
Medication 
BT+Medication 
Placebo (PL) 
50 primary care physicians 
(incl. 2 psychiatrists); 30 hour 
training program that included 
exposure therapy, training 
video, written material, role 
playing. local group supervision 
(Manualised)  
Treatment by 
new GP.  
At 24 wks; all groups 
improved on Social Phobia 
Scale. On response -  
BT+Med=Med >PL. 
BT=PL; BT+Med=BT. 
From 24-52 wks; only 
BT+PL improved. 
Judd et al. 
(54) 
RCT 
(MDD) 
General 
Practice, 
Australia 
Medication 
Medication+IPT (6 
sessions). 
Trained with video and written 
materials (Patient and 
Treatment Manuals) 
Treatment by 
regular GP  
On depression, at wk 12; 
Med=Med+IPT 
King et al 
(55) 
RCT 
(Depression) 
General 
Practice, 
England UK 
 
CT 
TAU 
Four half-day workshops. 
(NA) 
Treatment by 
regular GP.  
On depression, at 6 mth, 
CT=TAU. 
van Boeijen 
et al (57) 
RCT 
(GAD/PD) 
General 
Practices, 
Netherlands  
Guideline Based 
treatment (GP; 
included CBT) 
Guided Self-help 
(GP; 5 sessions) 
CBT (therapist; 12 
sessions) 
GPs present at two educational 
meetings on diagnosis, 
management. Supervision 
every 2 months. Weekly 
supervision for therapists. 
(self-help and CBT manualised) 
Treatment by 
regular GP. 
All groups improved 
significantly on anxiety to 
follow-up. GP 
Guideline=GP Self-
help=CBT. 
Finucane 
and Mercer 
(58) 
SBA 
(Dep and 
Anx) 
Scotland, UK 
 
Mindfulness-based 
CBT 
One research GP with training 
(8 wk course, further training).  
(Manualised) 
New GP for 
mindfulness 
course. 
On depression; significant 
fall at 3 mths. 
Note: RCT=Randomised Controlled Trial; MDD=Major Depressive Disorder; Soc Ph=Social Phobia; GAD=Generalised Anxiety Disorder; PD=Panic 
Disorder; Dep=Depression; Anx=Anxiety; PL=Placebo; CBT=Cognitive Behavioural Therapy; BT=Behaviour Therapy; IPT=Interpersonal Therapy; 
TAU=GP Treatment-as-usual.  
C. Scott and colleagues (53) conducted a pilot study, using a before-after design for Major 
Depressive Disorder (MDD). They found that 6/7 patients treated no longer met criteria 
following six weeks of CBT. A further pilot study was conducted by Finucane and Mercer (58), 
examining the use of mindfulness-based group CBT for depressive and anxiety symptoms, with 
the patients reporting significantly lower symptoms following the trial. While promising, the 
small sample size and uncontrolled nature of these studies limits any conclusions that can be 
drawn. 
Mynors-Wallace and colleagues conducted two trials of PST for MDD that we judged to be at 
low-risk of bias. In these studies, they found evidence that six weeks of PST delivered by GPs 
was superior to placebo and equivalent to medication (52), and that GP-delivered PST was 
equivalent to nurse-delivered PST, medication and combined medication and nurse-delivered 
PST (51).  
Blomhoff and colleagues (56) conducted the largest trial in primary care, examining the effect 
of placebo or medication and GP-delivered behavioural therapy (BT) or treatment-as-usual in a 
cross-over design for Social Phobia in Scandinavia. 
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They found the medication groups were superior to placebo at 24 weeks, while the BT group 
did not differ from the placebo or medication groups. However, only the BT group improved 
from 24-52 weeks, suggesting a slower response to the non-medication treatments. 
The previous studies provide some support for the efficacy of GP-provided psychological 
treatments. In particular, the Mynors-Wallace studies provide good quality evidence for the 
efficacy of PST delivered by these providers (51, 52). However, one difficulty is that in the 
above studies, patients were generally not seeing their regular GP, but rather were assigned to 
a trained research GP, making the transferability to regular practice settings open to question. 
Three studies explicitly utilised the patients’ regular GPs in treatment (57).  
In the first of these studies, conducted in an Australian setting, Judd and colleagues examined 
whether medication plus six sessions of IPT (adapted for usability by GPs) was superior to 
medication alone for MDD. They found no differences at 12 weeks, although there were notable 
difficulties in recruitment of patients, leading to a small sample size and a risk of bias (31). King 
and colleagues (55) conducted a large trial in the UK, where patients with depressive symptoms 
were treated by their regular GP, half of whom had been trained in cognitive therapy in four 
half-day workshops. They found no differences on self-reported depression or anxiety 
symptoms at six months. Finally, van Boeijen et al. (57) found no difference for patients with 
Panic Disorder (69% of participants) and GAD (31%) undertaking 12 sessions of CBT with 
therapists in secondary care, compared to receiving either guided-bibliotherapy by GPs or 
guideline-based treatment by GPs (including CBT). However, the GP delivered guideline-based 
treatment, including CBT, was seen as unfeasible by participating GPs as they felt it was either 
too time consuming or they were incapable of delivering the treatment.  
In addition to published trials, we also explored relevant grey literature reports. An Australian 
RCT of GP-delivered CBT by the Primary Care Evidence Based Psychological Interventions (PEP) 
collaboration (59), including two of this report’s authors (GB, JG), has recently been submitted 
to Beyondblue’s Victorian Centre of Excellence, and updated unpublished results are presented 
in Table 6 (Final Report, 60). Of note, the training was 20 hours of CBT training based on the 
Better Outcomes criteria administered by the Royal Australian College of GPs’ General Practice 
Mental Health Standards Collaboration (61). 
Table 6: Summary of Unpublished RCT of GP Provision of CBT 
Summary and Key Findings 
GPs who undertook CBT training demonstrated an improvement in knowledge of CBT techniques 
GPs who undertook CBT training demonstrated increased confidence in providing CBT to treat depression 
GPs who undertook training in CBT demonstrated improvements in CBT skills as measured using standardised 
simulated patient consultations (Assessed by Young and Beck [62] scale of CBT skill) 
Patients in both the intervention (GPs trained in CBT) and control group (GPs not trained in CBT) showed 
clinical improvements at 3 months. However, there was no difference between intervention and control 
groups. 
Overall, there were high levels of satisfaction with their GP, although in most instances, the care seems to 
have been more of a supportive, empathetic nature rather than explicit provision of CBT. Additionally, 
interviews supported the idea that patients expect their GPs to work collaboratively with specialist mental 
health care providers. 
 
While studies are not supportive of the role of GPs in delivering more complex psychological 
strategies such those derived from CBT and IPT, a number of qualifications must be made with 
regard to the literature. First, there are few studies regarding the delivery of such strategies by 
GPs, and those that exist may be underpowered with respect to the ability to find differences. 
Second, the packages may include inadequate training interventions and clinical supervision to 
ensure adequate delivery of CBT or IPT. Third, the interventions generally do not account for 
the role of clustering within the randomisation of the trials. For this reason, we believe that it is 
premature to make clear-cut conclusions regarding the effectiveness of GP-delivered CBT or 
IPT. 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
20 
__________________________________________________________________________________________________ 
  
 
In summary, and as noted by Huibers et al. (50) there is support in the research for the use of 
GP-delivered problem-solving approaches to depression, although the GP in these trials (51, 52) 
was not the patient’s usual primary care provider. The evidence for the effectiveness of GP-
delivered CBT or IPT is inconclusive, with the limited evidence finding no advantage relative to 
usual treatment for depression or social phobia, but the evidence base was far from clear-cut. 
Promising results were provided in one study that found that guided self-help by GPs for two 
anxiety disorders (Panic Disorder, GAD) was as effective as CBT delivered in secondary care by 
trained therapists. These findings are shown in Box 1. 
Box 1 Summary of Key Findings Regarding GP-Provision of Psychological 
Treatments in Primary Care 
• Good evidence that GPs delivery of problem-solving therapy for depression is superior 
to usual treatment and equivalent to treatment by antidepressant medication. It is 
unclear the extent to which such results are relevant to real-world settings. 
• Limited evidence that GPs delivery of guided, manualised bibliotherapy for panic 
disorder is as effective as referral to secondary care therapist.  
• Inconclusive evidence for the effectiveness of CBT or IPT delivered by GPs. 
 
2.3.1.2. EFFECTIVENESS OF ALLIED HEALTH PROVISION OF 
PSYCHOLOGICAL TREATMENTS 
There is extensive evidence for the effectiveness of formal psychotherapies (particularly CBT 
and IPT) provided by well-trained clinical psychologists in secondary care (5, 63-65), and it is of 
interest whether similar results have been found for allied health delivered interventions in 
primary care populations. Around the world, a variety of “allied health” professionals with 
variable amounts of training have been incorporated in primary care, especially in the UK where 
link workers and counsellors are part of the workforce. In Australia, allied health workers such 
as social workers, occupational therapists and Indigenous health workers have been supported 
by a number of initiatives such as the Better Outcomes, Better Access and the Chronic Disease 
Management programs (25, 26). Allied health workers can fulfil a coordination or care manager 
role but in a number of programs are also funded to provide focussed psychological strategies. 
It is in this latter role of delivering psychological treatments in which we are most interested in 
this component of the review, with particular attention to the nature of the training of such 
allied health providers. While we also wished to report on RCTs involving occupational 
therapists and Indigenous health workers, the published literature was limited to trials involving 
social workers and psychologists. 
Therefore, in this section of the review, we report on those studies that involved psychological 
interventions provided to primary care patients, and the evidence of effectiveness regarding 
providers of care. Since such patients have necessarily been recruited from primary care, these 
studies often involve some form of multiprofessional care, for example GPs monitoring and 
reviewing patients or pharmacological treatments. Therefore, we also summarise collaborative 
elements of interventions where they are reported. 
Thirty-two studies were identified that focussed on the treatment of psychological disorders in 
primary care by psychologists and social workers. A summary of the papers is presented in 
Table 7, and full details are available in the appendices (see Text, Table 16, Table 17 in 
Appendix 5). Where details were not provided in primary reports, available supplementary 
reports were also consulted, and we also attempted to contact study authors by email for 
details. 
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Table 7: Summary of Study Properties for Allied Health Provision of 
Psychological Treatments 
 
Note: MDD=Major Depressive Disorder; RCT=Randomised Controlled Trial; CBT=Cognitive Behavioural Therapy; BT=Behavioural Therapy; 
IPT=Interpersonal Therapy; PST=Problem Solving Therapy. 
The 32 studies involved a total of 4893 subjects. Three studies had elderly populations, one 
adolescent, and the remainder adult. Most studies excluded participants with psychosis, bipolar 
disorder and organic brain syndromes after systematic screening (23/32). The median 
percentage of female participants in the studies was approximately 71%, and only six studies 
explicitly reported greater than 25% ethnic minority participants (19 studies not available). The 
majority of studies were from the UK (15/32) and US (12/32).  
The majority of studies examining treatment in primary care examined individuals with 
depressive disorders comprising major depressive disorder [MDD] (66-76), dysthymia (76-80), 
and depressive or minor anxiety symptoms (81-84). The remainder of studies examined Panic 
Disorder (57, 85-89), Generalised Anxiety Disorder (90-93) or unspecified psychological 
difficulties (94-96); no articles were identified that examined interventions for the other anxiety 
disorders such as Obsessive-Compulsive Disorder, Post-Traumatic Stress Disorder, and Social 
Phobia.  
As the majority of studies reported differences on continuous measures of effectiveness 
(22/32), or on both continuous measures and dichotomous rules of recovery and response 
(8/32), we largely examined outcomes used continuous measures. Twenty-five studies reported 
post-study outcomes compared to wait-list, treatment-as-usual (TAU) or placebo comparators 
(non-systematic comparators), with 11 reporting superior outcomes for therapy conditions, and 
15 equivalent, with none reporting worse outcomes. Ten studies compared psychotherapy to 
medication only, with largely equivalent results (1/10 superior, 8/10 equivalent, 1/10 worse).  
 
 Count
Provider Psychologist Only 20 
 Social Worker Only 4 
 Psychologist/Social Worker 1 
 Mixed (incl. other workers) 5 
 Not Stated 2 
Location UK 15 
 US 12 
 Netherlands 4 
 Canada 1 
Major Diagnosis MDD 11 
 Dysthymia 4 
Depressive/Anxiety Symptoms 4 
 Generalised Anxiety Disorder 4 
 Panic Disorder 6 
 Other Psychological Problems 3 
Patient Population <25% Ethnic Minority 7 
 >25% Ethnic Minority 6 
 NA 19 
Female Proportion <75% Female 18 
 >75% Female 12 
 Not Reported 2 
Primary Age Range Adolescent 1 
 Adult 28 
 Elderly 3 
Psychiatric comorbidity Not Excluded Systematically 9 
 Bipolar, psychosis, SubstanceAbuse Excluded 23 
Count 
Year Published <1990 7 
1990-1994 4 
1995-1999 4 
2000-2004 8 
2005-2007 9 
Design RCT 29 
Non-RCT 3 
Number in Trial 21-50 8 
51-100 7 
101-200 10 
201+ 7 
Patient Recruitment Systematic Screening 8 
Database 1 
Clinician Referral 19 
Mixed 4 
Psychological Approach CBT/BT 25 
IPT 3 
PST 4 
Group Format Yes 5 
No 27 
Length of Therapy <=6 10 
(sessions) 7-12 15 
13-18 3 
19+ 3 
Not limited 1 
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For those studies reporting follow-up assessments, the median length of follow-up was 12 
months. At follow-up, compared to wait-list, TAU or placebo, 6/13 studies reported better, and 
7/13 studies equivalent outcomes for psychotherapy. Only two studies with medication 
comparators reported 12-month depressive symptoms, with one of these reporting equivalence, 
and one reporting medication superiority.  
Considering the findings overall, there is encouraging but not unequivocal evidence for the 
usefulness of psychological therapies when delivered in primary care, with the studies 
suggesting that psychotherapy is effective for these disorders and no worse than medication 
when provided in the same trial. Below, we will further tease out the findings with respect to 
the providers of therapy, length and modality of therapy, and consideration with regard to 
efficacy for different disorders. 
When considering the anxiety disorders, studies were identified dealing with Panic Disorder and 
GAD. For patients with Panic Disorder, advantages were found for CBT compared to waitlist 
(85, 88), psychologist-guided bibliotherapy (87), non-CBT therapy (89), but CBT was equivalent 
to GP-delivered bibliotherapy (57). At follow-up, one study found lower levels of additional 
treatment had been sought by the CBT group at six months (85), suggesting superior 
outcomes, and one study found improvements in anxiety symptoms at 8.5 months but not two 
years (89, 97). Patients with GAD benefited at post-treatment from short-term CBT of four-to-
eight sessions (90-93). Follow-up information is limited, with Power and colleagues finding CBT 
patients sought less additional treatment in the next six (92) to twelve months (91), and Price 
and colleagues (93) finding greater recovery at six months for CBT in a non-RCT design.  
Of note, Durham and colleagues (98) followed-up patients from Power and colleagues’ 1990 
trial of CBT for GAD after 11-14 years (92, 99), interviewing 33 of the 93 patients who could be 
traced. They found no significant differences between the groups, although the amalgamated 
CBT group and not the non-CBT group had a significant fall on blinded ratings of anxiety 
symptoms compared to pre-treatment scores. Recovery did not differ between the two 
conditions, with 69% of patients having no DSM-IV diagnosis at follow-up. While the low follow-
up rates limit conclusions, affecting both the power to identify differences between groups and 
the potential for bias due to systematic drop-outs from the study, the results tend to point 
towards a small advantage for CBT, which is of interest given that the trial involved only seven 
sessions of treatment and follow-up was conducted over a decade later, with most participants 
(70%) not seeking additional treatment within this time. 
Regarding MDD, positive results were found for many studies in the short-term comparing CBT 
to TAU, placebo or Waitlist (66-68, 70-72), but not always (69, 73-75). There were only a 
limited number of studies reporting follow-up outcomes, with some studies finding superiority 
(70, 71, 75), and some equivalence (72-74). Fewer studies investigated dysthymia, with little 
evidence of superior outcome to placebo, TAU or waitlist. These results suggest that while there 
is evidence for the effectiveness of psychological treatment for major depression, regarding 
dysthymia the evidence is far sparser, with large trials failing to find superiority.  
When considering the make-up of the allied health workforce, most studies represented in this 
review utilised psychologists alone, with a minority of studies employing social workers alone, or 
a mixture of staff. Following the inclusion criteria, psychiatrist and nurse providers acting alone 
were not represented. Given the lack of studies, it is difficult to determine the efficacy of social 
workers when providing CBT. One study provided encouraging results for group but not 
individual treatment (68), a non-RCT showed evidence of improved outcome for combined 
medication and group CBT for PD (86), and one study found no difference between generic 
social worker counselling and psychologist-provided cognitive therapy (69). While two other 
studies failed to show an effect for social worker-provided treatment, one used brief PST (81) 
and the other a specific minority prenatal population (82), making it difficult to generalise from 
the studies. The lack of evidence suggests that further studies utilising providers such as social 
workers, general mental health workers, and counsellors is required.  
A further question is “how much therapy is needed”, particularly in real-world primary care 
contexts where therapy tends to be shorter or less intense than equivalent secondary settings 
(49).  
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The studies reviewed differed greatly in the intensity of sessions, from as little as four-to-six 
sessions of psychological treatment (71, 73, 79, 81, 83, 84, 90, 91, 93, 100), to those with over 
18 sessions (66, 67, 70). Generally, studies using low numbers of sessions tended to be more 
recent, perhaps reflecting the wider move towards cost-considerations in health care (44). In 
particular, the four studies utilising PST tended towards a low session length, commensurate 
with the intent of the therapy to be a simple, time-limited approach, while the CBT and IPT 
approaches tended to be longer. Power and colleagues directly examined the question of 
intensity of therapy for Panic Disorder, finding superiority at follow-up for CBT relative to 
minimal CBT and bibliotherapy. Furthermore, other studies suggest that the effect of 
psychotherapy may be slower than medication (70, 85). In a study of older adults, case 
management was shown to improve outcomes relative to CBT alone for depression/dysthymia 
(76). These studies suggest that longer-term assistance may be an important element in 
treatment, as suggested by the design of system level3 interventions (18, 101). It should be 
noted that van Boeijen (57) did not find CBT to be superior to guided self-help by GPs. It may 
that GPs are particularly credible therapists for panic disorder, due to the health-related 
concerns of many patients. 
Consideration also needs to be given to the generalisability of studies to settings with large 
numbers of minority patients, given the multicultural nature of Australia and considering the 
need to determine the applicability of findings to our Indigenous cultures. Likely reflecting the 
demographic make-up of the different countries, most studies with more than 25% ethnic 
participants were conducted in the US rather than the UK. The distribution of ethnic minorities 
across the studies seemed fairly independent of the success of CBT and target disorder. While 
the findings of such research are limited, there is cause for hope that treatments will transfer to 
ethnic minority populations. Indeed, one prominent collaborative study has directly addressed 
this issue, transferring an intervention effectively to a non-white population in Chile (102). It 
would be naïve to ignore that close attention must be paid to cultural considerations, such as 
matching as closely as possible the background of therapist and client (86), when transferring 
therapeutic approaches to minority cultures in Australia. 
Box 2 Summary of Key Findings Regarding Allied Health-Provision of 
Psychological Treatments in Primary Care 
• Good Evidence that psychotherapy delivered by psychologists has similar treatment 
effects to medication for Depression. Limited evidence for Panic Disorder and 
Generalised Anxiety Disorder  
• Good Evidence that psychotherapy delivered by psychologists is superior to usual 
treatment or Placebo for Major Depressive Disorder, and Panic Disorder, but not for 
Dysthymia. Limited evidence for Generalised Anxiety Disorder. 
• Limited evidence that psychological treatments can be effectively delivered to minority 
or non-Caucasian populations. 
• Limited evidence that social workers can effectively deliver psychological therapies for 
depression and anxiety.  
• No studies identified regarding effectiveness of psychotherapy by other workers (OTs, 
Indigenous health workers). 
                                               
 
 
3 Systems-level interventions refer to those where systems of care are altered, such as occurs in collaborative interventions which alter 
providers of care, communication between providers, plans for provision of care, and so forth. 
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Table 8: Summary of Evidence for the Effectiveness of Allied Health 
Provision of Psychological Treatments 
Authors Design 
(Diagnosis) 
Organisation  Interventions Location and Collaborative 
Elements 
Primary Outcomes - Symptoms 
Blackburn 
et al. (66) 
RCT 
(MDD) 
General Practice, 
Scotland, UK  
CT (23 sessions) 
CT+Medication. 
Med 
Location unclear. Medication 
in consultation with 
Psychiatrists 
At post; on depression 
(CT+Med=CT)<Med. 
Earll and 
Kincey (94) 
RCT 
(None) 
General practice, 
England, UK.  
BT (not limited) 
TAU 
Wthin practice. Reports and 
verbal feedback to GP 
At 7 mths from referral; proportion not 
“personally ill”; BT 45% TAU 50%.  
Robson et 
al (95) 
RCT 
(None) 
General Practice, 
England, UK.  
BT+TAU (10 weeks) 
TAU 
Working within health centre.  BT<TAU on severity to 32 wks from 
referral; at 12 mths BT=TAU. 
Teasdale et 
al. (67) 
RCT 
(MDD) 
General Practice, 
England UK.  
CT (20 sessions) 
TAU 
Location not stated. GPs 
prescribed medication  
Post treatment, CT<TAU on depression; 
3 mths follow-up no difference. 
Trepka et 
al. (96) 
CCT 
(None) 
Health Centre, 
Scotland UK  
Group CT (11-13 
sessions) 
Individual Counselling  
Location not stated.  Individual<Group CT at post on anxiety; 
At 1 yr Group CT reductions ns; 
individual counselling remained sig. 
Lindsay et 
al. (90) 
RCT 
(GAD) 
GPs, Scotland UK  CBT group (8 sessions) 
Anxiety Management 
Group (8 sessions) 
Medication  
Wait-list 
Location not stated.  At post; fall on Anxiety for CBT and AMT 
but not Medication and WL; 
CBT=AMT=Med<WL on anxiety post-
treatment. At follow-up no changes on 
anxiety for CBT and AMT (Medication 
and WL not assessed) 
Power et al 
(91) 
RCT 
(GAD) 
GP setting, 
Scotland UK  
CBT (4 sessions)  
Medication  
Placebo 
Treatment in primary care.  Anxiety decreased in all groups. At post-
treatment CBT<PL. CBT=Med; Med=PL. 
Power et al 
(1990) 
Durham et 
al (103) 
RCT 
(GAD) 
GP setting, 
Scotland UK 
 
CBT (7 sessions) 
Medication  
CBT+ Medication 
CBT+Placebo 
Placebo 
Treatment provided in 
primary care.  
On anxiety;  
(CBT+Medication=CBT=CBT+PL)<PL 
Med=PL; Med+CBT<Med 
CBT, PL+CBT=Med 
M. Scott 
and 
Stradling 
(68) 
RCT 
(MDD) 
Health Centre, 
Liverpool UK.  
CBT (12 sessions)  
Group CBT (12 
sessions) 
TAU 
Treatment at health centre. 
Assessments available to GPs. 
GPs managed medication.  
On depression, Group CBT=CBT; Group 
CBT<WL. 
A. Scott 
and 
Freeman 
(69) 
RCT 
(MDD) 
General Practices 
Scotland, UK 
CT (to 16 sessions) 
SW Counselling 
Psychiatrist Medication 
GP TAU. 
Treatment in primary care.  At wk 16 on depression Social 
Work<TAU (but initial differences). 
Recovery- Social Work superior to TAU.  
Miranda 
and Munoz 
(77) 
RCT 
(Minor Dep) 
Primary care, US.  Group CBT (8 
sessions) 
No-intervention/ brief 
information control 
Location not stated. No 
collaboration stated. 
 
For those with minor depression; 
greater reduction in depression at 6 
mth/1 yr for CBT vs control group. No 
differences for non-minor depression. 
Schulberg 
et al (70). 
Coulehan et 
al. (104) 
RCT 
(MDD) 
Ambulatory health 
centres, US 
IPT (20 sessions) 
Medication 
(psychiatrist) 
GP TAU  
All treatments in usual 
primary care setting. Usual 
GP care. Non-responder after 
8-10 weeks, referred to GP. 
Med<TAU on depression at all 
assessment points; IPT<TAU at 8 
months; Med=IPT at all points.  
 
Sharp et al. 
(85) 
(105) 
RCT 
(PD) 
General practice, 
Scotland, UK.  
CBT (12 sessions) 
Medication 
Placebo 
Placebo+CBT 
Medication+CBT 
Treatment in usual primary 
care setting. Access to GP.  
On anxiety, at all time points to 12 wks, 
CBT=Med =PL+CBT=Med+CBT. From 
wk 4, FL+CBT<PL. At wk 6-12, all 
treatment groups<PL.  
 
C. Scott et 
al (71) 
RCT 
(MDD) 
General Practice, 
England UK  
CBT (6 sessions) 
TAU 
Location not specified. All 
patients managed by GPs.  
On depression, no differences post. 
CBT<TAU at 58 wks. Greater recovery in 
CBT than TAU at post. 
Mitchell 
(86) 
Before-After 
(PD) 
Self-referred to 
large HMO, US 
Medication +Group 
CBT (8 sessions) 
Medication 
Group at HMO. Medication by 
psychiatrist. 
On anxiety, Group CBT+medication 
superior to Medication only. 
Power et al. 
(87) 
RCT 
(PD) 
General Practice, 
Scotland UK  
CBT (8 sessions)  
Minimal CBT (6 
sessions) 
Guided bibliotherapy 
Treatments in primary care. 
Patients required to take 
medication as prescribed. 
On anxiety; at wk 7 and 12 
CBT<minimal CBT=bibliotherapy.  
At 6 mths, CBT superior to (minimal 
CBT=bibliotherapy) on recovery.  
Price et al. 
(93) 
Non-RCT; 
case-control 
trial 
(GAD, 
anxiety 
secondary 
to MDD) 
Family practice in 
HMO; US.  
Matched sample 
from internal 
medicine patients  
Integrated care 
including CBT (4-6 
sessions) 
TAU (internal medicine 
patients) 
Treatment at HMO. Patient, 
psychologist and primary care 
provider formulated 
treatment. Regular 
communication between PCP 
and psychologist. Liaison 
psychiatrist on call. 
Anxiety at 3 mth CBT=TAU; 6 mth 
CBT<TAU. At 6 mth; recovery higher in 
CBT than TAU.  
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Authors Design 
(Diagnosis) 
Organisation  Interventions Location and Collaborative 
Elements 
Primary Outcomes - Symptoms 
Ward et al. 
(72)  
RCT (3 way 
randomised 
data)  
(MDD) 
General Practices, 
England, UK 
CBT (6-12 sessions) 
Counselling (6-12 
sessions) 
TAU 
Treatment in primary care. 
Patient free to see GP, but 
refrain from medication in 
CBT/Counselling groups.  
On depression; at 4mth 
CBT=counsel<TAU; at 12 mth 
CBT=counsel=TAU. 
Williams et 
al. (78)  
RCT 
(Dysthymia/ 
Minor 
depression) 
Primary care 
practices, US  
PST (6 sessions) 
Medication  
Placebo 
Treatment in primary care 
setting. No medication for 
PST group. 
On depression; 11 wks, Med<PL; 
Med=PST; PST=PL.  
Greater symptom improvement in wks 
2-11 in PST compared to PL. 
Barrett et 
al. (79) 
RCT 
(Dysthymia/ 
Minor 
depression) 
Primary care 
practices, US 
PST (6 sessions) 
Medication  
Placebo 
Treatment in primary care. 
No medication for PST group. 
On depression; 11 wks, PST=Med=PL.  
For completers, remission higher in 
dysthymia for PST and Med than PL. For 
minor depression, no difference 
Browne et 
al. (80) 
RCT 
(Dysthymia) 
 
Primary care Health 
Services 
Organisation, 
Canada.  
IPT (12 sessions) 
Medication  
IPT+ Medication 
Treatment in HMO. No other 
med. 
On depression, at 6 mth and 2 yrs 
Med=Medication+IPT<IPT.  
Greater responding at 6 mth in Med, 
Med+IPT than IPT only. 
Lang (83) RCT 
(Anxiety 
and 
Depression) 
Veterans primary 
care clinic, US  
CBT (4 sessions) 
Wait-list 
Treatment at psychologist 
offices. 
At post, significant reduction on anxiety 
and depression for treatment but not 
Waitlist. Significant increase in anxiety 1 
month following treatment. 
Sharp et al. 
(88) 
RCT 
(PD) 
General Practices, 
Scotland, UK 
 
CBT (8 sessions) 
Group CBT (8 
sessions) 
Waiting list (12 wks) 
Seen in general practice 
setting. Patients allowed to 
continue taking medications. 
At 12 wks, on anxiety, Group 
CBT<Waitlist, CBT<Waitlist.  
At 3 mth follow-up, group CBT poorer 
than CBT on responding. 
Arean et al. 
(76)  
RCT 
(MDD/ 
dysthymia) 
Primary Care 
provider and self-
referral. US.  
Group CBT (18 
sessions). 
Case Management 
(CM) 
Group CBT+CM 
Therapists at hospital site and 
conducted groups there.  
On depression. At 6 mths, no 
differences. At 12 mth, Group 
CBT+CM<Group CBT. CM=Group 
CBT+CM, CM=Group CBT.  
Clarke et al 
(73) 
RCT 
(MDD) 
Pediatric HMO, US.  TAU+CBT(Ave 5.3 
sessions) 
TAU (inc. Medication) 
On-site therapist. GP 
monitored medication. 
Therapist/GP consultation. 
To 52 wks, depression, no differences 
between conditions by time. 
van Boeijen 
et al (57) 
RCT 
(GAD/PD) 
General Practices, 
Netherlands  
Guideline Based (GP; 
inc. CBT) 
Guided Self-help (GP; 
5 sessions) 
CBT (therapist; 12 
sessions) 
Treatment at alternative 
location. Medication allowed. 
All groups improved significantly on 
anxiety to follow-up. No differences by 
condition. 
Addis et al. 
(97); 
RCT 
(PD) 
HMO, US.  CBT (12-15 sessions,) 
Non-CBT therapy 
Therapists HMO workers at 
independent clinical agency. 
GP monitored medication. 
On panic symptoms; At 5.5 mths, 
CBT=TAU. At 8.5 mths, CBT<TAU. 
At 2 yrs, CBT=TAU.  
Brouwers et 
al. (81) 
RCT 
(GAD, mild 
dep, other). 
Netherlands. PST (5 sessions) 
TAU 
Treatment at primary care 
clinic where SW work. 
Medication allowed by GP. 
On anxiety; both groups reached normal 
levels in 3-6 months; no differences in 
improvement at 3, 6 or 18 mths. 
Lang et al 
(84) 
RCT 
(Anx and 
Dep) 
Primary care clinics, 
California, US 
Modified PST(4 
sessions) 
TAU 
Location not specified. Not 
restricted in medication use  
Greater decrease in anxiety and 
depression for PST group compared to 
TAU. Some decay of effect to 6 mth. 
McKee et 
al. (82) 
RCT 
(depressive 
symptoms) 
Community health 
centres, US. 
CBT (8 sessions) + 
education+ social 
support. 
TAU 
Treatment at home or health 
centre.  
At 3-mths, on depression CBT=TAU. 
van Schaik 
et al. (74) 
RCT 
(MDD) 
Amsterdam, 
Netherlands  
IPT (10 sessions) 
TAU 
Intervention in general 
practice. GP informed of 
diagnosis and asked not to 
prescribe antidepressants. 
At 2 and 6 mths, depression IPT=TAU.  
No differences in remission at 2 and 6 
mth. 
Conradi et 
al. (75) 
RCT 
(MDD) 
General Practice, 
Netherlands  
Education program (3 
sessions) 
Education+ 
psychiatrist consult 
Eucation+ brief CBT 
(12 sessions) 
TAU by GP 
Treatments in primary care, 
included GP TAU. Feedback 
from program to GP, 
including care plan. GPs given 
2 hour session regarding 
depression management. 
At 6 mth, all groups same on recovery 
from depression; At 36-mth on 
depression, Psychiatrist+education and 
CBT+education< TAU=Education. 
 
Note: RCT=Randomised Controlled Trial; CCT=Case Control Trial; MDD=Major Depressive Disorder; GAD=Generalised Anxiety Disorder; 
Dep=Depression; CT=Cognitive Therapy; BT=Behavioural Therapy; CBT=Cognitive Behavioural Therapy; PST=Problem Solving Therapy; 
TAU=Treatment as usual; SW=Social Worker; inc=including; Med=Medication; AMT=Anxiety Management Training; WL=Waitlist; PL=Placebo; 
CM=Case Management; mth=month; yr=year. 
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2.3.2. COST-EFFECTIVENESS OF GP AND ALLIED HEALTH 
PROVISION OF PSYCHOLOGICAL TREATMENTS 
The majority of the economic evaluation papers meeting the inclusion criteria for review4 were 
focused on the assessment of the cost-effectiveness of allied health provision of psychological 
treatment (summarised in Table 9, for detail see Appendix 8, Table 22). Thirteen studies clearly 
evaluated the cost-effectiveness of CBT delivered by a psychologist within a primary care 
setting. Of these thirteen, four utilised a two-group design (i.e., CBT versus usual GP care) and 
the remainder included a third pharmacotherapy arm. One study also evaluated CBT but did not 
specify who delivered the intervention (106). A further three studies evaluated self-help CBT, 
either using computerised administration (107, 108) or bibliotherapy (109). One study 
evaluated a mixed CBT/counselling intervention (80), another evaluated IPT delivered by a 
psychologist or psychiatrist (110) and a third (111) evaluated two quality improvement 
strategies for medication and psychological therapy. The majority of the studies focused on 
either depression alone (six studies) or depression and anxiety (8); the remaining three only 
included subjects with anxiety (two of these were modelled studies). No economic evaluations 
were identified regarding psychological treatment provided by GPs.  
The majority of studies adopted a health sector perspective whereby only costs accruing to the 
health sector are included in the analysis. While this is common practice in many health 
economic evaluations, caution must be exercised in the interpretation of such results, as limited 
costing perspectives may sometimes miss important costs that accrue within other sectors 
(such as welfare). This could lead to incorrect recommendations about the true cost-
effectiveness of interventions. However, a broad health sector perspective (including both 
government and non-government financed health services) is usually sufficient to pick up 
important resource use and rarely misses important costing categories. Though a few primary 
studies did adopt wider costing perspectives (usually with the addition of productivity and travel 
costs5), the conclusions of these studies did not differ widely from those with more limited 
costing perspectives. The majority of studies adopted a cost-effectiveness framework whereby 
costs were expressed in monetary terms and outcomes were expressed in physical units (such 
as reductions in the Beck Depression Inventory). In contrast, cost utility studies measured 
outcomes using a generic outcome metric such as a quality-adjusted life-year (QALY) or a 
disability-adjusted life-year (DALY). The defining feature of these metrics is that they can be 
used across disease categories (whereas disease specific measures are only meaningful within a 
single disease context) and more importantly the outcomes across diseases can be compared. 
For example, the cost-effectiveness of depression interventions may be compared to the cost-
effectiveness of interventions for heart disease. Such studies are certainly preferable from an 
economic viewpoint, as decisions regarding resource use within the health sector as a whole 
need to be made, leading inevitably to comparisons across diseases. Cost-utility studies help to 
make this process explicit rather than implicit (see next paragraph for discussion of the results 
of such studies). Of the total studies included in this section of the review, 13 also included a 
cost-utility analysis (whereby outcomes where measured in either DALYs or QALYs).  
                                               
 
 
4 The inclusion criteria were the same as for the effectiveness research question except that the papers also had to undertake a full 
economic evaluation whereby the costs and consequences of at least two alternatives (in terms of treatment – usually an intervention 
and a comparator condition) were considered. Due to lower direct research evidence, modeling studies not directly targeting primary 
care, and studies using alternative forms of psychological administration (i.e., computerised) were also considered. 
5 Productivity costs (sometimes referred to as indirect costs) refer to lost work-time due to either having to attend health 
appointments or time off due to the intervention (which might be permanent if the person has had to give up work, or temporary if 
shorter absences from work were required due to ill-health). The inclusion of such costs is controversial due largely to equity reasons 
and methodological uncertainty, and are therefore not included in many health economic evaluations (see Drummond et al., 2005; for 
further information).  
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Focusing on the thirteen studies clearly evaluating CBT, the majority (8) of the studies received 
an excellent rating of quality, with only two poor quality studies noted.  
The best studies involved the use of more than one intervention group (usually CBT versus 
pharmacotherapy versus usual GP care) and are largely characterised by a series of Australian 
modelled cost-utility studies (59, 112-116). The studies show that CBT delivered by 
psychologists is a cost-effective intervention within the Australian context. These six studies all 
use a modeled design drawing on international evidence of effectiveness, in order to assess the 
cost-effectiveness of different strategies to treat depression and anxiety using cost-utility. The 
setting was not necessarily primary care, as all simply modeled evidence-based care (largely a 
mental health specialist delivering CBT, a psychiatrist delivering pharmacotherapy or some form 
of self-help or bibliotherapy). The inclusion of a GP was apparent in all studies, usually in terms 
of initial referral. All studies found the interventions to be cost-effective from an Australian 
perspective (all fell below the shadow-price cut-off of $50,000 per DALY averted). However, it 
should be noted that these studies only considered costs from a health sector perspective and 
important costs which may fall outside this perspective were not included (such as costs 
accruing to the welfare sector or the general economy). All these publications can be traced 
back to two major studies, one led by Associate Professor Theo Vos, called the ACE (Assessing 
Cost-Effectiveness) in mental health study which aimed to assess the cost-effectiveness of a 
number of different treatment options compared to usual care within an Australian setting. The 
other study was headed by Professor Gavin Andrews, and aimed to assess current Australian 
practice and evidence-based practice compared to a “do nothing” or null scenario.  
In contrast only one of the four studies using a two-group design (which were of an overall 
lower quality rating) found that CBT delivered by a psychologist was cost effective (the 3 other 
studies found no differences observed in costs or outcomes). The two studies evaluating 
computer delivery of CBT were both of excellent quality and found the intervention to be cost-
effective. The McCrone et al. (2004) study is notable in its breadth of service coverage, though 
the methodology used to measure Quality Adjusted Life-Years (QALYs) was crude (108). 
However, this particular study included both cost-effectiveness and cost-utility methods6 
allowing different types of outcomes to be considered in the incremental cost-effectiveness 
ratios, hence providing policy advisors with a broad range of economic information. 
The majority of primary studies (defined as trial type designs) were set in the UK, and therefore 
have some transferability to the Australian setting in terms of having a GP as the primary 
gateway to the mental health system and a large publicly-financed health sector. However, in 
these studies subjects generally did not pay for psychological treatment as an out-of-pocket 
expense, with such costs accruing to the government or the UK National Health Service.  
Finally, there appears to be relatively good economic evidence suggesting that psychological 
therapies delivered by allied health professionals represent good value for money. However, 
even though there are some Australian studies supporting this conclusion, all such studies are 
modelled utilising largely international evidence of effectiveness. There is a need for more 
Australian based primary studies to verify this conclusion.  
                                               
 
 
6 The key difference between these two types of economic evaluations is the way in which outcomes are expressed. Cost-effectiveness 
studies report outcomes in physical units meaningful to the intervention or disease being considered (such as reductions in depression 
scores on the BDI or HDRS) in contrast cost-utility studies express outcomes in generic health outcome indices (usually preference 
weighted) such as DALYs or QALYs. Cost-benefit studies are a third type of economic evaluation technique whose distinguishing 
feature is the monetarisation of health outcomes (usually expressed in a willingness to pay format).  
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Box 3. Summary of Key Findings Regarding Cost-Effectiveness of Provision 
of Psychological Treatments in Primary Care 
• No studies identified regarding the cost-effectiveness of GP-delivered psychological 
treatments. 
• Good evidence that psychologist-delivered therapies represent good value-for-money, 
but all Australian studies utilised modelling methodology. 
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Table 9: Summary of Evidence for the Cost-Effectiveness of Allied Health 
Provision of Psychological Treatments  
Study 
Disorder 
(patient 
description) 
Intervention Comparator Study Type and setting 
Costs and 
Outcomes Results Q
1 
Antonuccio, 
Thomas et al., 
1997 (106) 
 
Unipolar 
depression 
(using several 
studies) 
CBT (15 sessions with 
unspecified 
professional + 5 
booster sessions) and 
group CBT  
Medication 
(Prozac) 
Modeled 
No particular 
setting - stated 
aim is to do 
with managed 
care in US.  
Direct health sectors 
costs, productivity 
costs and other 
effects such as 
multiplier effect due 
to Outcomes not 
modeled (but come 
in via probability of 
success) 
CBT cheaper than 
drugs (+33%) and 
combination (+23%) 
3 
Bower, Byford 
et al., 2000 
(117) 
 
Depression 
(with and 
without anxiety 
as a co-
morbidity) 
CBT and non-directive 
counseling by 
therapists (up to 12 
sessions) 
Usual GP care Prospective 
randomised 
trial 
UK study - 
relatively 
transferable to 
Australia 
Costs: Health care 
services and non-
treatment costs 
(e.g. travel and 
childcare. Lost 
production  
Outcomes: BDI and 
EQ 5D 
No differences in 
outcomes between 2 
interventions (at 4 
months diffs 
compared to Usual 
care observed but 
disappears by 12 
months) No cost diffs 
observed.  
8 
Browne, 
Steiner et al., 
2002 (80) 
 
Dysthymia 
disorder (DSM-
IV)  
Setraline alone or 
interpersonal therapy 
(by ‘counsellors’) (time 
limited therapy of 12 
sessions alone or 
combination  
All three 
treatments 
were compared 
to each other – 
No control 
group 
Single blind 
RCT 6 month & 
2 year f’up 
 
Canada 
specifically in 
primary care 
setting. 
Costs: Health sector 
costs and 
production effects 
including welfare 
payments.  
Outcomes: 
Montgomery Asberg 
Primary measure: 
Depression Rating 
Scale. Secondary 
measures Social 
Adjustment Scale, 
McMaster Family 
Assessment device, 
CES-D and VAS to 
also measure 
depression 
All treatments 
effective and setraline 
also cheaper than 
others  
8 
Chisholm, 
Sanderson et. 
al., 2004 (118) 
 
Depression 
(not 
differentiated 
by co-
morbidities .)  
Broad range of 
pharmaceutical and 
psychotherapeutic 
interventions 
The null 
(natural course 
of depression). 
Plus 
incremental 
analysis of the 
different 
Treatment 
options 
Modeled using 
WHO-Choice 
Generalised 
Cost-
Effectiveness 
Analysis 
 
Costs: Health sector 
Outcomes: :DALYs 
modeled from 
published studies 
using popmed 
(Markov model)  
All treatment 
strategies appear 
cost-effective – 
particularly Proactive 
collaborative care 
strategies  
10 
Gould, Otto et 
al., 1995 (119)  
Panic Disorder CBT (psychologist) + 
drug Treatment 
Compared to 
each other 
Meta-analysis 
USA 
Costs- psychology 
consults 
Outcomes-effect 
size  
CBT as effective than 
drugs and group CBT 
was cheaper 
1 
Haby, Tonge 
et al., 2004 
(112) 
 
Major 
depression in 
children and 
adolescents 
(using DSM-IV 
criteria)  
CBT (defined as 12 
sessions) by different 
types of professionals 
and 
SSRIs 
Current 
Australian 
practice 
(people not 
receiving 
effective 
treatments 
Modeled using 
best available 
evidence 
Australia – GP 
referral to 
others 
Costs: Health sector  
Outcomes: DALY 
(modeled from 
existing literature 
and the NSMHWB) 
CBT by a publicly 
financed psychologist 
most cost-effective – 
SSRIs and other 
therapists providing 
CBT (public and 
private psychiatrists 
as well as private 
psychologists) all fall 
below the threshold of 
$50,000/DALY 
10 
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Study 
Disorder 
(patient 
description) 
Intervention Comparator Study Type and setting 
Costs and 
Outcomes Results Q
1 
Heuzenroeder, 
Donnelly et al., 
2004 (113) 
8 
Generalised 
Anxiety 
Disorder and 
Panic Disorder 
(using DSM-IV 
criteria) 
CBT and SNRIs Current 
Australian 
practice 
(people not 
receiving 
effective 
treatments 
Modeled using 
best available 
evidence 
Australia – GP 
referral to 
others 
Costs: Health sector  
Outcomes: DALY 
(modeled from 
existing literature 
and the NSMHWB) 
CBT by a publicly 
financed psychologist 
are the most C/E –
CBT delivered by 
various therapists are 
all more CE than 
Medication. 
10 
Issakidis, 
Sanderson et 
al., 2004 (114) 
 
Anxiety 
disorders 
differentiated 
by severity 
 
Mild anx: 10% self-
help, 60% CBT rest 
drugs. Mod-severe: 
70% CBT mainly 
(70%) – with some 
drugs. The remaining 
30% - Treatment with 
meds managed by a 
GP 
Current 
Australian 
practice and 
the null 
Modeled using 
best available 
evidence 
 
Australia 
Costs: Govt and 
health service 
perspective  
Outcomes: YLD (as 
in the DALY) 
All modeled 
interventions appear 
cost-effective – if we 
swapped from current 
care to optimal care 
the costs would 
remain similar but the 
health gains would be 
markedly increased 
(to <$20,000/DALY 
averted 
10 
Kaltenthaler, 
Brazier et al., 
2006 (107) 
anxiety, 
depression, 
phobias, panic 
and obsessive-
compulsive 
behaviour 
(OCD) 
Computerised CBT (4 
different products 
considered) – HTA 
review 
Treatment as 
usual 
Modeled (based 
on sponsor 
data) 
 
UK – National 
Health Service 
Outcome – 
depression treated 
(classified into 
minimal, mild, 
moderate and 
severe ) 
Costs: Intervention 
costs including 
license fees, 
computer hardware, 
screening, clinical 
support, capital 
overheads + other 
costs (personal 
communication from 
McCrone) 
All products 
considered cost-
effective with a high 
probability of the ICER 
falling below £30,000 
per QALY), When 
modeling OCD 
packages, the CE was 
highly influenced by 
the assumptions made 
around licensing  
10 
King, Sibbald 
et al., 2000 
(120) 
 
depression or 
mixed 
depression 
with anxiety  
*Non-directive 
counseling (provided 
by counselors) 
*CBT (provided by 
clinical psychologists) 
 
 
Usual GP care 
–  
RCT – 4 and 12 
month f’up (not 
total) however 
included 
provisions for 
patient 
preferences 
 
24 general 
practices in the 
UK 
Costs: Health sector 
costs  
Outcomes: BDI, 
Clinical Interview 
Schedule (ICD-10 
Diagnosis), Brief 
symptom Inventory, 
modified social 
adjustment Scale, 
Satisfaction 
questionnaire, 
EuroQoL 
The two interventions 
were more effective at 
4 month follow-up but 
differences 
disappeared by 12 
months. No sig 
differences in costs 
were found. Overall 
conclusion was that 
psych therapy more 
C/E in the short-term 
only. 
9 
Lave, Frank et 
al., 1998 (110) 
 
 Major 
Depression 
(n=276) 
*Medication 
(nortriptyline 
hydrochloride)  
*Interpersonal 
psychotherapy  
Usual care – 
GPs told 
patient has 
depression 
only. 
RCT – with up 
to 12 months 
follow-up 
 
USA 
Costs: health sector 
costs plus time and 
travel costs Trial 
costs of 
interventions,  
Outcomes: 
depression free 
days (measured by 
the HAM-D), BDI 
and quality adjusted 
days (using a 
conversion 
methodology from 
previous research 
 The ICER for 
Medication relative to 
usual care ranges 
from US$12.66 to 
$16.87 which 
translates to direct 
cost per quality-
adjusted year gained 
from $11270 to 
$19510 (drugs slightly 
better than psych 
8 
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Study 
Disorder 
(patient 
description) 
Intervention Comparator Study Type and setting 
Costs and 
Outcomes Results Q
1 
McCrone, 
Knapp et al., 
2004 (108) 
 
Anxiety and 
depression  
Computer delivered 
CBT  
Usual GP care  RCT – various 
f’up points up 
to 12 months 
 
General 
practices in 
England 
Costs: Societal 
(including lost 
productivity)  
Outcomes: BDI, 
BAI, Work and 
Social Adjustment 
Scale – depression 
free days using the 
BDI, (same method 
as Lave was used to 
estimate QALYs) 
Intervention was cost-
effective and resulted 
in a net benefit 
(where outcomes 
were multiplied by a 
shadow price)  
10 
Mihalopoulos, 
Kiropoulos et 
al., 200 (59) 
 
Depression 
and anxiety 
Panic online (internet 
based therapy for 
panic disorder) and 
PEP (GP training in 
CBT) 
Usual care in 
PC 
Modeled and 
Threshold 
analysis 
 
Australia 
Costs: Health sector 
(derived from 
published literature 
Outcomes: Modeled 
DALYs using 
interpolation 
PEP is likely to be 
quite C/E – though 
evidence is based on 
other published trials. 
PEP type interventions 
are also likely to be 
cost-effective even 
with moderate effect 
sizes (in the vicinity of 
0.1) 
9 
Revicki, 
Siddique et al., 
2005 (121) 
 
Major 
depression in 
low income 
minority 
member 
*Medication  
*CBT – delivered by 
psychotherapists 
supervised by a 
clinical psychologist 
Community 
referral – 
educated on 
depression and 
then referred 
to community 
providers  
RCT (12 
months f’up) 
 
USA – 
recruitment 
was from PC 
but 
interventions 
were not 
necessarily PC 
based 
Costs: Only direct 
med costs included 
as the study 
adopted a largely 
payer perspective 
Outcomes: 
Depression free 
days measured by 
the HAM-D (DFD 
were also used to 
estimate QALYs, SF-
36,  
The cost per 
additional depression-
free day was USD 
24.65 for Medication 
and USD 27.04 for 
CBT compared with 
community referral. 
Small initial diffs on 
the SF-36 not 
maintained @ f’up. 
8 
Richards, 
Barkham et al., 
2003 (109) 
 
mild-moderate 
anxiety and 
depression in 
PC (GHQ used 
to detect 
caseness) 
Cognitive behavioural 
based self-help 
package facilitated by 
practice nurses  
Usual care by 
GPs 
RCT (up to 3 
month follow-
up) 
 
PC teams in the 
UK 
Costs: health sector  
Outcomes: CORE-
OM, EuroQol-5D, 
consultation 
satisfaction 
questionnaire 
No differences really 
observed on costs or 
outcomes except CBT 
group had greater 
satisfaction 
6 
Sanderson, 
Andrews et al., 
2003 (115) 
 
Depression, 
dysthymia and 
bipolar 
disorder (from 
the NSMHWB) 
*Current mental 
health services in Aust 
(derived from the 
NSMHWB) 
*Broad range of 
Evidence based 
medicine including 
psychological and 
pharmacotherapies 
Do nothing  Modeled 
 
Australia 
Costs: 
Outcome: YLD 
(modeled by best 
available literature) 
Current direct mental 
health-related health 
averted just under 
30,000 YLDs giving a 
cost-effectiveness 
ratio of $20,633/YLD. 
Outcome could be 
increased by nearly 
50% at similar cost 
with implementation 
of an evidence-based 
package bringing the 
ICER to 10,737 dollars 
per YLD. 
10 
Schoenbaum, 
Unützer et al., 
2001 (111) 
 
1356 pats with 
Depression 
(measured by 
telephone 
CIDI) 
2 quality improvement 
strategies to do with 
meds – and 
psychotherapy (CBT 
training)  
Usual care Group level 
RCT (where 
randomisation 
occurred at the 
practice level). 
F’up up to 2 
years 
46 PC clinics in 
6 Managed care 
organisations 
Costs: health sector 
plus productivity 
and time costs 
(separately 
measured) 
Outcomes :SF-12, 
QALYs (using the 
SF-12), days with 
depression burden 
The Quality 
intervention appears 
to be cost effective. 
QI-therapy may have 
a better overall value 
in terms of cost per 
QALY than QI-meds, 
therefore value to 
improving access to 
structured 
psychotherapy for 
depressed primary 
care patients. 
7 
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Study 
Disorder 
(patient 
description) 
Intervention Comparator Study Type and setting 
Costs and 
Outcomes Results Q
1 
Scott and 
Freeman, 1992 
(69) 
Depression  Amitryptiline 
prescribed by a 
psychiatrist and CBT 
by a clinical 
psychologist, case 
work by a social 
worker  
Routine care by 
a GP (could 
include referral 
to another 
agency) 
RCT with 16 
weeks of 
follow-up 
(ratings at 0, 4 
and 16 weeks) 
 
14 UK primary 
care practices 
Standard observer 
rating of depression 
(HAM-D) at outset 
and after four and 
16 weeks. Numbers 
of patients 
recovered at four 
and 16 weeks. 
Structured 
evaluation of 
treatment by 
patients at 16 
weeks. 
Costs: Very limited 
health sector (only 
cost of therapist 
contact plus drug 
costs only)  
Small clinical 
advantage of 
intervention groups 
and large costs 
differences observed 
– therefore 
interventions deemed 
not very cost-effective 
6 
Shapiro, Sank 
et al., 1982 
(122) 
 
Anxiety or 
depression  
CBT group 
Individual CBT 
administered by a 
mental health 
specialist 
 
Traditional 
process-
orientated 
interpersonal 
group. 
 
RCT pre and 
post Treatment 
(average of 24 
days) 
USA - HMO 
Costs: Only of the 
interventions – very 
roughly calculated 
Outcomes: BDI, 
State-Trait Anxiety 
Inventory, Adult self 
expression scale 
All three experimental 
groups improved and 
no diffs in outcome 
found Group CBT 
cheaper than 
individual  
2 
Vos, Corry et 
al., 2005 (123) 
 
Depression – 
from NSMHWB 
Bibliotherapy 
CBT (individual and 
group delivered by 
psychologists and 
psychiatrists) 
Medication 
 
Usual care 
(from 
NSMHWB) 
Modeled 
 
Australia 
Costs: health sector  
Outcomes: DALYs 
(using effect size 
translations from 
previous literature 
All interventions for 
MDD have favourable 
ICERs under 
Australian health 
service conditions.  
10 
Notes: RCT=Randomised Controlled Trial; PC = Primary Care; QI=Quality Improvement; F’up = Follow-up; NSMHWB = National Survey of Mental 
Health and Well-being; HMO = Health Maintenance Organisation; QoL = Quality of Life; QALYs = Quality Adjusted Life Years; DALYs = Disability 
Adjusted Life Years; ICERs = Incremental costs effectiveness ratios; YLD = Years Lost due to Disability; C/E=Cost-Effective; DFD = Depression Free 
Days; SSRI = Selective Serotonin Reuptake Inhibitors; BDI = Beck Depression Inventory; VAS = Visual-Analogue Scale; SF-36 = Short-Form Health 
Survey – 36 Item Version; CORE-OM = Clinical Outcomes in Routine Evaluation - Outcome Measure; EQ-5D = EuroQol-5D Measure of Quality of Life.  
Q1 – refers to the Drummond quality ratings. All studies were rated by according to the 10 point Drummond criteria (see Appendix 10). The scores in 
the table refer to the total numbers of ‘yes’ ratings received for the 10 criteria. Note that the rating forms also included the categories ‘can’t 
tell’ and ‘partially’ which implicitly carry a score of 0 (equal to ‘no’). Therefore the ratings presented here are purposefully stringent. We 
consider scores 9 -10 to represent high quality evaluations, 6-8 to represent reasonable studies with some notable flaws and <5 to represent 
poor quality evaluations whose results can not be relied upon. 
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3. COLLABORATIVE MODELS OF MENTAL HEALTH 
CARE INVOLVING PSYCHOLOGICAL TREATMENTS 
3.1. INTRODUCTION 
The trajectory of primary mental health care reforms in Australia has been towards greater 
collaboration between GPs and mental health care specialists. This has been achieved through 
the gradual introduction of a range of educational, financial and bureaucratic mechanisms 
introduced over the last decade, with the initiatives aiming to increase cooperation and 
communication between health providers. For example, for GPs to refer a depressed patient to 
psychologists through the Better Access program, they are required to create a “GP Mental 
Health Care Plan” and forward a referral form to the psychologist, while the psychologist must 
provide a written report to the medical practitioner, including information on assessments 
conducted, treatment provided, and recommendations on future management (14).  
There is a significant body of published literature regarding interventions involving collaborative 
models of mental health care. Such collaborative models incorporate at least two individuals 
working together to improve treatment for the individual, such as a primary care physician (in 
US studies), mental health specialist, or a depression-care manager. We will draw on recent 
reviews and on individual studies for this component of our report, with particular emphasis on 
elements of those models that appear to be effective, and the cost-effectiveness of these 
programs. In addition, results of a series of interim reports from the Better Outcomes ATAPS 
program undertaken by some of the authors of this report (JP, GB, LN) are summarised (see 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/mental-boimhc-repts). 
3.2. FINDINGS 
3.2.1. EFFECTIVENESS OF COLLABORATIVE MODELS OF 
MENTAL HEALTH CARE INVOLVING PSYCHOLOGICAL 
TREATMENTS 
3.2.1.1. REVIEWS 
We identified five recent research reviews dealing with collaborative approaches to managing 
depression, which are listed in Table 10. Note that the reviews included both psychological and 
pharmacological approaches to treatment. Gilbody et al. (124) performed a meta-analysis of 
outcomes, showing improvements due to collaborative care in depression outcomes at 6 
months and for up to 5 years. Effect size was related to medication compliance, and to the 
professional background and supervision of case managers, although they failed to find 
improved outcomes when psychotherapy was included as an element of collaborative models. 
Gunn et al. (101) concluded that collaborative interventions were associated with modest 
improvements in outcomes. Four caveats were noted, that most trials recruited patients willing 
to take medication so may not generalise to the broader population, that trials were almost 
exclusively conducted in the US and may not generalise, that attrition rates were not accounted 
for by trials, and that the quality of reporting according to CONSORT guidelines was generally 
poor. Craven and Bland (125) noted that collaboration is most successful when building on 
preexisting clinical relationship, that it is most effective when paired with clinical guidelines, that 
skill transfer requires service restructuring, and that patient education and follow-up were 
powerful predictors of positive outcomes. They also flagged the issues that most studies 
focused on depression and the number of studies was small. Christensen et al. (126) found that 
good outcomes were associated with studies that included case-management, enhanced 
systematic care, supervised self-help programs, and community-care, but not with studies that 
incorporated training and feedback to GPs alone. Finally, Williams and colleagues (2007) found 
that almost all multifaceted interventions led to clinically important improvements in short-term 
depression outcomes, which persisted for up to four years. 
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All interventions included care management for depression, general support and patient 
education. They suggest that such approaches are particularly important for patients with major 
depression and dysthymia, significant medical, psychiatric or social comorbidity, or treatment 
resistant depression, whereas minor depression may be better served by watchful waiting 
approaches. 
Table 10: Description of Five Reviews of Collaborative Approaches to Mental 
Health Care 
Authors Databases Search date Article type Articles 
Included 
Review 
Christensen et al. 
(126) 
PubMed, Cochrane, 
PsycINFO  
To Oct 2005. RCT, CCT 71 Narrative, 
basic 
statistical
Craven and Bland 
(125) 
Medline, Embase, 
PsycINFO, Cochrane, 
others. 
To June 2005 Mostly RCTs 38 Narrative
Gilbody et al. 
(124) 
Medline, Embase, CINAHL, 
PsycINFO, Cochrane 
To Feb, 2006 RCT 37 Meta-
analysis 
Gunn et al. (101) Medline, PubMed, Cochrane 2004 RCT 11 Narrative
Williams et al. 
(18) 
Medline, HealthSTAR, 
CINAHL, PsycINFO, 
Cochrane 
To Feb, 2006 RCT 28 Narrative
3.2.1.2. COMPONENTS OF MODELS IN INDIVIDUAL STUDIES 
From the research review, we identified nine studies of collaborative or complex interventions 
that involved psychotherapeutic approaches in primary care (see Table 11). Studies dealt with a 
variety of age-groups in depression, including adolescents (127), adult patients (102, 128-130), 
and the elderly (131, 132). Two additional studies detailed interventions for Panic Disorder and 
GAD (133, 134). Risk of bias in the studies was judged to be low-to-moderate for all studies, 
with the exception of the single non-RCT design (131). The studies included a total of 5042 
participants, with a median age of 44.2, a median gender ratio of 73.8% female, and a median 
of 71.25% Caucasian participants. 
With the exception of Katon et al. (128), all the studies identified were published in the last four 
years, indicating a recent move towards collaborative models that incorporate psychotherapy as 
a component. Nevertheless, given the paucity of research, there will necessarily be gaps in the 
evidence base. While the studies took differing approaches to reporting results, most studies 
reported improvements for collaborative-care interventions relative to treatment as usual. 
Grympa et al. (131) did not have a treatment-as-usual control group, but found similar 
naturalistic results to a previous RCT utilising comparable methods on the same site. Hedrick et 
al. (130) also found no effect, but her control group had equal access to the specialists, biasing 
towards a null result (18). Thus, the reported collaborative models were generally successful.  
This being the case, what then are the elements and processes adopted within these 
collaborative models that lead to their success? One difficulty in answering this question is that 
in most of the reported studies it is difficult or impossible to tease out which aspects of the 
collaborative model led to its success (125). Mirroring a recent review (101) by some of the 
authors of this report (JG, GB), we assessed the effectiveness of collaborative approaches and 
examined the components of these models with respect to the inclusion of (i) a 
multiprofessional approach, where a GP or family physician and at least one other health 
professional were involved; (ii) A structured management plan, where practitioners were 
required to instigate an agreed treatment plan; (iii) Scheduled patient follow-up, where patients 
were scheduled for at least one telephone or face-to-face follow-up appointment; (iv) Enhanced 
inter-professional communication, where communication between professionals was facilitated 
through standardised mechanisms such as referral correspondence, letters, case-conferences, 
shared records or other forms of feedback between care-givers. 
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3.2.1.3. MULTIPROFESSIONAL APPROACH 
Consistent with our definition of a collaborative model in primary care, all studies involved a 
primary care physician/GP working in tandem with at least one-other care provider. The most 
common care structure was for the GP to retain responsibility for the patient; with a range of 
specialist providers engaged including psychologists, care managers and social workers. 
Notably, although our review did not focus specifically on the role of psychiatrists and nurses, 
both these groups featured prominently in a number of collaborative models. The overall care 
management role was usually adopted by the GP, a care manager, or interestingly, the 
specialist provider of psychological treatment. Psychological treatment tended to be provided by 
a specialist with mental health qualifications, though they were not necessarily psychologists.  
3.2.1.4. STRUCTURED MANAGEMENT PLAN 
All of the studied utilised a structured management plan as part of the collaborative 
intervention, and this generally was reported clearly within the methodological descriptions of 
the studies. In general, these plans were developed as part of the study protocols and were 
then supplemented by the GP or a care manager. Structured management plans tended to 
incorporate core elements such as education, encouraging self-care and monitoring, and 
additional elements depending on illness severity, such as prescribing medication or a stepped-
care approach to referral (usually based on clinical guidelines or the study protocol). For 
example, depending on patient preference, guideline-based pharmacological or psychological 
interventions would be trialled alone or in combination. If the first approach failed to produce a 
response, medication dose or type would be altered, or the patient would augment the initial 
CBT/pharmacological approach with the alternative treatment approach. 
3.2.1.5. NATURE OF PSYCHOLOGICAL INTERVENTION 
Psychological interventions varied across studies, but generally were short-term and evidence-
based. Interventions spanned from those that were less demanding on therapist time, including 
seven weekly sessions of group-psychoeducation (102) and guided self-help in a CBT approach 
(133), to those that were more intensive, for example, utilising 12 sessions of individual or 
group CBT (127, 129). Consistent with the prominence of problem-solving approaches within 
short-term psychological treatments in primary care, these approaches were also used in some 
of the collaborative studies (131, 132). 
3.2.1.6. SCHEDULED FOLLOW-UP  
Most studies included scheduled follow-up sessions as a component of the intervention. These 
generally incorporated psychotherapy booster-sessions or the monitoring of mood-state and 
medication usage. The follow-up sessions were mostly not specified to occur at specific weeks 
of treatment, but were flexible depending on perceived need by the care managers. Two 
studies also utilised a computerised tracking system to assist with patient follow-up. The 
integrated care-manager/psychotherapist role assumed in some studies allowed the flexibility 
for the follow-up session to reinforce psychological techniques for most patients, while linking 
the patient in with other pharmacological options if they were failing to respond to their past 
psychological or pharmacological treatment, or had worsened in their condition. Notably, as 
reported earlier, one non-collaborative study directly comparing group CBT, case management, 
and combined CBT and case management found the combined condition outperformed the 
CBT-only condition for depression in an elderly population, highlighting the potential benefits of 
having staff performing ongoing follow-up (76). 
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3.2.1.7. ENHANCED COMMUNICATION 
Reflecting the primary role of the GP in the patient’s provision of services, enhanced 
communication with the GP formed a core-component of most interventions. These again varied 
in intensity, with some studies having minimal discussions with the GP regarding medication, to 
those such as Katon et al. (128), where the psychologist consulted with the GP on each case, 
had weekly meetings, the psychologist provided handwritten and immediate feedback to the GP 
regarding each case, and placed the relapse prevention note on file. 
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Table 11: Elements of Collaborative Models of Mental Health Care Involving Psychological Treatments. 
   Elements   
Authors Design 
(Diagnosis) 
Organisation Multi-professional 
Approach 
Structured Treatment 
Plan 
Psychological 
Intervention 
Scheduled Follow-
up 
Enhanced 
Communication 
Training (Manual)  Outcomes - symptoms 
Katon et 
al.(128) 
RCT 
(MDD) 
HMO, US Primary care 
physician, 
psychologists, 
psychiatrists. 
Highly structured 
depression treatment 
program. 
Solution-focussed 
cognitive therapy. 4-6 
contacts, 
Psychologist 
completed 
telephone contacts
Case-by-case psychol-
PCP contact, weekly 
team meeting, notes; 
plan in file. 
Doctoral trained. 
20 hrs training, 
supervision. 
(patient manual) 
 At 7-mths; response for 
MDD; intervention>TAU. 
For minor depression, 
intervention=TAU. 
Araya et 
al. (102) 
RCT 
(MDD) 
Primary Care 
Clinics, Chile 
GP and SW or Nurse 
from local clinics 
Structured groups; 
Monitoring; 
Systematic medication
7 weekly group 
psychoeducation; 
Information on 
depression. 
2 booster sessions Alert notes, arranging 
appointments for 
patients. 
12 hrs training; 8 
hrs supervision. 4 
hr training GPs 
(booklet) 
 On depression level; 
Stepped Care<TAU 
Hedrick 
et al. 
(130) 
 
RCT 
(MDD/ 
Dysthymia) 
VA primary 
care clinic, US 
PCP; psychologist; 
SW; psychology 
technician. 
All available in both 
models. 
Guideline based 
treatment, stepwise 
plan reviewed at 6/12 
weeks. 
CBT group by 
psychologist/SW (6 
sessions); individual 
session with psychol/ 
psychiatrist. 
SW staff 
member/student 
contacted 
participants on 
regular basis. 
Weekly meetings. 
Electronic progress 
notes with tracking 
system. 
PCP given 3 hrs of 
training in 
collaborative and 
liaison care. 
(workbook) 
 3 mths, on depression, 
intervention<Liaison 
model; 9 mths; 
intervention=Liaison 
model. 
Wells et 
al.(129).  
RCT 
(MDD/ 
Dysthymia/ 
depression) 
Managed care, 
US 
PCP, nurses (case 
managers), 
psychiatrist (meds 
cond), psychologist 
(therapy cond) 
Guidelines given to 
staff on treatment, 
medication, treatment 
plans 
To 12 sessions 
individual/group CBT. 
No formal follow-up 
in therapy, monthly 
contact in meds 
condition. 
Team meetings and 
case reviews held by 
team leaders. 
2-day workshop. 
For specialists. 
Local supervision 
(manuals) 
At 12-mths and 57 mth, 
intervention<TAU on % 
depressed. 
 
Asarnow 
et al. 
(127) 
RCT 
(MDD) 
Mixed Primary 
Care sites, US 
PCP, care managers 
(PhD level). 
Plan developed with 
primary care physician 
including CBT or 
medication 
CBT in individual or 
group, 12 wks and 
relapse prevention. 
Brief follow up 
contacts by care 
manager 
Treatment 
collaborative, 
coordinated care with 
physician. 
1 day training -
CM. PCP given 
training. 
(manuals) 
 On depression level; 
Quality Improvement < 
TAU at 6 mths. 
Rollman 
et al 
(133) 
RCT 
(PD/GAD) 
Primary care, 
US 
GP, Care Manager 
(non-psychologists), 
consultant 
doctor/psychiatrist 
Preference-guided 
systematic treatment 
- self-management, 
pharmacological, 
specialist. Education 
Self-help CBT 
workbook, with 
guidance from care 
manager. 
Regular care-
manager contact. 
Weekly 60-75 minute 
patient review, 
suggestions to PCP, 
patient. 
CMs -workbooks; 
lectures; weekly 
meeting; super- 
vision; 1 meeting 
with PCPs. 
(workbook) 
 At 12 mths; on Panic/ 
anxiety levels; 
intervention<TAU 
Superior outcomes for 
those with PD, PD/GAD 
but not GAD only. 
Roy-
Byrne et 
al.(134)  
RCT 
(PD) 
Primary care 
clinics, US 
PCP, psychologist, 
psychiatrist 
Structured CBT, 
workbook, medication 
algorithm 
6 sessions CBT in 3 
months. 
6 follow-up booster 
sessions to monitor, 
reinforce CBT and 
check meds. 
Weekly meeting. 
Coordinated care by 
behavioural health 
specialist, telephone, 
fax, email with PCP 
Training for 
psychologists. 
PCP - 1-hr med 
training 
(workbook) 
 At 12 mths; Remission in 
intervention>TAU 
(superior). 
Grympa 
et al. 
(131) 
Non RCT 
(Depression)
Primary care, 
HMO, US 
PCP, psychiatrist, 
depression care 
manager, medical 
assistant 
Stepped care, 
education, medication 
management, PST, 
depression class. 
Variable sessions 
Problem solving 
treatment. 
Follow up by DCM, 
tracking system. 
As-needed 
consultation. 
Medication by PCP. 
CM -4 days; 
training patients. 
(manuals) 
 With >6 mths treatment; 
Post-study=RCT on 
depression level. 
Hunkeler 
et al. 
(132).  
RCT 
(MDD/ 
Dysthymia) 
Mixed Primary 
Care Sites, US 
PCP, psychiatrist and 
depression care 
manager 
(psychologist/ nurse)
Stepped care. 
Education, treatment 
algorithm. 
6-8 sessions of 
Problem Solving 
Therapy 
Monthly telephone 
appointments with 
DCM, tracking 
system. 
Weekly team review. 
Medication by PCP on 
advice. 
CM - 4 days; 
training patients. 
Med protocol for 
PCP. (manuals) 
 At 12 mth and 24 mth on 
depression level, Stepped 
Care<TAU. 
 
Note: RCT=Randomised Controlled Trial; MDD=Major Depressive Disorder; PD=Panic Disorder; GAD=Generalised Anxiety Disorder; SW=Social Worker; TAU=Treatment as Usual; PCP=Primary Care Physician 
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3.2.2. COST-EFFECTIVENESS OF COLLABORATIVE MODELS 
OF MENTAL HEALTH CARE INVOLVING PSYCHOLOGICAL 
TREATMENTS 
In contrast to the previous section where a number of economic evaluation studies of 
psychological therapies by allied health professionals were identified, only three economic 
evaluation studies of collaborative care were located, and two of the studies were conducted by 
the same authors (refer to Table 12)7. Two of the studies used a cost-utility methodology and 
all adopted a health sector perspective. The two best studies in terms of quality (136, 137) both 
concluded that collaborative care was a cost-effective model of treatment, in that it produced 
acceptable cost-effectiveness ratios in comparison to usual care. The study for the WHO using 
WHO-CHOICE methodology8 by Chisholm et al. (118) also found that proactive and 
collaborative care is a highly cost-effective option for the epidemiological subregion to which 
Australia belongs. However it is important to note that the comparator in this study is ‘do 
nothing’ or the ‘null’ condition, which is not the true comparator within the Australian Primary 
care sector. 
It must be cautioned that all the primary collaborative care studies were undertaken in the USA, 
which offers a fundamentally different paradigm of health care to Australia, with quite different 
associated health costs (usually higher). Interestingly, the Von Korff et al. (137) study found 
that patients with major depression benefited much more from the intervention compared to 
patients with mild depression. However, benefits were found for both groups. Finally, all studies 
report the short-term cost-effectiveness of these models of care, such that studies determining 
whether the benefits are maintained over the longer term are required.  
3.3. SUMMARY  
Taken together, these findings provide evidence for the efficacy and cost-effectiveness of 
collaborative interventions for depression and for panic disorder, which incorporate forms of 
focussed psychological strategies. However, there are notable limitations to these findings. 
First, no Australian trials were conducted, with the trials almost exclusively taking place in the 
US primary care system, possibly limiting generalisability. Second, it is unclear to what extent 
psychotherapy provided in the trials is a crucial aspect of the program. In their meta-analysis of 
wider collaborative approaches, Gilbody et al. (124) reported that trials with specific forms of 
psychotherapy were added to medication management were no more effective, although trials 
where antidepressant medication were prescribed at entry were also no more effective than 
other collaborative care models. This is consistent with general findings of the relative equality 
of medication and psychotherapy approaches to treatment. In addition, without formal 
decomposition studies, it is difficult to compare across studies as to the necessity of 
psychological aspects of interventions. Third, most studies deal with depression in various age 
groups or panic disorder in adults, and it is unclear how generalisable these studies are various 
groups with other high prevalence disorders. 
 
 
7 One other study identified in this review, [135. Croghan TW, Melfi CA, Dobrez DG, Kniesner TJ. Effect of mental health specialty 
care on antidepressant length of therapy. Med Care 1999;37(4 Suppl Lilly):AS20-3.], bundled people receiving antidepressant therapies 
with ‘psychotherapies’ (in a retrospective case control design). While this study cannot be classified as collaborative care it is certainly 
not psychotherapy. This study received a very low quality rating and can not be considered particularly useful in answering the key 
research question of this review. Details are available in Table 22, Appendix 8. 
8 The WHO-CHOICE methodology refers to largely modelled studies using specified costing and outcome methods developed by the 
WHO and detailed in their website: http://www.who.int/choice/en/ 
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Table 12: Summary of Evidence for the Cost-Effectiveness of Collaborative 
Models of Mental Health Care Involving Psychological Treatments 
Study Disorder 
(patient 
description) 
Intervention Comparator Study type 
and setting 
Costs and 
Outcomes 
Results Q 
Katon, 
Schoenbaum 
et al. 2005 
(138) 
 
Depression and 
dysthymic 
disorder (DSM – 
IV) in 60+ year 
olds 
1 year stepped 
collaborative plan 
including either a 
psychologist or 
nurse supporting 
the PC physician. 
Treatment involved 
either an anti-
depressant or 
problem solving 
Treatment 
Usual care were 
physician was 
notified of 
diagnosis and could 
then offer usual 
care which included 
both 
antidepressant 
medication and/or 
supportive 
counselling 
RCT with added 
EE – up to 2 
year F’up 
18 primary care 
clinic in USA  
Costs: Largely 
health sector (not 
all HS costs 
though)  
Outcomes: 
Depression free 
days (measured by 
the 20 item 
Hopkins Symptom 
checklist) and 
QALYs – using a 
rudimentary 
method  
Incremental 
outpatient cost per 
QALY US$2,519. 
Bootstrapping 
suggested that in 
25% of iterations 
the intervention is 
dominant 
5 
Katon, Russo 
et al. 2006 
(136) 
 
Panic Disorder 
(DSM-IV) – 
N=232 
Collaborative Care 
including CBT (up 
to 6 sessions 
modified for the PC 
setting) and up to 6 
phone calls by a 
mental health 
specialist, 
Medication (usually 
SSRIs) usually 
managed by the PC 
physician 
Usual care (could 
include medication 
and/or referral to a 
mental health 
professional) 
RCT – 12 month 
f’up 
 
6 PC clinics in 
USA 
Cost: largely health 
sector perspective  
Outcomes: Anxiety 
free days 
(measured by the 
anxiety severity 
index, depression 
also measured by 
the CES-D, QALYs 
measured by 
interpolation from 
previous studies 
which used the SF-
12 Brazier weights) 
Intervention sig 
more effective – 
incremental 
analysis shows 
US$14,158-$24,776 
per QALY 
9 
Von Korff, 
Katon et al. 
1998 (137) 
 
Depressive 
illness 
1 RCT 217 
2 RCT 153. 
Diagnosed by 
Inventory of 
Diagnostic 
Symptoms using 
DSM-III-R 
criteria 
Collaborative care – 
brief CBT and 
enhanced patient 
education – mainly 
by psychologists 
Usual care – 
Unclear 
2 RCTs 
1) about 
enhanced 
management of 
Medication and 
brief 
psychoeducation 
2) collaborative 
care  
F’up – 12 
months 
 
USA 
Costs: Health 
sector  
Outcomes: % of 
patients achieving a 
reduction of 50% 
on the SCL-90 4 
months after 
randomisation 
Collaborative Care 
increased costs 
with modest cost 
offsets. For MDD 
there was a modest 
increase in cost-
effectiveness (due 
to lower costs for 
collaborative care 
vs TAU). For pats 
with minor dep 
collaborative care 
was more costly 
(therefore less 
C/E). 
9 
3.4. BETTER OUTCOMES REPORTS 
As noted above, none of the individual effectiveness studies were conducted in Australia. The 
Better Outcomes Access to Allied Psychological Services program and its detailed evaluations 
using a Minimum Data Set, provide insights into an Australian model of collaborative care, 
although the evaluations are naturalistic rather than being RCTs. A series of ten interim reports 
and related publications (e.g., 139, 140-142) provide useful information (for details, see 
Appendix 7, Table 20).  
The Better Outcomes reports suggest that the various programs operating under the initiative 
produced positive clinical results, and reflecting this, provider and consumer participation 
increased drastically over the life of the program. In these programs, Divisions of General 
Practice developed models of psychotherapy provision to suit local conditions, and significantly, 
these models were seen to change over time in response to feedback from consumers, GPs and 
allied health providers involved in the program. For example, some pilot projects that initially 
had either very simple or very complex models of referral moved to models with intermediate 
complexity in response to GP-feedback (143). Many divisions also offered a combination of 
referral models to respond most effectively to service needs (144). 
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Over time, initial difficulties reported with the initiative also lessened, again reflecting 
adaptations by divisions in response to local feedback (145). 
Three reports are of particular relevance to this review. First, the Eighth Interim Report 
examined consumer’s clinical outcomes with respect to models of service delivery (146). While 
limited by relatively low levels of reporting of outcome data and the observational nature of 
findings, the report found that models with referral direct from GP to allied health provider, 
such as are now used in the Better Access system, were associated with improved clinical 
outcomes. Furthermore, delivery of services by allied health from their own consulting rooms 
(as opposed to co-locating with GPs or using other locations) was associated with poorer 
outcomes. Earlier reports had reported positive views of co-location models, which provide 
greater opportunity for communication, collaboration and knowledge transfer, although such 
models reduce the range of providers to whom GPs can refer (147). Such findings are 
consistent with the positive clinical outcomes from systems-level interventions leading to 
greater collaboration between providers (see above). 
In the Seventh Interim Report, differences in models and usage were examined with relation to 
rural and urban settings (148). There was greater relative uptake of rural services, perhaps due 
to gaps in existing services. Further, while outcomes were positive in both localities, allied 
health staff in rural areas were more likely to be directly employed, co-located and receive 
direct referrals. This difference reflects regions adapting to local conditions, and highlights that 
regional divisions moved towards being employers in an attempt to guarantee services. Such 
findings provide further support for the government’s support for both direct fee-for-service 
models (i.e., Better Access) and models that are free to be adapted to local conditions (i.e., 
Better Outcomes). 
Finally, the most recent report (10th interim report) further examined changes over time (149). 
In particular, the report suggests that there have been continued positive results from the 
program in terms of consumer outcomes and GP involvement. The report also notes that while 
the introduction of the Better Access program coincided with an initial decrease in referrals to 
the Better Outcomes programs in urban areas, the change was not sustained and the Better 
Outcomes program continues to be utilised, consistent with the Federal Government aim for the 
programs to be complementary rather than competing initiatives.  
A summary of all findings regarding collaborative treatments is provided in Box 4. 
Box 4 Summary of Key Findings Regarding Collaborative Psychological 
Treatments in Primary Care 
• Good evidence that collaborative Interventions involving (1) psychotherapy; (2) 
structured management plans; (3) scheduled follow-up; (4) a multiprofessional 
approach; and (5) enhanced communication are superior to treatment as usual in 
primary care for Depression, Panic Disorder and GAD. 
• Limited evidence suggests that collaborative and pro-active interventions are cost-
effective for depression and panic disorder 
• Limited evidence that collaborative programs involving psychotherapy under the 
Australian Better Outcomes program produce reduction in symptoms. Models with 
greater collaboration in Australia (direct-referral with co-location) produced superior 
results.  
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4. KEY FINDINGS AND POLICY OPTIONS 
4.1. KEY FINDINGS 
A summary of all key findings is provided in Box 5. 
4.1.1. GP PROVISION OF PSYCHOLOGICAL TREATMENTS IN 
PRIMARY CARE 
There was inconclusive evidence that GP-delivery of specific psychological treatments led to 
clinical improvements for primary care patients experiencing depression and anxiety disorders. 
However, there were two exceptions. First, GP delivery of PST for depression appeared to be 
more effective than treatment as usual and equivalent to treatment by antidepressants, when 
the GP had received appropriate training. Second, GP delivery of guided manualised 
bibliotherapy for Panic Disorder appeared to be as effective as referral to a specialist provider in 
one study. There were no studies identified regarding the cost-effectiveness or otherwise of GP-
provision of psychological treatments. 
4.1.2. PSYCHOLOGIST PROVISION OF PSYCHOLOGICAL 
TREATMENTS IN PRIMARY CARE 
There was substantial and consistent evidence to support psychologist-delivered therapy, 
including CBT, IPT, and PST, to primary care populations experiencing anxiety or depressive 
disorders. Psychologist-delivered psychotherapy was generally more effective than placebo, 
waitlisted groups and GP-treatment as usual. There was relatively good economic evidence that 
psychologist-delivered psychological treatment to primary care populations was good value-for-
money, although there were no primary Australian studies to verify this conclusion.  
4.1.3. NON-PSYCHOLOGIST ALLIED-HEALTH PROVISION OF 
PSYCHOLOGICAL TREATMENTS IN PRIMARY CARE 
There is a scarcity of research for the effectiveness of social worker, occupational therapist, or 
Indigenous health worker-provision of specific psychological treatments in primary care 
populations. Only one RCT provided evidence for the effectiveness of group treatment by social 
workers compared to GP treatment-as-usual for MDD.  
4.1.4. COLLABORATIVE MODELS OF MENTAL HEALTH CARE 
INVOLVING PSYCHOLOGICAL TREATMENTS 
Collaborative interventions involving (1) psychotherapy, (2) a multiprofessional team, (3) 
structured management plans, (4) scheduled patient follow-up and (5) enhanced 
communication were consistently more effective than treatment as usual, although the precise 
contribution of each of these elements to treatment success is not known. Such collaborative 
models also appeared to be more cost-effective in the short-term. However, evidence regarding 
whether the benefits are maintained in the longer-term was not available.  
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
42 
__________________________________________________________________________________________________________________________________ 
  
Box 5 Summary of All Key Findings Regarding Provision of Psychological Treatment in Primary Care 
Theme 
 
Key Findings 
 
GP Provision • Good evidence that GPs delivery of problem-solving therapy for depression is superior to usual treatment and equivalent to 
treatment by antidepressant medication. It is unclear the extent to which such results are relevant to real-world settings. 
 • Limited evidence that GPs delivery of guided, manualised bibliotherapy for panic disorder is as effective as referral to secondary 
care therapist.  
 • Inconclusive evidence for the effectiveness of CBT or IPT delivered by GPs. 
• No studies identified regarding the cost-effectiveness of GP-delivered psychological treatments. 
 
Allied Health 
Provision 
• Good Evidence that psychotherapy delivered by psychologists has similar treatment effects to medication for Depression. 
Limited evidence for Panic Disorder and Generalised Anxiety Disorder  
• Good Evidence that psychotherapy delivered by psychologists is superior to usual treatment or Placebo for Major Depressive 
Disorder, and Panic Disorder, but not for Dysthymia. Limited evidence for Generalised Anxiety Disorder. 
• Good evidence that psychologist-delivered therapies represent good value-for-money, but all Australian studies utilised 
modelling methodology. 
• Limited evidence that psychological treatments can be effectively delivered to minority or non-Caucasian populations. 
 • Limited evidence that social workers can effectively deliver psychological therapies for depression and anxiety.  
• No studies identified regarding effectiveness of psychotherapy by other workers (OTs, Indigenous health workers). 
  
Collaborative 
Interventions 
• Good evidence that collaborative Interventions involving (1) psychotherapy, (2) structured management plans, (3) scheduled 
follow-up, (4) a multiprofessional approach; and (5) enhanced communication are superior to treatment as usual in primary 
care for Depression, Panic Disorder and GAD. 
 • Limited evidence suggests that collaborative and pro-active interventions are cost-effective for depression and panic disorder 
 • Limited evidence that collaborative programs involving psychotherapy under the Australian Better Outcomes program produce 
reduction in symptoms. Models with greater collaboration in Australia (direct-referral with co-location) produced superior 
results.  
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4.2. POLICY OPTIONS 
In this section, we aim to provide options for policy based on findings from our review, which 
we hope will assist policy advisors in relation to the delivery of psychological treatments in 
Australian primary care. As we are employing a knowledge support approach with an 
aggregative aim (16), we have a primary goal of providing policy advisors with a relevant 
synthesis of the evidence so as to inform decision-making. In providing policy options we 
recognise the significant limitations in moving from the research evidence. In addition to 
consideration of effectiveness, multiple economic, pragmatic and logistical considerations will 
influence the feasibility of policy options. In the case of Australia’s mental health system, which 
is in the midst of reforms of an unprecedented scale, it would be naïve to suggest system-level 
changes without careful consideration of current policies and their implementation.  
Additionally, we recognise that the research evidence we have synthesised often fails to answer 
the context-specific questions that most interest policy advisors. For example, evidence for the 
effectiveness of collaborative models of mental health care does not easily translate into 
answering policy questions about which elements of such models should be incorporated into 
Australian reforms. Finally, it should be noted that few of the RCTs reviewed were conducted 
within Australia, and the reports most relevant to Australia (the interim reports of the Better 
Outcomes programs) are limited by being naturalistic reports rather than RCTs.  
With these caveats in mind, we provide policy advisors options for policy directions that flow 
from the key principles identified in our review. We focus on options that are feasible based on 
discussions with stakeholders, and include the following options for Australia’s primary mental 
health care system: (1) Support Collaboration in the Workforce; (2) Train the Workforce; and 
(3) Undertake Strategic Evaluations.  
4.2.1. SUPPORT COLLABORATION 
• Increase use of existing collaborative service incentives such as the Better Outcomes 
ATAPS and Better Access programs by GPs and allied health providers 
• Support non-psychologist allied health providers workforce to utilise existing service 
incentives 
• Continue to support locally developed collaborative models such as the Better 
Outcomes ATAPS program 
• Develop systems that provide GP supervision and support by psychologists or other 
allied health providers 
• Give additional financial/training support to GPs who provide limited psychological 
treatments, especially in areas where there is a dearth of specialist services 
4.2.2. TRAIN THE WORKFORCE 
• Fund targeted professional training of GPs focusing on training regarding mental health 
assessment, planning, reviewing, problem solving and behavioural treatment, gate-
keeping and matching therapist-patient according to need (stepped care)  
• Fund targeted training of psychologists, focusing on working with primary care 
populations 
• Fund targeted training of non-psychologist allied health providers, focusing on training 
in focussed psychological strategies, problem-solving and working with primary care 
populations 
• Promote primary mental health care workforce training approaches that incorporate an 
emphasis on early inter-professional training and training in primary health care 
settings, and that make explicit a coherent career pathway 
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4.2.3. UNDERTAKE STRATEGIC EVALUATIONS 
• As part of scheduled evaluations, commission a national evaluation strategic framework 
that includes data on clinical outcomes 
• As part of scheduled evaluations, monitor psychological-service utilisation and cost to 
consumers, especially for geographic or demographic groups less able to access 
services (e.g., rural and regional areas, Northern Territory, Indigenous, youth, health 
care card holders) 
• Identify and support priority research areas (e.g., (1) cost-effectiveness studies of 
psychological treatments in an Australian setting, (2) effectiveness studies of non-
psychologist allied health providers, (3) consumer and carer experiences of primary 
care psychological treatments) 
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APPENDIX 1. ADDITIONAL DETAILS REGARDING 
PRIMARY CARE PSYCHOLOGICAL SERVICES IN 
AUSTRALIA 
BETTER OUTCOMES IN MENTAL HEALTH CARE INITIATIVE 
Through the Better Outcomes in mental Health care initiative the barriers to delivery of 
quality mental health care in General Practice, for example inadequate mental health education 
and training and limited referral pathways, have begun to be addressed in a structured and 
systematic way.  
The program was introduced in 2001 with funding of $120.4 million over four years. It is 
improving community access to quality primary mental health services by providing better 
education and training for general practitioners (GPs) and more support for GPs from allied 
health professionals and psychiatrists. Further funding of $142.7 million over four years has 
been provided to continue and expand the program to 2008-09. It encourages the use of 
evidence-based practice in the treatment of mental health disorders in primary care settings. 
The key components of the initiative were: 
• Education and training for GPs - to familiarise GPs with the initiative and to increase 
their mental health skills 
• The 3 Step Mental Health Process - a Service Incentive Payment (SIP) was provided to 
encourage effective management of mental health problems by GPs through a 3-Step 
Mental Health Process that included an assessment, a mental health plan and a review. 
GPs were reimbursed for providing the 3 step mental health plan via a combination of 
service incentive payments and Medicare Benefits Schedule rebates. This component 
commenced on 1 July 2002 
• Focused Psychological Strategies - to encourage appropriately trained GPs to provide 
evidence based focused psychological strategies (FPS) through the provision of 
Medicare Benefits Schedule (MBS) rebates. This component commenced on 1 November 
2002. General practitioners are required to have appropriate training for the provision of 
FPS and be registered with the Health Insurance Commission 
• Access to Allied Psychological Services (ATAPS) - to enable GPs to access psychological 
and other allied health services to support their patients with mental health disorders. 
This component was rolled out through 16 pilots in 2002-2003, with Divisions of 
General Practice as fund-holders 
• Access to Psychiatrist Support - to better enable psychiatrists and GPs to participate in 
case conferencing and for psychiatrists to provide emergency advice to support GPs. 
Changes to the case conferencing component of the Enhanced Primary Care MBS items 
for consultant physicians from 1 May 2002 supports psychiatrists to participate in case 
conferencing 
REQUIREMENTS FOR THE PROVISION OF FOCUSSED 
PSYCHOLOGICAL STRATEGIES (FPS) UNDER THE GENERAL 
PRACTITIONER MBS ITEM FOR FPS.  
Doctors eligible to use the MBS item for FPS are:  
• Medical practitioners including general practitioners, but excluding specialists and 
consultant physicians 
• Registered with the Health Insurance Commission as participating in the Better 
outcomes in mental health care initiative 
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• Have completed the relevant FPS training requirements and are registered with the HIC 
to use these item numbers 
• Provide FPS services from a practice that is either participating in the Practice Incentive 
Program or is an accredited general practice 
REQUIREMENTS FOR GENERAL PRACTITIONER REFERRAL 
OF PATIENTS FOR FOCUSSED PSYCHOLOGICAL STRATEGIES  
Where general practitioners determine that psychological interventions are the preferred 
treatment for patients with mental health disorders, they may still use any existing pathways 
and systems to access these services, such as referral to a psychiatrist or to existing public or 
private mental health sector services.  
However General Practitioners who are registered with the HIC as participating in the Better 
outcomes in mental health care initiative, have two additional pathways available to access FPS 
for their patients with defined mental health disorders. The decision to refer a patient must be 
made in the context of the 3 Step Mental Health Process. The additional pathways are:  
1. In the Access to Allied Health Pilot sites, the General Practitioner may refer to a specific allied 
health professional for the provision of FPS for the defined mental health disorders; and  
2. In all areas, FPS may be provided by General Practitioners who are registered with the HIC 
for the provision of FPS. Where the referring General Practitioner also has the required FPS 
registration, they can provide these services themselves. Where they do not have the required 
FPS registration, they can refer to another General Practitioner who has this registration for the 
provision of FPS for the defined mental health disorders. 
CHANGES TO BETTER OUTCOMES INITIATIVE FOLLOWING 
INTRODUCTION OF BETTER ACCESS INITIATIVE 
The Australian Government will continue to honour its commitment to supporting the key 
components of the BOIMHC Initiative, including education and training for GPs, appropriate 
remuneration of GPs for delivery of Focused Psychological Strategies, support from 
psychiatrists, and access to allied health services. 
• The increased range of referral pathways under Better Access complements the range 
of initiatives funded under the Better Outcomes in Mental Health Care Program 
(BOIMHC) 
• Divisions of General Practice will continue to operate their Access to Allied Psychological 
Services projects to 2008-09 
• The Access to Allied Psychological Services (ATAPs) component will continue through 
Divisions of General Practice to offer an alternative referral pathway for GPs, and the GP 
Psychiatrist Support component will continue to provide advice to GPs on the 
management of patients 
• Divisions of General Practice will continue to manage the ATAPs component of BOIMHC 
and this has been reflected in the recent renewal of funding agreements to June 2009 
• The 3 Step Mental Health Process items (or PIP incentive payment ‘trigger’ items) will 
run in parallel to the new GP Mental Health Care items from 1 November 2006 to 30 
April 2007 
• The 3 Step Mental Health Process incentive payment and associated MBS trigger items 
will be withdrawn from 1 May 2007 
• Consultation will take place with professional groups and Divisions about adapting 
education, training and infrastructure associated with BOIMHC to support the Better 
Access initiative 
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• The new MBS items for clinical psychologists and other allied health professionals will 
be implemented in consultation with key stakeholders, including GP representative 
groups and the Australian Psychological Society, to ensure alignment with the BOIMHC 
program 
• Access by appropriately trained GPs to MBS items for the delivery of Focused 
Psychological Strategies will continue 
• It is likely the introduction of the new MBS items for psychology and allied health 
services may, over the medium term, reduce demand for allied health services through 
ATAPS, although the impact is likely to vary from Division to Division 
• The GP Psychiatrist Support Service will also continue to provide a network for GPs to 
seek patient management advice from a psychiatrist within 24 hours 
BETTER ACCESS INITIATIVE 
The 'Better Access to Psychiatrists, Psychologists and General Practitioners through the 
Medicare Benefits Schedule', COAG initiative, aims to increase community access to general 
practitioners, psychiatrists, clinical psychologists and other allied mental health professionals for 
mental health care. The Better Access to psychiatrists, psychologists and GPs commenced 1 
November 2006. Some changes occurred on May 1 2007. 
New MBS Items have been introduced as part of the initiative, including services provided by 
psychiatrists, GPs, Psychologists and other allied health providers. 
• New Psychiatrist items 296, 297, and 299 for new patients, and an increase in rebate 
levels for psychiatrist items 291, 293, 304, 306, 314, 316, 319, 324, 326, 334, and 336 
• New GP items for preparation of a GP Mental Health Care Plan (2710); for review of a 
GP Mental Health Care Plan (2712); and for a GP Mental Health Consultation (2713); 
and minor changes to referral arrangements and an increase in rebates for Focused 
Psychological Strategies services provided by GPs (items 2721 – 30-40 minute 
consultation; and 2725; 40+ minute consultation) 
• New Psychological Therapy items (80000 to 80020) for up to 12 individual and up to 12 
group consultations per patient with eligible clinical psychologists in a calendar year 
BETTER ACCESS REFERRAL PATHWAYS 
• All GPs can refer patients who are being managed under a mental health care plan 
through Better Access  
• GPs can refer to clinical psychologists, psychologists, social workers and occupational 
therapists who are registered with Medicare Australia 
• All patients who are assessed as having a Mental Disorder as defined in the MBS are 
eligible for services under the initiative  
• There are no mandatory training requirements to access the new GP items 
TRAINING AND EDUCATION  
As of 1 November there are no mandatory training requirements for GPs to refer patients 
through the new Better Access initiative. This includes GPs referring patients under Better 
Access for services through the Access To Allied Psychological Services (ATAPS) projects. 
However, it is strongly recommended that GPs providing mental health care using the new GP 
mental health care items have completed appropriate mental health training, such as receiving 
training recognised through the General Practice Mental Health Standards Collaboration. GPs 
claiming service incentive payments for the 3 step mental health process services, or providing 
focused psychological strategies (FPS), continue to require level 1 or level 2 training respectively 
and registration with Medicare Australia. 
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Completion of familiarisation training will no longer be required. In order to access Medicare 
items for GP Focused Psychological Strategies, GPs will still need to complete Level 1 and Level 
2 training. 
 
3-STEP MENTAL HEALTH PROCESS - SERVICE INCENTIVE 
PAYMENT 
The new GP Mental Health Care items under the Better Access initiative incorporate the existing 
3 Step Mental Health Process items and associated Service Incentive Payment (SIP). These 
existing 3 Step Mental Health process SIP items will be available until 30 April 2007 to enable 
GPs to complete and claim for work commenced but not finished by 1 November 2006. From 1 
November 2006 GPs should use the new GP Mental Health Care items to prepare new mental 
health care plans for patients who require them.  
MEDICARE BENEFIT SCHEDULE ITEMS 
GP ITEMS 
• 2710 the GP Mental Health Care Plan preparation 
• 2712 the GP Mental Health Care Plan review 
• 2713 the GP Mental Health Care Consultation 
• 291 or 293 the psychiatrist assessment and management plan 
GROUP M6 PSYCHOLOGICAL THERAPY SERVICES 
• 80000 - 80020 services by a registered clinical psychologist referred by a medical 
practitioner as part of the GP mental health care plan (up to 12 sessions per cal year of 
individual and group services) 
GROUP M7 FOCUSSED PSYCHOLOGICAL STRATEGIES (ALLIED 
MENTAL HEALTH) 
• 80100-80120 services by a psychologist referred by a medical practitioner as part of the 
GP mental health care plan (up to 12 sessions per cal year of individual and group 
services) 
• 80125 - 80145 services by an occupational therapist referred by a medical practitioner 
as part of the GP mental health care plan (up to 12 sessions per cal year of individual 
and group services) 
• 80150-80170 services by a social worker referred by a medical practitioner as part of the 
GP mental health care plan (up to 12 sessions per cal year of individual and group 
services) 
GROUP M8 PREGNANCY SUPPORT COUNSELING  
• 81000-81010 non-directive counseling services by a psychologist, social worker or 
mental health nurse to a woman concerned with a current or past 12 months 
pregnancy, where referred by a medical practitioner. (max of 3 services)  
SERVICES TO BE DELIVERED BY ALLIED HEALTH 
There are two types of services able to be redeemed by allied health under the Better Access 
initiative. Firstly, clinical psychologists registered with Medicare are eligible to provide 
“Psychological Therapy Services”, in which the government suggests that “In addition to 
psycho-education, it is recommended that cognitive-behaviour therapy be provided.  
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However, other evidence-based therapies ─ such as interpersonal therapy ─ may be used if 
considered clinically relevant.” In contrast, non-clinical psychologists, social workers and 
occupational therapists must provide “Focused psychological strategies”, which are defined as: 
Psychoeducation (including motivational interviewing); Cognitive-behavioural therapy including 
behavioural interventions (Behaviour modification, exposure techniques, activity scheduling) and 
cognitive interventions (cognitive therapy); relaxation strategy (including progressive muscle 
relaxation and controlled breathing), and skills training (including problem solving skills and 
training, anger management and social skills training). Note that “Psychological Therapy 
Services” attract a higher rebate than “Focused Psychological Strategies” (14). 
References accessed 3 May 2007 (Better outcomes in mental health care initiative) 
http://www.crufad.com/phc/index.htm 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/mental-boimhc 
http://www.adgp.com.au/Site/index.cfm?display=2550 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/coag-mental-overview-
mental+health+care+items.htm 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/mbsonline-downloads 
http://www.health.gov.au/internet/wcms/publishing.nsf/Content/B444E30202CBDD93CA2570A
400097806/$File/SummaryofChanges.pdf 
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APPENDIX 2. LIST OF ACRONYMS AND 
ABBREVIATIONS USED IN REPORT 
Diagnoses and Diagnostic Manuals 
Anx = Anxiety 
Dep = Depression 
DSM = Diagnostic and Statistical Manual of Mental Disorders (editions include DSM-III; DSM-III-
Revised; DSM-IV). 
GAD = Generalised Anxiety Disorder 
ICD-10 = International Classification of Diseases – 10th Edition 
MDD = Major Depressive Disorder 
OCD = Obsessive Compulsive Disorder 
PD = Panic Disorder 
PTSD = Post-traumatic Stress Disorder 
RDC = Research Diagnostic Criteria 
Soc Ph = Social Phobia 
 
Design 
CCT = Case Control Trial 
RCT = Randomised Controlled Trial 
SBA = Simple Before-After 
 
Health-Economics 
C/E = Cost-Effective 
DALYs = Disability Adjusted Life Years 
DFD = Depression Free Days 
EE = Economic Evaluation 
ICERs = Incremental Cost-Effectiveness Ratios 
QALYs = Quality Adjusted Life Years 
OOP = Out-Of-Pocket 
YLD = Years Lost due to Disability 
 
Medications 
Antidep = Antidepressant Medication 
Amit = Amitriptyline (Class - Tryclic Antidepressant) 
Fluv = Fluvoxamine (Class – SSRI) 
Med = Medication 
Parox = Paroxetine Hydrochloride (Class – SSRI) 
PL = Placebo 
Sert = Sertraline Hydrochloride (Class – SSRI) 
SNRI = Serotonin-Norepinephrine Reuptake Inhibitors  
SSRI = Selective Serotonin Reuptake Inhibitors 
Ven = Venlafaxine Hydrochloride (Class – SNRI) 
 
Other/Generic 
Diffs = Differences 
F’up = Follow-up 
HMO = Health Maintenance Organisation 
Inc = Including 
Mth = Month 
MBS = Medicare Benefits Schedule 
NA = Not available 
ns = Non-significant (statistically) 
NSMHWB = National Survey of Mental Health and Well-being 
PC = Primary Care 
QI = Quality Improvement 
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QoL = Quality of Life 
Sig = Significant (Statistically) 
Wk = Week 
Yr = Year. 
 
Professional Groups/Government 
COAG = Council of Australian Governments 
MHPA = Mental Health Professionals Association 
 
Scales and Diagnostic Interviews 
Depression 
BDI = Beck Depression Inventory (BDI-I and BDI-II versions) 
CES-D = Center for Epidemiologic Studies-Depression Scale 
DSSI/sAD = Delusions-Symptoms-States Inventory/states of Anxiety and Depression 
HAM-D = Hamilton Rating Scale – Depression 
HSCL-D-20 = Hopkins Symptoms Check List - Depression  
MADRS = Montgomery Ashberg Depression Rating Scale 
VAS = Visual-Analogue Scale 
 
Anxiety 
HAM-A = Hamilton Rating Scale - Anxiety 
PDSS = Panic Disorder Severity Scale 
STAI = State Trait Anxiety Inventory 
 
Functioning 
BSI = Brief Symptom Inventory  
CORE-OM = Clinical Outcomes in Routine Evaluation - Outcome Measure 
EQ-5D = EuroQol-5D Measure of Quality of Life  
GHQ = General Health Questionnaire 
HSC = Hopkins Symptoms Checklist 
SF-36 = Short-Form Health Survey – 36 Item Version 
SF-12 = Short-Form Health Survey – 12 Item Version 
 
Interview 
CIDI = Composite International Diagnostic Interview 
MINI = The Mini-International Neuropsychiatric Interview 
PRIME-MD = Primary Care Evaluation of Mental Disorders  
PSE = Present State Examination 
SCID-IV = Structured Clinical Interview for DSM-IV Diagnoses (also SCID-P = patient version) 
 
Staff 
GP = General Practitioner 
OT = Occupational Therapist 
PCP = Primary Care Physician 
Psychol = Psychologist 
SW = Social Worker 
 
Therapy Modalities/Conditions 
AMT = Anxiety Management Training 
BT = Behaviour Therapy 
CBT = Cognitive Behavioural Therapy 
CM = Case Management 
CT = Cognitive Therapy 
IPT = Interpersonal Therapy 
PST = Problem Solving Therapy 
TAU = GP Treatment-as-usual.  
WL = Waitlist 
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APPENDIX 3. FULL SEARCH TERMS FOR NON-MEDLINE DATABASES 
Table 13: Full Search Terms for SCOPUS, PSYCINFO, Cochrane, Web of Science, and PubMed. 
Note: Forward slash (/) represents the Boolean operator “OR”. 
Database Search Terms  
MEDLINE See Table 1, Main Text 
2780 
SCOPUS TITLE-ABS-KEY("primary health care"/"primary healthcare"/"primary care"/(general practi*)/"family practice"/"primary mental health 
care"/"family physician"/"primary nursing care"/"primary medical care"/"GP"/"GPs"/family medicine/"Delivery of Health 
Care"/"cooperative care"/"cooperation"/"interdisciplinary team"/"patient care team"/"mental health services"/"primary medical care 
delivery"/"general practice delivery"/"comprehensive care"/"coordinated care"/"integrated care"/"continuity of care"/"accessibility of 
care"/"service planning"/"health service structures"/"health service organization"/"health service funding"/"health service 
governance"/"health care services"/"continuum of care"/"mental health services"/"primary health care"/"community services"/"health 
care delivery"/"health care utilization"/"health care seeking behavior"/"health maintenance organizations"/"health service 
needs"/"managed care"/"mental health programs"/"outreach programs"/"telemedicine"/"health care policy"/"health care administration") 
AND 
TITLE-ABS-KEY("Depressive Disorder, Major"/"Depressive Disorder"/"Depression, Postpartum"/"Dysthymic Disorder"/"Seasonal Affective 
Disorder"/"Anxiety Disorders"/"Agoraphobia"/"Obsessive-Compulsive Disorder"/"Panic Disorder"/"Phobic Disorders"/"Stress Disorders, 
Traumatic"/"Combat Disorders"/"Stress Disorders, Traumatic, Acute"/"Stress Disorders, Post-Traumatic"/"Adjustment 
Disorders"/"Neurotic Disorders"/depressi*/dysthymi*/"Seasonal Affective Disorder"/anxiety/agoraphobia/"Obsessive-Compulsive 
Disorder"/ocd/"Panic Disorder"/"GAD"/"Generalised anxiety Disorder"/"Generalized Anxiety Disorder"/phobi*/stress 
disorder*/ptsd/"Adjustment Disorder"/"Adjustment Disorders")  
AND 
TITLE-ABS-KEY(psychotherapy/counsel*/"supportive therapy"/"behavior therapy"/"cognitive behavior therapy"/"cognitive 
therapy"/"cognitive behaviour therapy"/"behavior analysis"/"behavior modification"/"exposure techniques"/"activity 
scheduling"/"cognitive analysis"/"cognitive interventions"/"thought challenging"/"cognitive restructuring"/"psychotherapy, rational-
emotive"/relaxation/"guided imagery"/"imagery psychotherapy"/"problem-solving"/"anger management"/"stress 
management"/(psychotherapy and therapeutics)/"social skills"/"motivational interviewing"/"interpersonal therapy"/"parent management 
training"/psychoeducation/"psychological treatment"/cbt/"interpersonal techniques"/"behavior control"/"aversive therapy"/"psychological 
desensitization"/(desensitization, psychologic*)/"implosive therapy"/bibliotherapy/"Psychotherapy, Brief"/"Psychotherapy, 
Multiple"/"Psychotherapy, Rational-Emotive"/"self-help"/"family therapy"/"psychological treatment") 488 
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Note: Forward slash (/) represents the Boolean operator “OR”. 
Database Search Terms  
PsycINFO KW=("anxiety disorders"/"acute stress disorder"/"generalized anxiety disorder"/"obsessive compulsive disorder"/"panic 
disorder"/"phobias"/"social phobia"/"posttraumatic stress disorder"/ "major depression"/"dysthymic disorder"/"endogenous 
depression"/"postpartum depression"/"reactive depression"/"recurrent depression"/"treatment resistant depression"/PTSD/GAD/OCD) 
AND  
KW=("health care services"/"continuum of care"/"mental health services"/"primary health care"/"community services"/"health care 
delivery"/"health care utilization"/"health care seeking behavior"/"health maintenance organizations"/"health service needs"/"managed 
care"/"mental health programs"/"outreach programs"/"telemedicine"/"health care policy"/"health care administration"/"general 
practi*"/"primary mental health care")  
AND  
KW=("psychotherapy"/"behavior therapy"/"child psychotherapy"/"cognitive behavior therapy"/"cognitive behaviour therapy"/"behaviour 
therapy"/"individual psychotherapy"/"interpersonal psychotherapy"/"rational emotive behavior therapy"/"solution focused 
therapy"/"cognitive therapy"/"online therapy"/"anxiety management"/"behavior modification"/"behavior therapy"/"cognitive 
techniques"/"relaxation therapy"/"stress management"/counseling/counseling/psychotherapy/counsel*/"supportive therapy"/"behavior 
therapy"/"cognitive therapy"/"cognitive behaviour therapy"/"behavior analysis"/"behavior modification"/"exposure techniques"/"activity 
scheduling"/"cognitive analysis"/"cognitive interventions"/"thought challenging"/"cognitive restructuring"/"psychotherapy, rational-
emotive"/relaxation/"relaxation strategies"/"guided imagery"/"imagery psychotherapy"/"problem-solving"/"anger management"/"stress 
management"/(psychotherapy and therapeutics)/"social skills"/"motivational interviewing"/"interpersonal therapy"/"parent management 
training"/psychoeducation/"psychological treatment"/cbt/"interpersonal techniques"/"behavior control"/"aversive therapy"/"psychological 
desensitization"/(desensitization, psychologic*)/"relaxation techniques"/"implosive therapy"/bibliotherapy/"psychotherapy, 
brief"/"psychotherapy, multiple"/"psychotherapy, rational-emotive"/"self-help"/"family therapy"/"psychological treatment") 867 
 
  
 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
65 
__________________________________________________________________________________________________________________________________
Note: Forward slash (/) represents the Boolean operator “OR”. 
Database Search Terms  
Cochrane ("primary health care"/"primary healthcare"/"primary care"/(general practi*)/"family practice"/"primary mental health care"/"family 
physician"/"primary nursing care"/"primary medical care"/"GP*"/"family medicine"/"Delivery of Health Care"/"cooperative 
care"/"cooperation"/"interdisciplinary team"/"patient care team"/"mental health services"/"comprehensive care"/"coordinated 
care"/"integrated care"/"continuity of care"/"accessibility of care"/"service planning"/"health service structures"/"health service 
organization"/"health service funding"/"health service governance"/"health care services"/"continuum of care"/"mental health 
services"/"community services"/"health care delivery"/"health care utilization"/"health care seeking behavior"/"health maintenance 
organizations"/"health service needs"/"managed care"/"mental health programs"/"outreach programs"/"telemedicine"/"health care 
policy"/"health care administration")  
AND 
("Depressi*"/anxiety/"Dysthymic Disorder"/"Seasonal Affective Disorder"/"Anxiety Disorders"/"Agoraphobia"/"Obsessive-Compulsive 
Disorder"/"Panic Disorder"/"Phobic Disorders"/"Combat Disorders"/"Neurotic Disorders"/dysthymi*/ocd/"Panic 
Disorder"/"GAD"/"Generalised anxiety Disorder"/"Generalized Anxiety Disorder"/phobi*/stress disorder*/ptsd/"Adjustment 
Disorder"/"Adjustment Disorders")  
AND 
(psychotherapy/counsel*/"supportive therapy"/"behavior therapy"/"cognitive behavior therapy"/"Cognitive Therapy"/"cognitive behaviour 
therapy"/"behavior analysis"/"behavior modification"/"exposure techniques"/"activity scheduling"/"cognitive analysis"/"cognitive 
interventions"/"thought challenging"/"cognitive restructuring"/relaxation/"guided imagery"/"imagery psychotherapy"/"problem-
solving"/"anger management"/"stress management"/"social skills"/"motivational interviewing"/"interpersonal therapy"/"parent 
management training"/psychoeducation/"psychological treatment"/cbt/"interpersonal techniques"/"Behavior Control"/"Aversive 
Therapy"/"psychological desensitization"/"Implosive Therapy"/bibliotherapy/"self-help"/"family therapy") 
 279 
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Note: Forward slash (/) represents the Boolean operator “OR”. 
Database Search Terms  
Web of 
Science 
TS=("primary health care"/"primary healthcare"/"primary care"/(general practi*)/"family practice"/"primary mental health care"/"family 
physician"/"primary nursing care"/"primary medical care"/"GP"/"GPs"/family medicine/"Delivery of Health Care"/"cooperative care"/ 
"cooperation"/"interdisciplinary team"/"patient care team"/"mental health services"/"primary health care delivery"/"primary medical care 
delivery"/"general practice delivery"/"comprehensive care"/"coordinated care"/"integrated care"/("continuity of care")/"accessibility of 
care"/"service planning"/"health service structures"/"health service organization"/"health service funding"/"health service governance" 
/"primary care"/"health care services"/"continuum of care"/"mental health services"/"primary health care"/"community services"/"health 
care delivery"/"health care utilization"/"health care seeking behavior"/"health maintenance organizations"/"health service needs" 
/"managed care"/"mental health programs"/"outreach programs"/"telemedicine"/"health care policy"/"health care administration") 
AND 
TS=("Depressive Disorder, Major"/"Depressive Disorder"/"Depression, Postpartum"/"Dysthymic Disorder"/"Seasonal Affective Disorder"/ 
"Anxiety Disorders"/"Agoraphobia"/"Obsessive-Compulsive Disorder"/"Panic Disorder"/"Phobic Disorders"/"Stress Disorders, Traumatic" 
/"Combat Disorders"/"Stress Disorders, Traumatic, Acute"/"Stress Disorders, Post-Traumatic"/"Adjustment Disorders"/"Neurotic Disorders" 
/depressi*/dysthymi*/"Seasonal Affective Disorder"/anxiety/agoraphobia/"Obsessive-Compulsive Disorder"/ocd/"Panic Disorder"/"GAD" 
/"Generalised anxiety Disorder"/"Generalized Anxiety Disorder"/phobi*/stress disorder*/ptsd/"Adjustment Disorder"/"Adjustment 
Disorders")  
AND 
TS=(counseling/counseling/psychotherapy/counsel*/"supportive therapy"/"behavior therapy"/"cognitive behavior therapy"/"cognitive 
therapy"/"cognitive behaviour therapy"/"behavior analysis"/"behavior modification"/"exposure techniques"/"activity scheduling"/"cognitive 
analysis"/"cognitive interventions"/"thought challenging"/"cognitive restructuring"/"psychotherapy, rational-emotive"/relaxation/"relaxation 
strategies"/"guided imagery"/"imagery psychotherapy"/"problem-solving"/"anger management"/"stress management"/(psychotherapy and 
therapeutics)/"social skills"/"motivational interviewing"/"interpersonal therapy"/"parent management training"/psychoeducation/ 
"psychological treatment"/cbt/"interpersonal techniques"))/(("behavior control"/"aversive therapy"/"psychological desensitization"/ 
(desensitization, psychologic*)/"relaxation Techniques"/"Implosive Therapy"/bibliotherapy/"Psychotherapy, Brief"/"Psychotherapy, 
Multiple"/"Psychotherapy, Rational-Emotive"/"self-help"/"family therapy"/"psychological treatment") 1418 
 
  
 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
67 
__________________________________________________________________________________________________________________________________
Note: Forward slash (/) represents the Boolean operator “OR”. 
Database Search Terms  
PubMed ("primary health care"/"primary healthcare"/"primary care"/(general practi*)/"family practice"/"primary mental health care"/"family 
physician"/"primary nursing care"/"primary medical care"/"GP"/"GPs"/family medicine/"Delivery of Health Care"/"cooperative 
care"/"cooperation"/"interdisciplinary team"/"patient care team"/"mental health services"/"primary medical care delivery"/"general 
practice delivery"/"comprehensive care"/"coordinated care"/"integrated care"/"continuity of care"/"accessibility of care"/"service 
planning"/"health service structures"/"health service organization"/"health service funding"/"health service governance"/"primary 
care"/"health care services"/"continuum of care"/"mental health services"/"primary health care"/"community services"/"health care 
delivery"/"health care utilization"/"health care seeking behavior"/"health maintenance organizations"/"health service needs"/"managed 
care"/"mental health programs"/"outreach programs"/"telemedicine"/"health care policy"/"health care administration")  
AND 
("Depressive Disorder, Major"/"Depressive Disorder"/"Depression, Postpartum"/"Dysthymic Disorder"/"Seasonal Affective 
Disorder"/"Anxiety Disorders"/"Agoraphobia"/"Obsessive-Compulsive Disorder"/"Panic Disorder"/"Phobic Disorders"/"Stress Disorders, 
Traumatic"/"Combat Disorders"/"Stress Disorders, Traumatic, Acute"/"Stress Disorders, Post-Traumatic"/"Adjustment 
Disorders"/"Neurotic Disorders"/depressi*/dysthymi*/"Seasonal Affective Disorder"/anxiety/agoraphobia/"Obsessive-Compulsive 
Disorder"/ocd/"Panic Disorder"/"GAD"/"Generalised anxiety Disorder"/"Generalized Anxiety Disorder"/phobi*/stress 
disorder*/ptsd/"Adjustment Disorder"/"Adjustment Disorders")  
AND 
(psychotherapy/counsel*/"supportive therapy"/"behavior therapy"/"cognitive behavior therapy"/"cognitive therapy"/"cognitive behaviour 
therapy"/"behavior analysis"/"behavior modification"/"exposure techniques"/"activity scheduling"/"cognitive analysis"/"cognitive 
interventions"/"thought challenging"/"cognitive restructuring"/"psychotherapy, rational-emotive"/relaxation/"relaxation 
strategies"/"guided imagery"/"imagery psychotherapy"/"problem-solving"/"anger management"/"stress management"/(psychotherapy 
and therapeutics)/"social skills"/"motivational interviewing"/"interpersonal therapy"/"parent management 
training"/psychoeducation/"psychological treatment"/cbt/"interpersonal techniques"/"behavior control"/"aversive therapy"/"psychological 
desensitization"/(desensitization, psychologic*)/"Relaxation Techniques"/"Implosive Therapy"/bibliotherapy/"Psychotherapy, 
Brief"/"Psychotherapy, Multiple"/"Psychotherapy, Rational-Emotive"/"self-help"/"family therapy"/"psychological treatment") 
LIMITS: English, Clinical Trial, Editorial, Letter, Meta-Analysis, Practice Guideline, Randomized Controlled Trial, Review, Case Reports, 
"Clinical Trial, Phase I", "Clinical Trial, Phase II", "Clinical Trial, Phase III", "Clinical Trial, Phase IV", Comment, Comparative Study, 
Controlled Clinical Trial, Corrected and Republished Article, Government Publications, Guideline, Historical Article, Journal Article, 
Multicenter Study, Scientific Integrity Review, Technical Report, Core clinical journals, Nursing journals, PubMed Central 664 
TOTAL (EXCLUDING DUPLICATES) 4520 
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APPENDIX 4. ADDITIONAL DETAILS REGARDING GP PROVISION OF 
PSYCHOLOGICAL TREATMENTS 
Table 14: GP-Delivered Interventions – Study Entry, Demographics and Quality 
    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-
up rates) 
Blinding Risk 
C. S. 
Scott et 
al. (53) 
SBA 
(MDD) 
General 
Practice, 
England, UK 
(1 practice, 1 
clinician) 
 7 Referred by one GP. 
Screened by independent 
assessor (DSM-IIIR); 
BDI>20. Age 18-65. 
 
Psychosis; bipolar; organic 
brain damage; psychosis; 
secondary depression to non-
affective disorder. 
Mean age: 35.8 
Female 100% 
White NA 
 NA  
(NA) 
NA 
(post-7-9 
wks; 
100%) 
Yes High 
Mynors-
Wallace 
et al. 
(52) 
RCT 
(MDD) 
General 
Practice, 
England UK 
(15 practices, 
26 clinicians) 
 91 GPs referred patients into 
trial. Met criteria for MDD. 
HAM-D≥13. 
18-65. 
Comorbid disorders except 
Anxiety disorders; current 
treatment; current/past 
psychosis; serious suicidal 
intent; recent drug/alcohol 
abuse; physical problems 
precluding medication. 
Mean Age 37.1 
Female 76.9% 
White 95.6% 
 Patient, stratified by 
MDD severity 
(sealed envelopes) 
Defined 
Completers, 
>4 sessions 
(post-12 
wks; 
90.1%) 
Yes Low 
Mynors-
Wallace 
et al. 
(51); 
RCT (MDD) General 
Practice, 
England UK 
(24 clinicians) 
 151 GPs referred patients into 
trial. Met criteria for MDD. 
HAM-D≥13; illness 
duration≥4 wks. 18-65. 
Comorbid psychiatric disorders 
or physical illness predating 
MDD; current treatment; brain 
damage; learning difficulties; 
psychosis; serious suicidal 
intent; recent drug/alcohol 
abuse; other problems 
precluding participation. 
Mean Age 35 
Female 76.8% 
White 94.7% 
 Patient, stratified by 
MDD severity and 
chronicity 
(independent 
researcher using 
random number system 
with cards in sealed 
envelopes) 
Intent-to-
treat 
(post-12 
wks; 
89.4%) 
(1 yr from 
entrance; 
74.8%) 
Yes Low 
Blomhoff 
et al. 
(56) 
RCT 
(Soc Ph) 
Primary Care 
Centres, 
Norway/ 
Sweden (41 
practices, 47 
physicians) 
 387 Consecutively recruited 
from primary care 
(N=238) or from 
advertisements. Social 
Phobia to DSM-IV based 
on MINI-R clinical 
interview, duration≥1 yr; 
Clinical Global Impression 
Social Phobia Scale≥4. 
18-65. 
PD predating Soc Ph, or any 
other current anxiety disorder 
(except specific phobia), MDD, 
substance use or eating 
disorder; lifetime history of 
psychosis, bipolar disorder; 
suicide risk; alcohol/ substance 
abuse; expected bad 
compliance. 
Mean Age 40.4 
Female 60.5% 
White NA 
 Patient, by blocks of 8 
to Med/PL; separated 
randomisation to BT 
(Computerised random 
number system, sealed 
envelopes) 
Intent-to-
treat 
“efficacy” 
analysis 
(wk 24 
from 
entrance; 
89.4%) 
(wk 52; 
84.8%) 
Partial 
(blind to 
med 
only) 
Mod 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-
up rates) 
Blinding Risk 
Judd et 
al. (54) 
RCT 
(MDD) 
General 
Practice, 
Australia 
(92 clinicians, 
22 recruited) 
 31 MDD meeting DSM-IV; 
duration≥4 wks; judged to 
need medication.  
18-65.  
Medical Screen. Mean Age 37.5 
Female 77.4% 
White NA 
 Recruited by treating 
General Practitioner 
(NA) 
Intent-to-
treat 
(post-12 
wks; 
90.3%) 
Self-
Report 
Mod 
King et 
al (55) 
RCT 
(Depression) 
General 
Practice, 
England UK 
(84 clinicians) 
 272 Screened consecutive 
patients for HADS≥11. 
18+. 
Psychosis, organic brain 
syndrome, learning disabilities. 
Mean Age NA 
Female 70.4% 
White NA 
 Cluster randomised by 
GP in blocks of six. 
(sealed, opaque 
envelopes) 
Intent-to-
treat 
(NA) 
Self-
report 
Mod 
van 
Boeijen 
et al (57) 
RCT 
(GAD/PD) 
General 
Practices, 
Netherlands 
(46 practices) 
 142 GPs identified PD or GAD 
with Short and Simple 
Screening Interview (≥5). 
Secondary screening using 
SCID-IV diagnostic 
interview (RDC) 
Organic Mental Disorder; 
mental retardation; psychosis; 
recent treatment of anxiety; 
use of antidepressants. 
Mean Age 38.4 
Female 62.7% 
White NA 
 General Practice 
assigned to 
manual/guidelines; 
patients assigned to 
CBT vs GP care (sealed 
opaque envelopes by 
independent clinician) 
Intent-to-
treat 
(post-at 12 
wks; 
88.0%) 
(follow up- 
1 yr 
following 
start; 
67.6%) 
Self-
report 
Mod 
Finucane 
and 
Mercer 
(58) 
SBA 
(Dep and 
Anx) 
Scotland, UK 
(NA) 
 13 GPs recruited patients. 
Assessed for 1.5 hrs. 
History of recurrent MDD 
or depression/anxiety; 
MDD symptoms>2 wks, 
BDI>14.  
18-65. 
Organic brain disease, 
drug/alcohol abuse, history of 
psychosis or mania, diagnosed 
personality disorder, currently 
suicidal by BDI, unable to 
participate due to low energy. 
Mean Age 43 
Female 76.9% 
White NA 
 Not Applicable. Completers 
(3 mth; 
84.6%) 
Self-
report 
High 
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Table 15: GP-Delivered Interventions – Interventions, Training and Outcomes 
       Clinical Outcomes  
Authors Design 
(Diagnosis) 
 Interventions Training (Manual) Collaborative 
Elements (med 
usage) 
 Symptoms Function Other 
C. S. Scott 
et al. (53)
SBA 
(MDD) 
 Brief CBT (6 wks; 6 
sessions) 
 
Visiting GP with extensive 
training. 
(standard patient booklet) 
In primary care. GP 
continued TAU. 
(one patient on 
med) 
 Post; Mean 54% fall on 
HAM-D. 6/7 patients no 
longer met criteria for 
MDD.  
NA NA 
Mynors-
Wallace et 
al. (52) 
RCT 
(MDD) 
 PST (12 wks, 6 
sessions) 
 
Med (Amit) 
 
PL 
Two GPs, 1 psychiatrist. 
Reading, role plays, training 
video, supervised practice for 5 
patients. 
(Manualised) 
Patient’s home or 
local health care 
centre. (no med) 
 At 12 weeks on HAM-D; 
PST<PL; PST=Med. No 
difference by provider. 
 
At 12 weeks on social 
adjustment scale; 
PST=Med; PST superior 
to PL. 
All 28 participants who 
completed PST were 
satisfied, compared 
with 21/25 Med. 
 
Mynors-
Wallace et 
al. (51); 
RCT (MDD)  PST (GP; 12 wks, 6 
sessions) 
 
PST (nurse; 12 wks, 
6 sessions) 
 
Med (Fluv; Parox) 
 
PST(nurse)+ 
Med(GP) 
Three GPs, 2 nurses delivered 
PST. GPs received theoretical 
training and supervised practice 
for 5 patients. Supervised by 
therapist. 
(Manualised) 
Patient’s home or 
local health care 
centre. (no med) 
 At 12 and 52 wks; All 
groups improved on HAM-
D. PST(GP)= PST(nurse) 
=PST +Med=Med 
At 12 and 52 wks; All 
groups improved on 
Social Adjustment Scale. 
PST(GP)= PST(nurse) 
=PST +Med=Med 
NA 
Blomhoff et 
al. (56) 
RCT 
(Soc Ph) 
 BT+PL (8 sessions 
in 12 wks) 
 
Med(Sert) 
 
BT+Med 
 
PL 
50 primary care physicians 
(incl. 2 psychiatrists); 30 hour 
training program that included 
exposure therapy, training 
video, written material, role 
playing. local group supervision 
(Manualised)  
Patients assigned to 
new GP 
 
 At 24 wks; all groups 
improved on Social phobia 
scale, by defined 
response; BT+Med=Med 
>PL. BT=PL; 
BT+Med=BT. 
From 24-52 wks; only 
BT+PL improved on SPS. 
ON the SF-36 mental 
health function; all 
groups improved to wk 
24.  
From wk 24-52; PL and 
BT improved, BT+Med 
and Med deteriorated. 
NA 
Judd et al. 
(54) 
RCT 
(MDD) 
 Med(Ven) 
 
Med+IPT (6 
sessions, 12 wks). 
Trained with video and written 
materials 
(Patient and Treatment 
Manuals) 
Treatment by 
regular GP  
 On BDI, at wk 12; 
Med=Med+IPT 
On SF-36 at wk 12; 
Med=Med+IPT 
NA 
King et al 
(55) 
RCT 
(Depression) 
 CT 
 
TAU 
Four half-day workshops. 
(NA) 
Treatment by 
regular GP. 
Informed of 
assessment. 
 On BDI, at 6 mth, 
CT=TAU. 
On SF-36 at 6 mth, 
CT=TAU. 
On STAI, at 6 mth, 
CT=TAU. 
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       Clinical Outcomes  
Authors Design 
(Diagnosis) 
 Interventions Training (Manual) Collaborative 
Elements (med 
usage) 
 Symptoms Function Other 
van Boeijen 
et al (57) 
RCT 
(GAD/PD) 
 Guideline Based 
treatment (GP; inc. 
CBT; variable 
sessions) 
 
Guided Self-help 
(GP; 5 sessions) 
 
CBT (therapist; 12 
sessions) 
GPs present at two educational 
meetings on diagnosis, 
management. Supervision 
every 2 months. Weekly 
supervision for therapists. 
(self-help and CBT manualised) 
Treatment by regular 
GP. 
 All groups improved 
significantly on STAI to 
follow-up. GP 
Guideline=GP Self-
help=CBT. 
All groups improved 
significantly on SDS to 
follow-up. GP 
Guideline=GP Self-
help=CBT. 
All groups improved 
significantly on BDI to 
follow-up. GP 
Guideline=GP Self-
help=CBT.  
GPs viewed CBT in 
guidelines as 
unfeasible, >50% 
given medication or 
referred to secondary 
care. 
Finucane 
and Mercer 
(58) 
SBA 
(Dep and 
Anx) 
 Mindfulness-based 
CBT 
One research GP with training 
as Mindfulness instructor (8 wk 
course, further training).  
(Manualised) 
New GP for 
mindfulness course. 
 On BDI; significant fall at 
3 mths. 
On STAI; significant fall. NA 
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APPENDIX 5. ADDITIONAL DETAILS REGARDING 
ALLIED HEALTH PROVISION OF PSYCHOLOGICAL 
TREATMENTS 
MAJOR DEPRESSIVE DISORDER 
Ten of the eleven studies examining psychotherapy for MDD were judged to be of low or 
moderate risk of bias. Encouraging results for psychotherapy were found in two small early 
studies from the UK, using long-term CBT (20 weeks), in comparison to medication (66, 150, 
151), and to TAU (67). At surface level, the four subsequent studies failed to find an advantage 
for CBT (68-71). However, while not finding an effect for individual CBT, M. Scott and Stradling 
found group-CBT to be superior to waitlist controls at post (68). A. Scott and Freeman found no 
advantage for cognitive therapy compared to wait-list control, although medication groups also 
had no advantage, while superiority of generic social-work counselling to TAU could have been 
due to initial differences between the groups. Schulberg and colleagues compared medication, 
TAU, and IPT comprising weekly sessions over 4 months, followed by 4 monthly maintenance 
sessions (70, 104). In this study, medication was seen to act more quickly to reduce depression 
in comparison with TAU, with IPT producing slower reductions that only reached significance by 
the end of the maintenance phase of therapy (8 months). C. Scott and colleagues (71) found 
no difference for short-term CBT (6 weeks) at post-treatment using the Hamilton Rating Scale 
for Depression (152), although differences were significant at one year follow-up, and also at 
post-treatment when using an alternative self-report inventory, or when using a recovery rather 
than absolute change criteria.  
Since 2000, five additional studies have been produced. Ward and colleagues (72) found 
psychologist-delivered CBT to be equivalent to non-directive counselling, and superior to TAU at 
post-treatment on self-reported depression, with the differences disappearing by 12 months 
post-randomisation. Areán and colleagues (76) found no differences between group CBT, case 
management, and combined case-management/CBT at post-treatment. At 12 months follow-up, 
they found the combined condition to be superior to CBT alone, although curiously the opposite 
pattern was observed with respect to functional outcomes. Clarke et al. (73) found no 
advantage for adolescents who received short-term CBT and medication compared with those 
receiving medication, although there was some improvement in function and service use. The 
most recent two studies hail from the Netherlands. Van Schaik and colleagues (74) found no 
differences between 10 sessions of IPT delivered by psychologists and nurses in an elderly 
population, compared to TAU, at both 2 and 6 months. Finally, Conradi and colleagues (75, 
153) compared patient education, education plus psychiatric consultation, education plus brief 
CBT, and TAU. They found that all groups were equivalent in the short-term (6 months), but at 
3 years the psychiatric and CBT conditions were superior to education only or TAU. 
MINOR DEPRESSION OR DYSTHYMIA 
A number of studies have been conducted examining minor depression, dysthymia, or sub-
clinical depression. In the earliest, Miranda and Munoz (77) excluded participants with major 
depressive disorder and dysthymia. They found that in comparison to TAU, 8 sessions of group 
CBT led to reductions in self-report depression at 6 months and 1 year, but only for those with 
minor depression. In a large study examining brief PST versus medication or placebo, no 
advantage was found for PST in adults (79) or the elderly (78), at post-treatment. Post-hoc 
analyses suggested remission was higher in adults for PST and medication versus TAU, but only 
for dysthymia and not minor depression (79). Browne and colleagues (80) conducted the 
largest study in primary care, involving 707 participants, and compared medication, IPT and 
combined medication and IPT. They found that medication and combined treatment were 
superior to IPT alone, at both 6 months (post-treatment) and 2 year follow-up. They note, 
however, that when examining costs, the combined treatment had advantages over the 
medication-only condition. 
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ANXIETY/DEPRESSION 
Lang and colleagues report on two studies examining mixed samples experiencing anxiety and 
depression in primary care. In a small pilot study in a veteran’s clinic, very brief CBT (4 
sessions) was superior on self-report depression and anxiety relative to TAU (83), although the 
low follow-up rates make the study at risk of bias. In a slightly larger study in primary care, 
modified problem solving treatment (4 sessions) was superior to TAU (84); approximately 68% 
of participants in this study had MDD. In a Dutch study, Brouwers and colleagues reported that 
PST (5 sessions) for generalised anxiety/mild MDD provided by a social worker was no superior 
to TAU (81). Finally, McKee and colleagues (82) examined social-worker provided CBT for low-
income, pregnant minority women, finding no difference at 3 months postpartum relative to 
TAU, although the low-follow up rates should be acknowledged. 
GENERALISED ANXIETY DISORDER 
Four studies have examined psychotherapy for GAD in primary care, although three were 
judged to be at high risk of bias. Lindsay and colleagues (90) found group CBT, group Anxiety 
Management and medication (benzodiazepine) to all be superior to waitlist, with the 
improvement maintained in the group treatments at 3 months following therapy. Power and 
colleagues found CBT (6 weeks) to be superior to placebo and no different to benzodiazepine 
treatment post-study (91). Their subsequent, larger study found similar results for longer term 
CBT (9 weeks) over TAU, with combined medication and CBT also being superior to medication 
(92, 99). Finally, in a non-RCT, Price and colleagues (93) found integrated care plus CBT to be 
superior to TAU up to 3 months post-therapy. 
PANIC DISORDER 
Six studies examined the use of psychotherapy for Panic Disorder. Sharp and colleagues 
compared 12 session CBT with medication, placebo and combined treatments, finding all 
treatment groups to be superior to placebo at post-treatment (85, 105, 154, 155), with the 
combined medication/CBT group differentiating from the placebo group at an earlier stage of 
treatment. The same group conducted two studies examining the effectiveness of different 
formats of CBT therapy. In a comparison of group CBT, individual CBT and waitlist for panic 
disorder, they found the two treatment groups to be superior (88). However, group CBT 
showed a lower proportion of individuals finishing treatment, and a lower percentage showing 
clinically significant change at follow-up. Their third study compared different intensities of 
treatment, contrasting bibliotherapy (1.5 hours therapist contact), minimal contact CBT (2 hours 
total contact) and normal CBT (12 hours contact) (87, 156). At post-study, minimal and full 
contact CBT were superior to bibliotherapy on anxiety and depression levels. The normal CBT 
group was also superior to the minimal CBT group on some measures of disability at 12-weeks 
(156), and superior to both the minimal CBT and bibliotherapy group on recovery from anxiety 
at 6 months (87).  
Mitchell examined medication only against combined medication and CBT delivered by a social 
worker, finding superior results in the combined treatment at post-treatment, although as a 
non-RCT, the study was potentially biased. Addis and colleagues (89, 97) compared CBT (12-15 
sessions) against non-CBT therapy, with no difference between groups post treatment, but both 
lower anxiety and depression in the CBT group at 8.5 months. At 2 years, there was no 
difference between the groups. Finally, in the Netherlands, van Boeijen et al. (57) found no 
difference for Panic Disorder (69% of participants) and GAD (31%) when comparing 12 
sessions of CBT by therapists to guided-bibliotherapy by GPs and to guideline-based treatment 
by GPs (including CBT). However, the guideline-based treatment, including CBT, was seen as 
unfeasible by participating GPs. 
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UNSPECIFIED DISTRESS 
Three studies examined treatment where no specific criteria for depressive or anxiety disorders 
were used, perhaps more generally mimicking conditions in primary care. Earll and Kincey (94) 
found no difference between behaviour therapy and TAU at 7 months from the start of 
treatment. Robson and colleagues (95) reported outcomes for a large number of participants 
given BT or TAU in a health centre. They found superiority on a non-standard measure of 
severity to 32 weeks from referral, with no difference at 12 months. Both of these studies were 
not manualised. Trepka and colleagues (96) compared group cognitive therapy and individual 
counselling of an unspecified nature for anxiety treatment, finding an advantage post-treatment 
for the individual-treatment group that was maintained at 12 months.  
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
75 
__________________________________________________________________________________________________________________________________ 
  
 
Table 16: Allied Health-Delivered Interventions – Study Entry, Demographics and Quality 
    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Blackburn 
et al. 
(66) 
RCT 
(MDD) 
General 
Practice, 
Scotland, UK (1 
practice) 
 39 Referred by 
clinicians. Screened 
using PSE (RDC); 
BDI≥14. Age 18-65. 
 
Deluded, Extreme retardation; 
bipolar; psychosis. 
Mean age: 43.3 
Female 78.1% 
White NA 
 Patient.  
(NA) 
Completers 
(20 wks from 
start, 62%) 
Yes High 
Earll and 
Kincey 
(94) 
RCT 
(None) 
General 
practice, 
England, UK. (1 
practice, 4 
clinicians) 
 48 No criteria. 
Age 15+ 
 
Psychosis, brain disease, 
current treatment. 
Mean age 37.1 
Female 71.4% 
White NA 
 Patient 
(sealed envelopes) 
Completers (7 
mths from ref; 
79%) 
Partial (If 
informed) 
Mod 
Robson 
et al (95) 
RCT 
(None) 
General 
Practice, 
England, UK. (6 
clinicians) 
 429 No criteria.  
 
None. Mean age 32.9 
Female 72% 
White NA 
 Patient  
(card system) 
Completers 
(12 mths from 
start; NA) 
No High  
Teasdale 
et al. 
(67) 
RCT 
(MDD) 
General 
Practice, 
England UK. 
(13 practices) 
 44 Screened by GP 
(RDC), BDI>20. 
Rescreened by 
psychiatrist. 
 
Psychosis Mean age 37.5 
Female 94% 
White NA 
 Patient 
(NA) 
Completers  
(post-ave 17 
wks, 77%) 
(3 mths post; 
75%) 
Yes Mod 
Trepka et 
al. (96) 
CCT 
(None) 
Health Centre, 
Scotland UK (1 
practice) 
 26 Anxiety assessed by 
psychologist. 
 
Comorbid psychiatric 
conditions 
Mean age 36.1 
Female 83.3% 
White NA 
 
 Matched with 12 
individual treatment  
(Not Applicable) 
Completers 
(post 65%;  
1 yr post 
54%) 
No (Self-
report) 
High 
Lindsay 
et al. 
(90) 
RCT 
(GAD) 
GPs, Scotland 
UK (2 practices) 
 40 GP referral; GHQ 
anxiety >3/7. 
 
GHQ dep>3/7. GP diagnosis 
of specific phobia. 
Mean age 36.1 
Female 60% 
White NA 
 Patient  
(no blinding) 
Completers 
(post 100%) 
(3 months 
post 85% of 
therapy 
groups only) 
 
No (self-
report) 
High 
Power et 
al (91) 
RCT 
(GAD) 
GP setting, 
Scotland UK 
(NA) 
 31 GP referral; 
Psychologist screen 
using PSE (RDC); 
HRS-A>15; 
symptoms>1 mth; 
No psychol Med in 3 
wks prior to study  
 
Primary phobic or MDD 
disorders. 
Mean Age 34.2 
Female 87% 
White NA 
 Patient 
(independent 
generation, sealed 
envelopes) 
Unclear 
(post NA) 
(12 mth post 
NA) 
Blind to 
medication; 
partial to 
CBT (If 
informed) 
Mod 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Power et 
al (92, 
99) 
Durham 
et al 
(103) 
RCT 
(GAD) 
GP setting, 
Scotland UK 
(NA) 
 111 GP referral; 
Psychologist screen 
using PSE (RDC); 
HRS-A>15; 
symptoms>1 mth; 
18-65. 
 
No psychol Med in 3 wks prior 
to study. 
Mean Age 40.5 
Female 71.2% 
White NA 
 Patient 
(independent 
generation, sealed 
envelopes) 
Completers 
(post-at 10 
wks; 93.5%) 
(6 mths post 
84.7%) 
 
(11-14 years 
post; 29.7%) 
Blind only 
to 
medication 
(GP/Psyc 
Rated) 
High 
M. Scott 
and 
Stradling 
(68) 
RCT 
(MDD) 
Health Centre, 
Liverpool UK. (1 
practice, 5 
clinicians) 
 67 GP referred 
depressed patients. 
Screened by 
psychiatrist for RDC 
for MDD. BDI≥14 
 
NA Mean age: 33  
Female 70.1% 
White NA 
 Patient 
(predetermined 
sequence based on 
referral flow and time 
constraints) 
Intent to treat 
(Post 71.6%) 
Self-Report  Mod 
A. Scott 
and 
Freeman 
(69) 
RCT 
(MDD) 
General 
Practices 
Scotland, UK 
(14 practices; 
63 GPs) 
 121 GP identification; 
Screened by lay 
trained coordinator 
for DSM-III.  
Delusions, Schizophrenia, 
Suicide risk, Alcohol/Drug 
abuse. 
Mean Age 31.8 
Female 75% 
White NA 
 Patient 
(sealed envelopes) 
Completers 
(post – at 16 
wk 93.2%) 
Partial (If 
informed) 
Mod 
Miranda 
and 
Munoz 
(77) 
RCT 
(Minor Dep) 
Primary care, 
CA, US. (NA) 
 150 Contacted from 
clinics. Diagnostic 
Interview Schedule 
to exclude. 18-69.  
(33% had BDI≥18) 
 
MDD, dysthymia, substance 
abuse, psychotic disorders, 
bipolar disorder, organic brain 
disorders. 
Mean Age 52.5 
Female 62% 
White 35.1% 
 Patient 
(NA) 
Intent-to-treat 
(post – at 2 
mth 92%) 
(4 mth post 
90%) 
(10 mth post 
92%) 
Self-Report Mod 
Schulberg 
et al 
(70). 
Coulehan 
et al. 
(104) 
RCT 
(MDD) 
Academically 
affiliated 
ambulatory 
health centres 
(4 practices), 
US 
 276 Recruited from 
waiting rooms. 18-
64 yrs.  
CES-D≥22; not 
presently treated. 
Second screening 
using interview 
schedule (RDC). 
Third screening, 
HAM-D≥13. 
 
No medical/ psychiatric 
conditions preventing 
randomisation.  
Mean age 38.1 
Female 83.3% 
White 55.4% 
 Patient, blocked by 
groups of 10 
(Computer generated, 
sealed envelopes) 
Intent-to-treat 
(8 mth from 
start, 54.3%) 
Yes Low 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Sharp et 
al. (85) 
(105) 
RCT 
(PD) 
General 
practice, 
Scotland, UK. 
(NA) 
 190 GP referral to study; 
clinical psychologist 
semi-structured 
interview. 
DSM criteria (RDC), 
HAM≥15 at entry 
and day 7; 
duration≥3 mnths; 
18-70. 
 
Washout from drugs; MDD as 
defined as MADRS≥21; OCD, 
psychosis, severe concurrent 
somatic disease, neurological 
deficits or disease; substance 
abuse; high suicide risk; 
pregnant; physical disability; 
psychological treatments in 
previous 6 months. 
Mean age 37.6 
Female 77.1% 
White NA 
 Patient 
(Opaque envelopes) 
“Defined 
Completers” 
(≥42 days 
treatment) 
(post – at 12 
wks, 78%) 
(6 mth post 
66.3%) 
Yes Mod 
C. Scott 
et al (71) 
RCT 
(MDD) 
General 
Practice, 
England UK (11 
practices) 
 48 Identified by GPs. 
Assessed by 
psychiatrist for DSM 
criteria, BDI≥20, 
duration<2 yrs. 
18-65. 
 
Bipolar disorder, organic brain 
damage, psychosis, dysthymic 
disorder, depression 
secondary to psychiatric 
illness, previous CBT, non-
reader. 
Mean age 41 
Female 66% 
White NA 
 Patient, Stratified by 
gender, severity- 
BDI≥30, chronicity  
(NA)  
Completers 
(post- at wk 
7; 71%) 
(1 yr post 
50%) 
Yes Mod 
Mitchell 
(86) 
SBA 
(PD) 
Self-referred to 
large HMO, 
Washington 
(NA) 
 56 18+. Diagnosed as 
having PD. 
 
No comorbid mental disorder. Mean age 38.1  
Female 76.8% 
White 33.9% 
 Not applicable. NA 
(post NA) 
Self-report High 
Power et 
al. (87) 
RCT 
(PD) 
General 
Practice, 
Scotland UK 
(26 practices) 
 104 Referred by GP; 
Screened by 
psychologist, DSM-
III criteria; HAM-
A≥15; symptoms≥3 
mths; no 
psychological 
treatment in 6 mths. 
18-70. 
 
Montgomery Ashberg 
Depression Scale<20 
Mean age 38.3 
Female NA 
White NA 
 Patient (blind 
assignment) 
 
“Defined 
Completers” 
(≥42 days 
treatment) 
(post - wk 12; 
87.5%) 
(6 mth post; 
60.5%) 
Yes Mod  
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Price et 
al. (93) 
Non-RCT; 
case-control 
trial 
(GAD, 
anxiety 
secondary to 
MDD) 
Family practice 
in HMO; 
Colorado, US.  
Matched 
sample from 
internal 
medicine 
patients (1 
practice).  
 214 Primary care 
providers screened 
all patients 
suspected of 
anxiety, secondary 
assessment by 
psychologist. 
Automated 
screening and 
diagnostic tool for 
DSM-IV.  
18+. 
 
Current alcohol/ substance 
abuse. Psychosis, dementia, 
bipolar disorder, terminal 
illness. Suicide risk referred to 
mental health department. 
(Family Practice 
Cohort) 
Mean Age 44.5 
Female 81.4% 
White 85.7% 
 Cohort controlled by 
treatment unit.  
(Not Applicable) 
Completers 
(6 mth from 
referral, 64%) 
Yes. High 
Ward et 
al. (72)  
RCT (3 way 
randomised 
data)  
(MDD) 
General 
Practices, 
England, UK 
(24 practices, 
73 GPs) 
 197 Referred by GP. 
Assessed by 
researcher. BDI≥14.  
18+. 
 
Suicidal intent, psychological 
therapy in past 6 mths, 
restricted mobility, organic 
brain disease, inability to 
complete questionnaire. 
Mean age 37 
Female 77.2% 
White 89.8% 
 Patient stratified by 
BDI 
(opaque envelopes; 
preference arm for 
refusers). 
Intent-to-treat 
(4 mth from 
referral, 
91.3%) 
(12 mth from 
referral, 
83.7%) 
Self-report Mod 
Williams 
et al. 
(78)  
RCT 
(Dysthymia/ 
Minor 
depression) 
Primary care 
practices, US (4 
practices) 
 415 Referral and 
screening at clinics. 
Assessed for DSM-
III-R criteria by 
psychologist/ 
psychiatrist using 
PRIME-MD. HAM-
D≥10.  
60+. 
 
MDD, psychosis, 
schizophrenia, schizoaffective 
disorder, bipolar disorder, 
substance abuse within 6 
mths, antisocial or borderline 
personality disorder, serious 
suicidal risk, moderate 
cognitive impairment, terminal 
illness, current treatment. 
Mean age 71 
Female 41.4% 
White 78.2% 
 Patients, blocked and 
stratified by site, 
diagnosis, using 
computerised random 
numbers, (concealed 
assignment codes). 
Intent-to-treat 
(post - 11 wk 
74.9%) 
Yes Low 
Barrett et 
al. (79) 
RCT 
(Dysthymia/ 
Minor 
depression) 
Primary care 
practices (2 
practices), US 
 241 Referral and 
screening at clinics. 
Assessed for DSM-
III-R criteria by 
psychologist/ 
psychiatrist using 
PRIME-MD. HAM-
D≥10.  
18-59. 
 
MDD, psychosis, 
schizophrenia, schizoaffective 
disorder, bipolar disorder, 
substance abuse within 6 
mths, antisocial or borderline 
personality disorder, serious 
suicidal risk, moderate 
cognitive impairment, terminal 
illness, current treatment. 
Mean age 44.1 
Female 63.9% 
White 90% 
 Patients, blocked and 
stratified by site, 
diagnosis, using 
computerised random 
numbers (concealed 
assignment codes). 
Intent-to-treat 
(post - 11 
week 79.3%) 
Yes Low 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Browne 
et al. 
(80) 
RCT 
(Dysthymia) 
 
Primary care 
Health Services 
Organisation, 
Canada. (NA) 
 707 Screening at for 
DSM-IV. 18-74. 
 
Pregnant, history of using 
Sert; acute suicide risk, 
participating in other study, 
unwilling to undertake 
washout, on any sertonergic 
drug, bipolar disorder, 
schizophrenia, psychosis, 
unstable medical condition. 
6 mth 
Completers 
Mean age 42.4 
Female 68% 
White NA 
 Patient  
(Computerised 
randomisation 
schedule) 
Completers 
analysis 
(post- at 6 
mths 82.8%) 
(2 yrs after 
entrance 
74.3%) 
Yes Mod 
Lang (83) RCT 
(Anxiety and 
Depression) 
Veterans 
primary care 
clinic, US (1 
practice) 
 35 Screened in waiting 
room using Brief 
Symptom Inventory. 
BSI≥63. On further 
assessment, entered 
if CES-D≥16 or 
BAI≥12. 18+ 
 
Excluded if BAI≥36 or CES-
D≥39 and judged to have 
major mental disorder and be 
severely distressed on Anxiety 
Disorders Interview Schedule. 
Psychosis, cognitively 
impaired, CBT in past two 
years. 
Mean age 48.6 
Female 14.3% 
White 63% 
 Patient 
(NA) 
Completers 
(post-at 1 mth 
54%) 
(1 mth after 
post- 54%) 
 
Self-report. High 
Sharp et 
al. (88) 
RCT 
(PD) 
General 
Practices, 
Scotland, UK 
(NA) 
 97 Referred by GPs. 
Meet DSM-IV 
criteria, HAM-A≥15, 
MADRS≤20; 
symptoms≥3 mths, 
no psychological 
treatment for PD in 
past 6 mths 18-70. 
 
NA Completers 
Mean age 37.7 
Female NA 
White NA 
 Patient (Opaque 
envelopes) 
“Defined 
completers” 
(>5 sessions) 
(post-at 12 
wks, 72.2%) 
(3 mth post 
57.7%) 
Yes Mod 
Arean et 
al. (76)  
RCT 
(MDD/ 
dysthymia) 
Primary Care 
provider and 
self-referral. 
US. (NA) 
 67 Clinician or self-
referral. Structured 
clinician interview. 
Low income, DSM-IV 
criteria for MDD or 
dysthymia, 60+ 
 
Cognitively impaired, history 
of psychosis or mania, current 
substance abuse or 
dependence, current 
antidepressant use. 
Mean age 65.3 
Female 64.2% 
White 58.2% 
 
 Patient, stratified by 
diagnosis and site 
(computer generated) 
NA 
(Post 74.6%) 
(6 mth post, 
65.7%) 
(12 mth post, 
71.6%) 
Yes Mod 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Clarke et 
al (73) 
RCT 
(MDD) 
Pediatric HMO, 
US. (NA) 
 152 Identified SSRI users 
using electronic 
records, with PCP 
permission to 
contact youth. DSM-
IV diagnosis using 
structured interview. 
12-18. 
 
Excluded schizophrenia, 
developmental/ intellectual 
disability. Extreme suicide 
risk. 
Mean Age 15.3 
Female 79% 
White 86% 
 Patient, block 
stratified, by age and 
depression severity.  
(computerised system) 
Intent-to-treat 
(6 wk from 
randomisation 
86.8%) 
(12 wk from 
randomisation 
80.2%) 
(6 mth from 
randomisation 
83.6%) 
(1 yr from 
randomisation 
75%) 
Yes Low 
van 
Boeijen 
et al (57) 
RCT 
(GAD/PD) 
General 
Practices, 
Netherlands (46 
practices) 
 142 GPs identified PD or 
GAD with Short and 
Simple Screening 
Interview (≥5). 
Secondary screening 
using SCID-IV 
diagnostic interview 
(RDC) 
Organic Mental Disorder; 
mental retardation; psychosis; 
recent treatment of anxiety; 
use of antidepressants. 
Mean Age 38.4 
Female 62.7% 
White NA 
 General Practice 
assigned to 
manual/guidelines; 
patients assigned to 
CBT vs GP care (sealed 
opaque envelopes by 
independent clinician) 
Intent-to-treat 
(post-at 12 
wks; 88.0%) 
(follow up- 1 
yr following 
start; 67.6%) 
Self-report Mod 
Addis et 
al. (97); 
RCT 
(PD) 
HMO, US. (NA)  80 Self-referred via 
member newsletter 
or by physicians. 
Diagnostic 
assessment for PD 
or sub-threshold 
panic. 
18-70 
 
Seeking treatment for other 
disorder, untreated substance 
use in past 6 mths, psychosis 
in past 5 yrs, at risk of suicide, 
involved in individual 
psychotherapy. 
Mean Age 39.9 
Female 70% 
White 80% 
 Patient 
(Independent 
allocation) 
Intent-to-treat 
(1 yr 93.8%) 
(2 yrs 90%) 
Yes Low 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Brouwers 
et al. 
(81) 
RCT 
(GAD, mild 
MDD, no 
disorder). 
Netherlands.(70 
clinicians) 
 194 Emotional 
distress/minor 
mental illness 
according to GP or 
self-report; on paid 
employment; on sick 
leave for emotional 
or mental 
problems<3 mths. 
Given CIDI.  
18-60. 
 
Severe mood disorders or 
anxiety disorders. Already 
receiving psychotherapy.  
Mean age: 39.7 
Female 59.3 
White NA 
 Patient, block 
randomisation, (sealed 
envelopes by 
independent 
administrator) 
Intent-to-treat 
(3 mth after 
randomisation 
96.9%) 
(6 mth after 
randomisation 
92.3%) 
(18 mth after 
randomisation 
84.0%) 
 
Partial 
(possibly 
informed) 
Low 
Lang et 
al (84) 
RCT 
(Anx and 
Dep; 67.7% 
MDD) 
Primary care 
clinics, 
California, US 
(4 practices). 
 62 Screened in waiting 
room or referred by 
PCP. 
BSI T score≥63 on 
any subscale. Given 
MINI interview. 18+ 
 
CBT in past year, serious 
medical illness, suicidality, 
lifetime schizophrenia, 
psychosis, mental retardation, 
organic mental disorder, 
bipolar disorder, OCD, eating 
disorder, alcohol substance 
abuse in previous 6 mths. 
Mean Age 46.6 
Female 53.2% 
White 79% 
 Patient, stratified by 
entrance method. 
(random-numbers 
table) 
Intent-to-treat 
(Post 83.8%) 
(3 mths post 
75.8%) 
(6 mths post 
74.2%) 
Self-report  Mod 
McKee et 
al. (82) 
RCT 
(depressive 
symptoms) 
Community 
health centres, 
US. 
 100 Low-income, 
minority women 
receiving prenatal 
care for low-risk 
pregnancy, with 
BDI≥14.  
 
No major mental illness or 
medical complication. 
Mean age 24.7  
Female 100%  
White 0% 
 Patient 
(independent 
allocation, sealed 
envelopes) 
Intention-to-
treat 
(3 mths 
postpartum 
approx 57%) 
Self-report Mod 
van 
Schaik et 
al. (74) 
RCT 
(MDD) 
Amsterdam, 
Netherlands (12 
practices) 
 143 Identified by 
screening 
questionnaire to 
recent attendees. 
Second screening by 
researcher using 
PRIME-MD for 
depression. 55+ 
 
Treatment at time of 
screening, severe cognitive 
impairment. 
Mean Age 67.9 
Female 69.2% 
White NA 
 Patient blocked by 
practice 
(independent 
researcher using 
random number table) 
Intent-to-treat 
(2 mth 
following 
entrance 
83.2%) 
(6 mth 
following 
entrance 
83.9%) 
 
Yes Low 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry  
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Conradi 
et al. 
(75) 
RCT 
(MDD) 
General 
Practice, 
Netherlands (49 
clinicians) 
 267 Patients currently 
treated for MDD by 
GP. Given telephone 
screening and face-
to-face structured 
interview for 
diagnosis. 
18-70. 
 
Psychosis, bipolar disorder, 
dementia, primary 
alcohol/substance abuse, 
pregnancy, receiving specialty 
mental health treatment. 
Mean Age 42.8 
Female 65% 
White NA 
 Patient, blocked 
(Computer generated 
random list, using 
opaque sealed 
envelopes) 
Intent-to-treat 
(3 mth from 
baseline 
90.3%) 
(6 mth from 
baseline 
85.0%) 
(36 mth from 
baseline 
84.6%) 
Partial. Mod 
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Table 17: Allied Health-Delivered Interventions – Interventions, Training and Outcomes 
 
       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Blackburn 
et al. 
(66) 
RCT 
(MDD) 
 CT (20 wks; 23 
sessions) 
 
CT+Med(antidep). 
 
Med 
Psychologists. 
(Followed Beck 
Manual, gave 
patient info sheet) 
Location unclear. Med 
Prescription in consultation 
with Psychiatrists 
 Significant percentage change on 
HAM-D post; 74.2% on CT+Med; 
77.3% on CT; 16.4% on Med. 
(CT+Med=CT)<Med. 
NA NA 
Earll and 
Kincey 
(94) 
RCT 
(None) 
 BT (not limited) 
 
TAU 
Psychologist. 
(No) 
Working within practice. 
Assessment and treatment 
reports to doctor; verbal 
feedback as necessary. 
(54.8% on med during 
trial) 
 At 7 mths from referral; 
proportion not “personally ill” on 
DSSI/sAD scale; BT 45% TAU 
50%. (ns) 
NA Lower prescriptions 
for psychotropic 
drugs in BT group. 
Robson 
et al (95) 
RCT 
(None) 
 BT+TAU (10 wks) 
 
TAU 
Psychologist. 
(No) 
Working within health 
centre. (NA) 
 BT<TAU on likert scale of 
severity to 32 wks from referral; 
at 12 mths BT=TAU. 
NA Satisfaction significant 
to 22 wks; at 12 mths 
71% BT vs 66% TAU 
(ns) 
Teasdale 
et al. 
(67) 
RCT 
(MDD) 
 CT (20 wks, 20 
sessions) 
 
TAU 
Experienced 
psychologists, 
trained by Beck’s 
centre. Therapy 
rated for fidelity. 
(No) 
Location not stated. GPs 
prescribed medication 
(67.6% on medication) 
 Post treatment, CT<TAU on 
HAM-D; 3 mths follow-up ns. 
NA NA 
Trepka et 
al. (96) 
CCT 
(None) 
 Group CT (11-13 
sessions, 11-13 
wks) 
 
Ind Counselling 
(Not Spec) 
Psychologist and 
Nurse-led group 
(Manualised group) 
Location not stated. TAU 
allowed. (Nine patients on 
meds prior to group.) 
 STAI significant red for both 
groups. Ind<Group CT at post on 
STAI; At 1 yr Group CT 
reductions ns; individual 
counselling remained sig. 
NA Fall in staff usage; 
significant for 
individual counselling; 
ns for group. 
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       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Lindsay 
et al. 
(90) 
RCT 
(GAD) 
 CBT group (4 
wks, 8 session) 
 
Anxiety 
Management 
Group (4 wks, 8 
session) 
 
Med group (BZ) 
 
WL group 
Psychologist. 3 
workshops; support 
group; review of 
session content. No 
formal rating of 
fidelity. 
(Manualised 
groups) 
Location not stated. (6-wk 
washout of drugs prior to 
trial) 
 At post; fall on Zung Anx for CBT 
and AMT but not Med and WL; 
CBT=AMT=Med<WL on Zung 
post-treatment. At follow-up no 
changes on Zung anxiety for CBT 
and AMT (BZ and WL not 
assessed) 
 
GHQ general health improved 
post for CBT, Med, AMT. 
CBT=Med<AMT=WL post; 
GHQ Social skills improved 
post for CBT, AMT. 
CBT=Med=AMT<WL post. 
No changes for CBT and AMT 
on GHQ general health or 
social (BZ, WL not assessed) 
NA 
Power et 
al (91) 
RCT 
(GAD) 
 CBT (6 wks, 4 
sessions) 
 
Med (DZ) 
 
PL 
Psychologist. No 
formal rating of 
fidelity. (Semi-
Manualised CBT) 
Treatment provided in 
primary care. (no med for 
therapy group) 
 HAM-A decreased in all groups at 
post. At post-treatment CBT<PL. 
CBT=Med; Med=PL. 
NA At 12 mth, 3/10 CBT, 
7/10 Med and 6/11 
PL sought additional 
treatment. 
Power et 
al (92, 
99) 
Durham 
et al 
(103) 
RCT 
(GAD) 
 CBT (9 wks, 7 
sessions) 
 
Med (DZ) 
 
CBT+Med 
 
CBT+PL 
 
PL 
Psychologist. No 
formal rating of 
fidelity. (Guidelines 
for CBT) 
Treatment provided in 
primary care. GP rating 
symptoms (no med for 
therapy group) 
 All groups improved by psych/GP 
ratings of severity at 10 wks; on 
HAM-A 
(CBT+Med=CBT=CBT+PL)<PL 
Med=PL; Med+CBT<Med 
CBT, PL+CBT=Med 
 
PL+CBT, Med< CBT+Med (GP 
rating). GPs noted improvements 
in 45% Med; 36% PL; 86% CBT; 
87% CBT+Med; 72% PL+Med. 
 
At 11-14 yrs; significant 
improvement on HAM-A for CBT 
but not non-CBT group. 
CBT=non-CBT. 
At 70 days; on GHQ total; 
Med<CBT; PL<CBT; 
Med<CBT+Med; 
PL<CBT+Med 
6 month post; no diff 
in number given Med; 
Greater referrals to 
further treatment for 
PL, Med. 
M. Scott 
and 
Stradling 
(68) 
RCT 
(MDD) 
 CBT (12 sessions, 
3 mths) 
 
Group CBT (12 
sessions, 3 mths) 
 
TAU 
CBT provided by 
SW. No fidelity 
review reported 
(NA) 
 
Treatment at health centre. 
Results of assessments 
made available to GPs. GPs 
managed medication. 
 On BDI, Group CBT=CBT; Group 
CBT<WL. 
NA NA 
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       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
A. Scott 
and 
Freeman 
(69) 
RCT 
(MDD) 
 CBT (up to 16 
sessions) 
 
SW Counselling 
 
Psychiatrist Med 
(Amit) 
 
GP TAU. 
Experienced 
psychologists No 
formal rating of 
fidelity. 
(No) 
Treatment provided in 
primary care. (No meds in 
therapy groups.) 
 At wk 4, HAM-D Med<TAU; wk 
16 SW<TAU (but could be due to 
initial differences). 
Recovery (HAM-D≤6) SW 
superior to TAU. 
NA Overall satisfaction 
SW>Med,GP 
Miranda 
and 
Munoz 
(77) 
RCT 
(Minor Dep) 
 Group CBT (8 
wks, 8 sessions x 
2hrs) 
 
No-intervention/ 
brief information 
control 
Doctoral Level 
psychologist. No 
formal rating of 
fidelity. 
(Manualised CBT) 
Location not stated. No 
collaboration stated. 
(Average of 4 medications 
per patient) 
 For those with minor depression; 
greater reduction in BDI at 6 mth 
and 1 yr for CBT vs control 
group. No differences for non-
minor depression. 
No differences in visit to 
medical clinic. 
For those with minor 
depression, 
somatisation by HSC 
lower at 6 mth and 1 
yr in group CBT vs 
control group. 
Schulberg 
et al 
(70). 
Coulehan 
et al. 
(104) 
RCT 
(MDD) 
 IPT (8 months; 20 
sessions) 
 
Med(NT by 
psychiatrist) 
 
GP TAU (informed 
of diagnosis) 
Psychologists and 
psychiatrists 
already skilled in 
IPT. Trained in 
standardised IPT, 
consultation 
meetings and 
review of 
audiotaped 
sessions. 
(no manual stated) 
All treatments in usual 
primary care setting. Usual 
GP care during 
intervention. If non-
responder after 8-10 
weeks, referred to GP for 
other treatment. Therapy 
patients free to see GP. GP 
informed of diagnosis in 
TAU condition. 
 Med<TAU at all assessment 
points; IPT<TAU at 8 months; 
Med=IPT at all points. 
Recovery (HAM-D≤6), CBT=med 
superior to TAU. 
At 8 mth, IPT and Med 
combined associated with 
greater improvement that 
TAU on SF-36 except for 
general health and pain. 
Medical comorbidity 
at baseline associated 
with poorer functional 
outcomes. 
42% of Med 
completed full 
protocol; 39% of IPT. 
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       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Sharp et 
al. (85) 
(105) 
RCT 
(PD) 
 CBT (12 wks; 12 
sessions) 
 
Med (FL) 
 
PL 
 
PL+CBT 
 
Med+CBT 
 
Masters level 
psychologist with 7 
years experience. 
Fidelity performed 
but not reported. 
(treatment manual 
for patients) 
Treatment conducted in 
usual primary care setting. 
None explicit, but patients 
continued to have access 
to GP. (No concurrent 
meds in CBT group) 
 On HAM-A, at all time points to 
12 wks, CBT=Med 
=PL+CBT=Med+CBT. From wk 
4, FL+CBT<PL. At wk 6-12, all 
treatment groups<PL. 
At 6 mths, clinically significant 
change on HAM-A descriptively 
higher in groups with CBT 
relative to FL and PL. 
At 12 wks, on General Health 
Questionnaire; CBT 
groups<Med-only groups; 
Med<PL, Med<PL+CBT. 
Same results for Sheehan 
Disability Scale. 
 
Higher levels of those 
with CBT did not have 
additional treatment 
at 6 mth. 
On Depression 
(MADRS), FL+CBT 
and CBT<PL at wk 6 
and 12, PL+CBT and 
FL< PL at wk 12. At 
all time points no diff 
between active 
treatment groups. 
Lower levels of 
anxiety and higher 
extraversion predicted 
better outcome at 
day 84; higher 
depression predicted 
worse outcome at 6 
months. 
C. Scott 
et al (71) 
RCT 
(MDD) 
 CBT (6 wks, 6 
sessions) 
 
TAU 
Post-graduate 
qualified (not 
specified). Quality 
of treatment 
assessed by audio-
taping of sessions. 
(Yes) 
Location of treatment not 
specified. All patients 
continued to be managed 
by GPs. (95.8% of patients 
on antidepressants) 
 On HAM-D, no differences post. 
CBT<TAU at 58 wks; On BDI, 
CBT<TAU at post 7 wks. 
Greater recovery in CBT than 
TAU at post (HAM-D≤6). 
NA NA 
Mitchell 
(86) 
SBA 
(PD) 
 Med+Group CBT 
(8 sessions, 8 
wks) 
 
Med 
CBT provided by 
SW. No fidelity. 
(Manualised) 
Group at HMO. Medication 
by psychiatrist. 
 On SCBAI, Group CBT+med 
superior on behavioural, 
cognitive and somatic subscale 
relative to Med. 
NA NA 
Power et 
al. (87) 
RCT 
(PD) 
 CBT (8 sessions, 
12 hours total); 
 
minimal CBT (6 
sessions, 2 hours 
total) 
 
bibliotherapy (1.5 
hrs contact) 
Clinical 
psychologist. 
Fidelity not 
reported. 
(treatment manual 
for patients) 
All treatments in primary 
care setting. Patients 
required to take medication 
as prescribed. 
 On HAM-A; at wk 7 and 12 
CBT<minimal CBT=bibliotherapy. 
At 6 mths, CBT<minimal 
CBT=bibliotherapy on recovery 
(HAM-A≤10). 
At wk 12 on Sheehan 
disability scale; disruption to 
work CBT<minimal 
CBT=bibliotherapy; on 
disruption to social life and 
home life CBT=minimal 
CBT<bibliotherapy. 
On depression 
(MADRS); at wk 12 
CBT=minimal 
CBT<bibliotherapy. 
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       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Price et 
al. (93) 
Non-RCT; 
case-control 
trial 
(GAD, 
anxiety 
secondary to 
MDD) 
 Integrated care 
including CBT (4-
6 sessions) 
 
TAU (internal 
medicine 
patients) 
PhD level 
psychologists. No 
report of treatment 
fidelity. (None) 
Treatment at Family 
Practice Department of 
HMO. Patient, psychologist 
and primary care provider 
formulated treatment plan. 
Regular communication 
between PCP and 
psychologist via voicemail, 
brief contact, joint 
sessions. Liaison 
psychiatrist on call for PCP 
or psychologist. 
 Anxiety by Shedler Quick 
Diagnostics Panel; 3 mth 
CBT=TAU; 6 mth CBT<TAU. At 6 
mth; recovery higher in CBT than 
TAU (Shedler≤10). 
NA CBT>TAU on 10/11 
indicators of 
satisfaction 
Ward et 
al. (72)  
RCT (3 way 
randomised 
data) 
(MDD) 
 CBT (6-12 
sessions, 6-12 
weeks) 
 
Counselling (6-12 
sessions, 6-12 
weeks) 
 
TAU 
Accredited 
psychologists. 
Ratings of 
treatment fidelity. 
(Manualised) 
Treatment in primary care 
setting. Patient free to see 
GP, but GP asked to refrain 
from prescribing 
medication in 
CBT/Counselling groups. 
28.5% of CBT/Counsel 
received medication. 
 On BDI; at 4mth 
CBT=counsel<TAU; at 12 mth 
CBT=counsel=TAU. 
12 mth, social adjustment 
superior in CBT/TAU 
(CBT=TAU<Counsel). 
Completers only; on 
satisfaction, at 4 mth 
CBT=Counsel> TAU. 
At 12 mth 
Counsel>TAU 
Williams 
et al. 
(78)  
RCT 
(Dysthymia/ 
Minor 
depression) 
 PST (6 sessions, 
11 weeks) 
 
Med (Par) 
 
PL 
7 PhD 
psychologists, 3 
SW, 2 masters-
level counsellors. 
Training including 
theory, role 
playing, training 
video, practice 
cases. No rating of 
fidelity reported 
(Manualised 
treatment) 
Treatment in primary care 
setting. Medication 
prohibited for PST group. 
 On HSCL-D-20; all groups 
significant improvement. 11 wks, 
Med<PL; Med=PST; PST=PL. 
Greater symptom improvement in 
wks 2-11 in PST compared to PL. 
No interaction with diagnosis. 
At 11 wk, mental health 
functioning (SF-36); Med>PL 
improvement for 
high/intermediate baseline 
functioning in dysthymia. 
PST=PL for all baseline levels 
in dysthymia. In minor 
depression, Med>PL and 
PST>PL for low baseline 
levels of functioning. 
NA 
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       Clinical Outcomes 
Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Barrett et 
al. (79) 
RCT 
(Dysthymia/ 
Minor 
depression) 
 PST (6 sessions, 
11 weeks) 
 
Med (Par) 
 
PL 
7 PhD 
psychologists, 3 
SW, 2 masters-
level counsellors. 
Training including 
theory, role 
playing, training 
video, practice 
cases. No rating of 
fidelity reported 
(Manualised 
treatment) 
Treatment in primary care 
setting. Medication 
prohibited for PST group. 
 On HSCL-D-20; all groups 
significant improvement. 11 wks, 
PST=Med=PL. 
No interaction with diagnosis. 
For completers, remission (HAM-
D≤6) higher in dysthymia for 
PST=Med>PL. For minor 
depression, PST=Med=PL. 
At 11 wk, mental health 
functioning (SF-36) change; 
PST=Med=PL. Greater 
improvements in Med group 
with low/initial functioning; 
no significant improvements 
in PST or PL group. 
NA 
Browne 
et al. 
(80) 
RCT 
(Dysthymia) 
 
 IPT (12 sessions, 
6 months) 
 
Med (Sert) 
 
IPT+Med 
15 masters- level 
therapists. 2 weeks 
of IPT training, 
weekly case 
conferences. 
Review of 
treatment fidelity. 
(NA) 
Treatment conducted in 
HMO. No other med. 
 On depression (MADRS), at 6 
mth and 2 yrs 
Med=Sert+IPT<IPT. 
Greater responding 6 mth Med, 
Med+IPT than IPT only (40% 
reduction on MADRS). 
Social adjustment Scale-Self 
Rating and family function at 
6mth and 2 yrs 
Med=Med+IPT=IPT. 
NA 
Lang (83) RCT 
(Anxiety and 
Depression) 
 CBT (4 sessions, 
4 weeks) 
 
Wait-list 
Clinical 
psychologist. 
Review of 
treatment fidelity. 
(Manualised) 
Treatment at psychologist 
offices. 
 At post, significant reduction on 
BAI and CES-D for treatment 
group but not Waitlist. Significant 
increase in anxiety 1 month 
following treatment for 
completers. 
At post, significant reduction 
on QOLI for treatment group 
but not Waitlist. 
NA 
Sharp et 
al. (88) 
RCT 
(PD) 
 CBT (8 sessions, 
12 wks) 
 
Group CBT (8 
sessions, 12 wks) 
 
Waiting list (12 
wks) 
Clinical 
Psychologist. No 
report of review of 
treatment fidelity. 
(Written treatment 
manual) 
All patients seen in general 
practice setting. Patients 
allowed to continue taking 
medications through study. 
 At 12 wks, on HAM-A, Group 
CBT<Waitlist, CBT<Waitlist. 
At 3 mth follow-up group CBT 
poorer than CBT on % showing 
significant change (HAM-A≤13). 
NA Drop-out in group 
CBT>CBT=Waitlist. At 
12 wks, on MADRS, 
Group CBT<Waitlist, 
CBT<Waitlist. 
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Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Arean et 
al. (76)  
RCT 
(MDD/ 
dysthymia) 
 Group CBT (18 
sessions, 6 
months). 
 
Case 
Management 
(CM) 
 
Group CBT+CM 
2 Clinical 
Psychologists, 2 
masters-level SW. 
Treatment fidelity 
assess by 
videotape. 
(maualised) 
Therapists worked at 
hospital site and conducted 
groups there. 
 HAM-D. At 6 mths, no 
differences. At 12 mth follow up, 
Group CBT+CM<Group CBT. 
CM=Group CBT+CM, CM=Group 
CBT. 
At 6 mth, Group CBT, Group 
CBT+CM superior to CM 
alone. 
At 12 months, Group CBT 
superior to Group CBT+CM, 
CM alone on functional 
outcomes. 
NA 
Clarke et 
al (73) 
RCT 
(MDD) 
 TAU+CBT(Ave 5.3 
sessions, follow 
up to 12-months) 
 
TAU (inc. SSRI) 
Master’s level 
psychologists. 20 
hours of training 
and weekly 
supervision, 
videotaped 
sessions for fidelity. 
(Manualised) 
On-site mental health 
specialist provided 
treatment. GP continued to 
monitor medication. 
Ongoing therapist and PCP 
consultation. 
 To 52 wks, HAM-D, no 
differences between conditions 
by time. 
To 52 wk, SF-12 Mental 
component greater 
improvement in CBT+TAU; 
no differences on global or 
physical components. 
Significant reductions 
in TAU services in 
CBT condition. 
No difference on 
satisfaction across 
conditions. 
van 
Boeijen 
et al (57) 
RCT 
(GAD/PD) 
 Guideline Based 
treatment (GP; 
inc. CBT; variable 
sessions) 
 
Guided Self-help 
(GP; 5 sessions) 
 
CBT (therapist; 12 
sessions) 
GPs present at two 
educational 
meetings on 
diagnosis, 
management. 
Supervision every 2 
months. Weekly 
supervision for 
therapists. 
(self-help and CBT 
manualised) 
Treatment at alternative 
location. Medication 
allowed. 
 All groups improved significantly 
on STAI to follow-up. GP 
Guideline=GP Self-help=CBT. 
All groups improved 
significantly on SDS to follow-
up. GP Guideline=GP Self-
help=CBT. 
All groups improved 
significantly on BDI to 
follow-up. GP 
Guideline=GP Self-
help=CBT. 
GPs viewed CBT in 
guidelines as 
unfeasible, >50% 
given medication or 
referred to secondary 
care. 
Addis et 
al. (97); 
RCT 
(PD) 
 CBT (12-15 
sessions, 12-15 
weeks) 
 
Non-CBT therapy 
Masters-level 
psychologists. 2-
day workshop in 
CBT, 2 training 
cases, audiotaped 
sessions, limited 
supervision. 
Therapists HMO workers 
who worked at 
independent clinical 
agency. GP continued to 
monitor medication. 
 At 5.5 mths, CBT=TAU. 
At 8.5 mths, CBT<TAU on PDSS. 
At 2 yrs, on PDSS, CBT=TAU. At 
1 yr, interaction with completer 
status, with completer CBT<TAU 
on panic severity. 
 
NA At 8.5 mths, 
CBT<TAU on BDI. 
At 2 yrs, CBT=TAU. 
No difference in use 
of additional SSRI, 
benzodiazepine or 
psychotherapy over 2 
yr follow-up 
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Authors Design 
(Diagnosis) 
 Interventions Training 
(Manual) 
Collaborative Elements 
(med usage) 
 Symptoms Function Other 
Brouwers 
et al. 
(81) 
RCT 
(GAD, mild 
MDD, no 
disorder). 
 PST (5 sessions, 
10 wks) 
 
TAU 
PST provided by 
SW. 3-day training 
with 2 follow-up 
sessions checking 
adherence to 
protocol. 
(manualised) 
Treatment at primary care 
clinic where SW work. 
Medication allowed by GP. 
 On HADS; both groups reached 
normal levels in 3-6 months; no 
differences in improvement at 3, 
6 or 18 mths. 
On SF-36; both groups 
reached normal levels in 3-6 
months; no differences at 3, 
6 or 18 mths. 
No significant 
difference in sick 
leave duration. 
At 3 mths, 5/8 
satisfaction 
statements higher in 
PST vs. TAU 
Lang et 
al (84) 
RCT 
(Anx and 
Dep; 67.7% 
MDD) 
 Modified PST(4 
sessions) 
 
TAU 
2 PhD level 
psychologists. No 
reported review of 
fidelity. 
(Manualised) 
Location not specified. Not 
restricted in medication use 
(55%) 
 Greater decrease in anxiety and 
depression (measured by BSI-18) 
for PST group compared to TAU. 
Some decay of effect to 6 mth 
post-test. 
On mental functioning (SF-
12) greater increase in 
intervention vs TAU. 
Generally positive 
satisfaction by those 
completing the 
program (4.3/5) 
McKee et 
al. (82) 
RCT 
(depressive 
symptoms) 
 CBT (8 sessions)+ 
education+ social 
support. 
 
TAU 
CBT provided by 
SW. 
Treatment at home or 
health centre. 
 At 3-mths, on BDI CBT=TAU. At 3-mths, on social support, 
CBT=TAU. 
NA 
van 
Schaik et 
al. (74) 
RCT 
(MDD) 
 IPT (10 sessions 
in 5 months) 
 
TAU 
Six psychologists 
and nine 
psychiatric nurses 
with 5+ years 
experience. Trained 
in IPT in 2 day 
course with 2 wkly 
supervision. 
Audiotaped 
sessions. 
(Manualised) 
Intervention delivered in 
general practice. GP 
informed of diagnosis and 
asked not to prescribe 
antidepressants. 
 At 2 and 6 mths, MADRS 
depression IPT=TAU. 
PRIME-D – no diff 2 mth; 
significantly lower rates of MDD 
at 6 mths in IPT group. 
No differences in remission by 
(MADRS<10) at 2 and 6 mth. 
At 6 mth, on mental and 
social functioning, IPT 
superior to TAU. On physical, 
IPT=TAU 
NA 
Conradi 
et al. 
(75) 
RCT 
(MDD) 
 Education 
program (3 
sessions) 
 
Education+ 
psychiatrist 
consult 
 
Eucation+ brief 
CBT (12 sessions) 
 
TAU by GP 
Clinical 
psychologists 
provided CBT. 
Adherence 
monitored by 
supervisor. 
(Manualised) 
Treatments in primary care 
setting. All treatments 
included TAU from GP. 
Written feedback from 
education program to GP 
after each session, 
including self-care plan. 
Feedback regarding CBT. 
GPs given 2 hour booster 
session regarding 
depression management. 
 At 6 mth, all groups same on 
recovery (BDI≤14) 
At 36-mth on BDI, 
Psychiatrist+education and 
CBT+education< 
TAU=Education. 
 
NA Significantly lower 
compliance with CBT 
than psychiatrist visit. 
At 6-mths, greater 
satisfaction with all 
education programs 
vs TAU. 
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APPENDIX 6. ADDITIONAL DETAILS REGARDING COLLABORATIVE 
INTERVENTIONS 
Table 18: Collaborative Interventions - Study Entry, Demographics and Quality 
    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry 
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Katon et 
al.(128) 
RCT 
(MDD) 
HMO, US (1 
clinic, 22 
physicians) 
 153 Referred by PCPs, agreed 
to initiate antidepressants. 
Inclusion, SCL-20≥0.75. 
Age 18-80. 
 
Current alcohol abuse; 
current psychosis; 
serious suicidal 
ideation; dementia; 
pregnancy; terminal 
illness; limited English; 
non-committed to 
HMO. 
Mean Age 46.4 
Female 73.8% 
White 86.9% 
 
 Patient, stratified 
by depression 
severity in blocks 
of 8 
(opaque 
envelope*) 
 
Completers 
(1 mth 
91.5%) 
(4 mth, 
83.7%) 
(7 mth, 
76.5%) 
Yes Medium 
Araya et al. 
(102) 
RCT 
(MDD) 
Primary Care 
Clinics, Chile (3 
practices). 
 240 Screened consecutive 
female patients; GHQ-
12≥5 at screening and 2 
wks later. MDD by MINI. 
Age 18-70. 
 
Psychosis; bipolar; 
organic current alcohol 
abuse; serious suicide 
risk; psychiatric consult 
in previous 3 mths. 
Mean age: 42.7 
Female 100% 
White 0% 
 Patient, blocked 
by 20; stratified 
by clinic. 
(Independent 
recruiters; 
numbered-sealed 
envelops) 
Intention-to-
treat 
(Post-3 mths 
87.9%; 
follow-up 6 
mths 87.9%) 
Yes Low 
Hedrick et 
al. (130) 
 
RCT 
(MDD/ 
Dysthymia) 
Veteran’s Affairs 
primary care 
clinic, US (4 
Firms, 79 
clinicians) 
 354 (1) Referral from 
unrelated study screening 
patients; (2) Mailed 
screening for other study; 
(3) Prevention survey at 
clinic check-in; (4) 
Referral by PCP. 
Structured interview 
(PRIME-MD) for 
MDD/Dysthymia. 
Patients currently 
undergoing specialty 
mental health 
treatment. Patients 
requiring treatment for 
substance abuse or 
PTSD. Acute suicidality; 
psychosis. 
Mean age 57.2 
Female 4.5% 
White 79.7% 
 Firm 
(NA) 
Intention-to-
treat 
(3 mths 
92.7%) 
(9 mths, 
92.1%) 
Yes Low 
Wells et 
al.(129).  
RCT 
(MDD/ 
Dysthymia/ 
Depressive 
Symptoms) 
Managed care, 
US (6 
organisations, 46 
practices, 181 
clinicians) 
 1356 Screened consecutive 
patients with stem items 
from CIDI for MDD/ 
dysthymia (51% with 
current depressive 
disorder). 
18+ 
Acute medical 
emergency, limited 
English/Spanish, non-
insured. For pilot only, 
bipolar and alcohol 
abuse. 
Mean age 43.7 
Female 71% 
White 57% 
43.3% anxiety 
dis, 50% 
dep.N=991 
follow-up. 
 Clinics, by 
random number 
table, in blocks 
(NA) 
 
Intention-to-
treat 
(6 mth 85%) 
(12 mth 83%) 
(57 mth 73%) 
 
Yes* Low 
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    Subject  Study Quality 
Authors Design 
(Diagnosis) 
Organisation 
(Practice, 
Clinicians) 
 N Entry 
 
Exclusion Demographics  Unit of 
Randomisation 
(Concealment) 
Analysis 
(Follow-up 
rates) 
Blinding Risk 
Asarnow et 
al. (127) 
RCT 
(MDD) 
Mixed Primary 
Care sites, US (6 
clinics) 
 418 Screened at clinic, for 
MDD or dysthymia on 
stem items from CIDI and 
CES-D≥16; OR CES-D≥24. 
42.6% MDD/Dysthymia 
Aged 13-21. 
Not English speaking, 
clinician not in study. 
Mean age 17.2 
Female 78% 
White 12.7% 
 Patient, stratified 
by site and 
clinician, blocked 
in pairs by 
clinician 
(Independent 
staff blind to 
assessment) 
Intention-to-
treat 
(follow-up; 6 
mths; 82%) 
Yes Low 
Rollman et 
al (133) 
RCT (PD/GAD) Primary care, US 
(4 practices) 
 191 Screened consecutive 
patients using PRIME-MD 
for anxiety. If positive and 
not excluded, 
administered PRIME-MD 
for DSM PD/GAD. 
HAM-A≥14 or PDSS≥7. 
18-64. 
Dementia; psychosis; 
unstable medical 
condition; alcohol 
abuse; language 
barrier; bipolar 
disorder; current 
treatment; plans to 
leave study practice. 
Mean age 44.2, 
Female 81% 
White 95%. 
 Patient; blocked 
by 25 or 30 
(opaque 
envelopes) 
Intention-to-
treat 
(2 mth 71%) 
(4 mth 67%) 
(8 mth 65%) 
(12 mth 75%) 
Yes Low 
Roy-Byrne 
et al.(134) 
RCT 
(PD) 
Primary care 
clinics, US (3 
clinics). 
 232 Referrals from clinicians; 
screening in waiting room 
using 2-question test. 
Administered telephone 
structured interview for 
PD. Willing to accept 
medication and CBT; panic 
attack in prior week. 18-
70. 
Limited English; 
suicidal ideation; 
terminal illness; 
psychosis; substance 
abuse; dementia; 
pregnancy; current 
treatment. 
Mean age 41.2, 
Female 58% 
White 65.5% 
 Patient; 
alternating 
assignment 
stratified by 
depression and 
referral status 
(independent 
allocation) 
Intention-to-
treat 
(3 mth 
77.2%) 
(6 mth 
75.9%) 
(9 mth 
71.1%) 
(12 mth 
77.2%) 
Yes High 
Grympa et 
al. (131) 
Non RCT 
(Depression) 
Primary care, 
HMO, San Diego 
(1 organisation, 
2 clinics, 36 
clinicians) 
 297 NA. Not restricted in age. NA. Mean age 61.5 
Female 79.2% 
White NA. 
 Not relevant. Completers 
(“post-study) 
compared to 
RCT in 
Hunkeler et al 
(below). 
No. High 
Hunkeler et 
al. (132). 
RCT 
(MDD/ 
Dysthymia) 
Mixed Primary 
Care Sites, San 
Diego, US (8 
organisations, 18 
clinics). 
 1801 Referrals and systematic 
screening. 2-item screener 
(PRIME-MD). Eligible given 
structured interview 
(SCID) for 
MDD/Dysthymia. Aged 
60+. 
Bipolar disorder; 
psychosis; alcohol 
abuse; severe cognitive 
impairment; acute 
suicide risk; current 
psychiatric treatment. 
Mean age 71.2 
Female 65% 
White 77% 
 
 Patient stratified 
by recruitment 
method and clinic 
(random numbers 
in sealed 
envelopes) 
Intention-to-
treat 
(6 mths; 
87.2%) 
(12 mths-
post; 82.3%) 
(24 mths-
follow-up; 
76.6%) 
Yes Low 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
93 
__________________________________________________________________________________________________________________________________ 
  
 
Table 19: Collaborative Interventions – Interventions, Training and Outcomes 
 Elements      
Authors Multi-
professional 
Approach 
Structured 
Treatment Plan
Psychological 
Intervention 
Scheduled 
Follow-up 
Enhanced 
Communication 
Training 
(Manual) 
 Medication 
usage 
Outcomes - 
symptoms 
Outcomes - 
Function 
Satisfaction 
Katon et 
al.(128) 
Primary care 
physician, 
psychologists, 
psychiatrist. 
Psychologists 
working within 
clinic. 
Highly structured 
depression 
treatment 
program. 
Solution-
focussed 
cognitive 
therapy. 4-6 
contacts, 2.5-3.5 
hours of contact
Psychologist 
completed 
telephone 
contacts at 2, 4, 
12 and 24 
weeks 
Case-by-case 
psychologist-PCP 
contact, weekly 
team meeting with 
psychologist, 
handwritten 
consultation note 
same day as each 
visit, copy of 
relapse prevention 
plan put in file. 
Doctoral 
trained, 
experienced 
therapists. 20 
hrs training, 
weekly 
supervision 
by 
psychiatrist. 
(patient 
manual) 
 At 7 mths; self-
report; greater 
medication use in 
intervention 
group compared 
to TAU. 
At 7-mths; response 
(>50% change) on 
SCL-20 for MDD; 
intervention> TAU. 
For minor depression, 
intervention=TAU in 
response. 
NA At 4 mths, 
greater 
satisfaction 
in 
intervention 
group. 
Araya et 
al. (102) 
GP and SW or 
Nurse from local 
clinics 
Structured 
groups; 
Systematic 
Monitoring 
For severe- 
systematic 
antidepressants 
7 weekly group 
psychoeducation; 
x 75 min. 
Information on 
depression, 
treatment, basic 
cognitive and 
relapse 
prevention 
strategies. 
2 booster 
sessions at 
weeks 9 and 12, 
each 75 min. 
Structured 
psychological 
Health workers 
communicated 
with doctors 
through alert notes 
and arranging 
appointments for 
patients. 
12 hrs 
training; 8 
hrs 
supervision. 4 
hr training for 
GPs 
(standard 
patient 
booklet) 
 79% vs 34% 
medication use in 
stepped care vs 
TAU. 
On HAM-D; Stepped 
Care<TAU 
On SF-36; Stepped 
Care>TAU 
(superior) on all 
subscales. 
NA 
Hedrick 
et al. 
(130) 
 
PCP; clinical 
psychologist; 
social workers; 
psychology 
technician. 
 
Providers notified 
of diagnosis. All 
professionals 
available in liaison 
model. 
Guideline 
recommendations 
by collaborative 
group, stepwise 
treatment plan 
by resource 
intensiveness 
reviewed at 6, 12 
wks. 
CBT group led by 
psychologist or 
SW (6 sessions); 
individual session 
with psychologist 
or psychiatrist. 
SW staff 
member/student 
contacted 
participants on 
regular basis. 
Team met weekly 
to discuss 
treatment plan. 
Team 
communicated 
with PCP via 
electronic progress 
notes, with 
tracking system. 
Psychiatrist 
contacted PCP 
when PCP queried 
treatment plan. 
PCP given 3 
hrs of 
training in 
collaborative 
care and 
liaison. 
(workbook 
for clients) 
 Medication part 
of treatment 
plan. Prescription 
higher in 
intervention 
group; but 
adequate 
medication not. 
At 3 mths, using 
SCL, 
intervention<Liaison 
model; At 9 mths; 
intervention=Liaison 
model. 
At 3 mths, using 
SDS, 
intervention<Liaison 
model; At 9 mths; 
intervention=Liaison 
model. 
At 3 and 9 mths; 
using SF-36; 
intervention=Liaison 
model. 
Both groups 
highly 
satisfied; no 
differences 
between 
groups. 
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 Elements      
Authors Multi-
professional 
Approach 
Structured 
Treatment Plan
Psychological 
Intervention 
Scheduled 
Follow-up 
Enhanced 
Communication 
Training 
(Manual) 
 Medication 
usage 
Outcomes - 
symptoms 
Outcomes - 
Function 
Satisfaction 
Wells et 
al.(129). 
Physician, nurses 
(case managers), 
psychiatrist (meds 
cond), 
psychologist 
(therapy cond) 
Guidelines given 
to staff on 
treatment, 
medication, 
treatment plans
Up to 12 
sessions 
individual or 
group CBT. In 
first and second 
6 months; QI-
therapy received 
38%/34% 4+ 
sessions. 
No formal 
follow-up in 
therapy, 
monthly contact 
in meds 
condition. 
Team meetings 
and case reviews 
held by team 
leaders. 
2-day 
workshop. 
Training to 
PCP, nursing 
supervisor, 
mental health 
specialist. 
Local leaders 
supervised 
therapists. 
(manuals) 
At 12 mths, 
intervention>TAU 
on medication use, 
counselling. 
At 12-mths, using 
CES-D cut-point, 
intervention<TAU on 
% depressed. 
At 57-months, using 
CIDI screening, 
intervention<TAU on 
% depressed (due to 
psychotherapy 
condition) 
At 12 mths, 
Intervention>TAU on 
mental health quality 
of life; 
Intervention=TAU on 
physical QoL. 
At 57 mths, mental 
health QoL 
intervention=TAU. 
NA 
Asarnow 
et al. 
(127) 
Primary care 
clinicians, care 
managers (PhD in 
mental health or 
nursing). 
Treatment plan 
developed with 
primary care 
physician 
including CBT or 
medication 
CBT in individual 
or group, 12 wks 
and relapse 
prevention. 32% 
saw 
psychotherapy/ 
counselling in 
intervention 
group. 
Brief follow up 
contacts by care 
manager 
Treatment plan 
developed 
collaboratively, 
coordinated care 
with physician who 
prescribed 
medication. 
1 day training 
for CM on 
CBT. PCP 
given training 
and 
educational 
materials in 
QI condition. 
(manuals) 
 12.5% QI vs 
16.2% TAU on 
any medication. 
On CES-D; Quality 
Improvement < 
TAU at 6 mths. 
On MHS-12; 
QI>TAU at 6 mths 
(superior) 
Satisfaction 
higher in QI 
group. 
Rollman 
et al 
(133) 
GP, Care Manager 
(non-
psychologists), 
consultant 
doctor/psychiatrist 
Preference-
guided 
systematic 
treatment - self-
management, 
pharmacological, 
referral to 
specialist. 
Education 
Self-help CBT 
workbook, with 
guidance from 
care manager. 
Regular care-
manager 
contact. 
Weekly 60-75 
minute patient 
review with Study 
authors, 
suggestions to PCP 
and patient, 
recommendations 
passed to PCP. 
CMs trained 
with 
workbooks; 
lectures at 
university; 
direct 
supervision of 
calls; weekly 
meetings. 1 
hr meeting 
with PCPs 
and 
medication 
suggestions. 
(workbook) 
 At 12 mths; 
intervention=TAU 
on medication 
use. 
At 12 mths; on PDSS, 
HAM-A; 
intervention<TAU 
(superior). 
Interaction with 
diagnosis; superior 
outcomes for those 
with PD, PD/GAD but 
not GAD only. 
At 12 mths; on SF-
12, mental outcomes 
intervention>TAU 
(superior); physical 
outcomes 
intervention=TAU. 
 
NA 
Roy-
Byrne et 
al.(134)  
Primary care 
physician, 
psychologist, 
psychiatrist 
Structured CBT, 
workbook, 
medication 
algorithm 
6 sessions CBT in 
3 months. 
6 follow-up 
booster sessions 
to monitor, 
reinforce CBT 
and check 
meds. 
Weekly meeting 
with psychiatrist. 
Coordinated care 
by behavioural 
health specialist 
using telephone, 
fax, email with PCP
Training 
given to 
psychologists. 
PCP received 
1-hr of 
training on 
medication. 
(workbooks) 
 At 12 mths; 
intervention=TAU 
on medication 
use. 
At 12 mths; 
Remission (no panic 
attacks; Fear 
Questionnaire<10) 
intervention>TAU 
(superior). 
At 12 mths; WHO 
disability; 
intervention<TAU 
(superior). SF-12 
mental and physical; 
intervention=TAU. 
NA. 
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 Elements      
Authors Multi-
professional 
Approach 
Structured 
Treatment Plan
Psychological 
Intervention 
Scheduled 
Follow-up 
Enhanced 
Communication 
Training 
(Manual) 
 Medication 
usage 
Outcomes - 
symptoms 
Outcomes - 
Function 
Satisfaction 
Grympa 
et al. 
(131) 
GP, psychiatrist, 
depression care 
manager, medical 
assistant 
Stepped care, 
treatment plan, 
education, 
antidepressant 
management, 
PST, depression 
class. 
Variable sessions 
Problem solving 
treatment. 46% 
utilised PST. 
Follow up by 
DCM, tracking 
system. 
As-needed 
consultation by 
psychiatrist with 
DCM. Medication 
prescribed by GP 
on advice. 
CM trained 
for study 
over 4 days; 
5 training 
patients in 
PST. 
(manuals) 
 At 6 mths; for 
those with >6 
mths treatment; 
Post-study=RCT 
on medication. 
At 6 mths; for those 
with >6 mths 
treatment; Post-
study=RCT on PHQ-
9. 
Post-study with <10 
wks treatment had 
less improvement 
than those with >6 
mths treatment. 
NA Lower use of 
PST in Post-
study than in 
RCT. 
Hunkeler 
et al. 
(132).  
GP, psychiatrist 
and depression 
care manager 
(psychologist/ 
nurse) 
Stepped care. 
Education, 
treatment 
algorithm for 
psychosocial vs. 
pharmacological 
treatment, level 
pharmacological 
treatment. 
6-8 sessions of 
Problem Solving 
Therapy in 
primary care 
setting, 30% 
received in 1st 
year. 
Monthly 
telephone 
appointments 
with DCM, 
tracking system.
Weekly team 
review by 
psychiatrist and 
DCM. Medication 
prescribed by GP 
on advice. 
CM trained 
for study 
over 4 days; 
5 training 
patients in 
PST. 
Medication 
protocol for 
PCP. 
(manuals) 
 At 12 mths; on 
medication, 
stepped 
care>TAU; 73% 
vs 57.2%. 
At post (12 mth) on 
SCL-20, Stepped 
Care<TAU. 
At 24 mth, stepped 
care<TAU. 
At 12 mths; 
functional 
impairment; stepped 
care<TAU (Superior). 
QoL stepped 
care>TAU (superior). 
At 24 mths; 
functional 
impairment; stepped 
care=TAU. QoL 
stepped care>TAU 
(superior). 
At 12 mths; 
satisfaction 
greater in 
stepped care 
group. 
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APPENDIX 7. ADDITIONAL DETAILS REGARDING BETTER 
OUTCOME PROJECTS 
Table 20: Summary of the Interim Reports of the Better Outcomes – ATAPS 
Programs. 
Report Main Area  Main Findings 
1. Pirkis et al. 
(157) 
Models of service delivery, uptake and 
advantages/disadvantages of pilots. 
Round 1 pilots. Operating under a range of models from simple voucher 
systems to complex brokerage systems, means of retaining allied health 
professionals (contractual, direct employment), location of allied health 
(services in GPs’ rooms, own rooms or third location). Different models have 
pros and cons. GPs appreciate the simplicity and efficiency of the voucher 
system, but feel that it does not promote good interprofessional 
communication and consumers argue that it means that they are not always 
referred to the most appropriate provider. Brokerage system more likely to 
cause confusion among GPs, but they are willing to accept this if advantages 
to consumers clearly demonstrated. The brokerage system promotes high 
quality care (improves collaboration, ensures good ‘match’ between 
consumer/allied health). Intermediate model – co-location of allied health in 
GPs’ practices – combines simplicity with good opportunities for 
communication, but reduces consumer choice of allied health.  
Pilots significant in terms of numbers of GPs, allied health and consumers 
involved. Appear to be reaching target groups (e.g., consumers on low 
incomes) and providing appropriate services (e.g., CBT), but lack of 
consistent reporting.  
For GPs, advantages included: saving time/cost; location of service delivery; 
feedback from allied health; upskilling and knowledge improvement. 
Disadvantages included barriers to education and training; delays in 
registration; confusion about system; opportunity costs and other risks; and 
sub-optimal communication. For allied health, advantages included increased 
referral base; improved relationships with GPs; clinical supervision. 
Disadvantages included payment anomalies; communication difficulties; and 
co-location issues. For consumers advantages included access to 
psychological services; increased satisfaction; and improved outcomes. 
Difficulties were barriers to attendance and inappropriateness of referrals. 
2. Morley et al. 
(143) 
Models of service delivery, levels and 
characteristics of users and usage, advantages/ 
disadvantages of Round 1 pilots and 
supplementary projects.  
Models utilised have changed over time to meet the needs of stakeholders. 
Some projects moving to intermediate complexity where GPs are provided 
with detailed registries of Allied Health professionals and their skills and 
competencies.  
Significant increase in uptake over time, although there are concerns about 
capping on referral numbers from GPs. Majority of participants of low-
income, with education lower than year 12, and experiencing anxiety or 
depression. Most participants receiving individual CBT, with no copayments 
necessary.  
GP report benefits of improved collaboration with allied health, increased 
referral options, new skills and knowledge in managing mental health, and a 
structured approach to managing mental health. Consumers benefiting 
through increased access to mental health services.  
Barriers for GPs include perceptions of complexity of the service and time 
demands, confusion about how the service operates, perceived lack of 
flexibility, referral limits, payment issues and caseload impact. Allied health 
concerns include lack of decision-making. Consumers have some issues with 
referral (i.e., who gets referred) and location. 
3. Morley et al. 
(147) 
Barriers and benefits associated with retaining 
allied health, with locations of allied health, and 
with different referral mechanisms. 
Evaluation forum held in September 2004, provided validity for first two 
reports. Allied health retained through contractual arrangements (e.g., with 
individual providers or community health agencies) or through direct 
employment. Allied health provide services generally from their own rooms 
or GP-practices. Provided support for original referral mechanisms (voucher, 
brokerage, register) but also a fourth (direct referral) in operation.  
Forum highlighted pros and cons of various models (e.g., provision through 
GP-rooms) and highlights need to account for contextual variation so as to 
best suit local needs. 
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Report Main Area  Main Findings 
4. Kohn, 
Morley, Pirkis, 
Blashki and 
Burgess (158) 
Models of service delivery, levels and 
characteristics of users and usage, benefits and 
barriers, lessons learnt. 
Round 1 and 2 summary. Increase in utilisation, with 2.5-3.5 fold increase 
relative to 2nd interim report. Majority of participants low income, 
experiencing depression or anxiety, and 46% have no previous history of 
specialist mental-health care. Most sessions individual-based CBT, with an 
average of 3.6 sessions/consumer. 63% of sessions did not require 
copayment.  
Stakeholders satisfied with project. Benefits for GPs included upskilling, 
improved capacity for quality care, range of referral options, but barriers 
included education and training requirements, limited referral capacity, 
suboptimal feedback for allied health, and issues with payment. Benefits for 
allied health include improved relationships with GPs and increased referral 
base, but barriers such as frustration at lack of decision-making power, and 
issues with referral process, remuneration and travel. Some consumers had 
equity issues related to number and format of sessions. However, there have 
been improvements since earlier reports with respect to confusion regarding 
systems, allied health express less difficulties with lack of guaranteed work, 
and problems with inappropriate referrals less common.  
5. Pirkis et al. 
(144) 
Profile of models of service delivery and 
association with access levels. 
Considerable variability across models used: 76% allied health retained 
under contract; 28% through direct employment and 7% other means. 63% 
provide services through GP rooms; 63% through own rooms; and 42% from 
other location. 27% of systems used a voucher system; 24% a brokerage 
system; 25% a register system and 51% direct referral systems. Many 
models adopt a combination of approaches.  
No models appeared to be significantly related to consumer outcomes. 
6. Kohn, 
Morley, Pirkis, 
Shandley et al. 
(145) 
Change over time of participation by professionals 
and consumers, experiences of the system; 
outcomes for consumers. 
There has been a dramatic increase in GP participation over the life of the 
projects (from 417 GPs to 1,266), and number of consumers receiving 
treatment (from 11.5/day to 46.1/day). The profile of consumers has 
remained stable over time, with typical participant being female, around 40, 
with low income, no history of mental health issues and diagnosed with 
anxiety/depression. Average number of sessions stable at four. While there 
was an increase over time in use of copayments, levels had subsequently 
fallen.  
Benefits for GPs reported in earlier reports remain, but less barriers reported 
than in earlier projects (e.g., remuneration, confusion over system, lack of 
feedback from allied health), perhaps due to action by divisions to remove. 
Allied health report barriers such as inadequate remuneration and travel 
time, but less difficulty than in earlier pilots. Consumers’ issues remain 
largely with equity in accessing service and restricted level of sessions. While 
level of report of clinical outcome low (<5%), it is positive in 88% of cases. 
7. Morley, 
Kohn et al. 
(148) 
Rural versus urban models of service delivery, 
levels and characteristics of users and usage, 
outcomes for consumers. General rural versus 
urban issues. 
 
Allied Health in rural areas are more likely to be directly employed, provide 
services from GPs rooms and receive direct referrals.  
Proportionally greater uptake of services in rural areas, perhaps reflecting 
greater service gaps.  
Differences in socio-demographic and clinical profiles of customers reflect 
make-up of local population and support needs of GPs. Customer outcomes 
positive in both localities.  
Local providers have addressed different hurdles in establishing programs, 
but responded to them as innovative ways. In rural areas, problems included 
distance, attracting qualified staff, lack of training and support for GPs, high 
unemployment and stigma. In urban areas, problems were related to uptake 
and demand, workforce shortages, and availability and coordination with 
other services. 
8. Morley, 
Pirkis et al. 
(146) 
Level of consumer outcome and association with 
model of service delivery. 
Projects achieving positive effects of medium magnitude. Models of service 
delivery did not impact significantly on outcomes, except that direct referral 
models achieving more positive outcomes. Trends towards employment of 
allied health by divisions being related to positive outcomes, and for delivery 
of services by allied health from their own consulting rooms being related to 
poorer outcomes. 
9. Naccarella et 
al. (159) 
Demand-management in Divisions of General 
Practice (see also Table 21) 
Administered survey to ATAPS project officers regarding the use of different 
demand management strategies aimed at the primary-secondary care 
interface, and asking which they found most useful. They found that most 
regions reported that they used, and found useful, centralised administration 
systems to monitor and enforce the management of demand. The use of 
limits on referral numbers and restrictive intake criteria were reported as the 
second and third most useful strategies, though they were less often utilised 
by regions. The use of additional copayments was both used infrequently 
and not highlighted as being helpful.  
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Report Main Area  Main Findings 
10. Flher et al. 
(149) 
Participation by GPs/allied health over time; 
profile of consumers and care over time, 
changes in the uptake of services following the 
introduction of the Better Access program; 
outcomes for consumers? 
 
Increase in GP participation from 449 GP referring to 135 allied health (July-
Sep 2003); to 2,451 GPs to 1,225 allied health (July-Sep 2006). Profile of 
consumers has remained fairly consistent; consumers typically female, 
around 40, on low incomes, no previous history of mental health care, and 
have been diagnosed with depression or anxiety disorders. The profile of 
care has not changed over time in either urban or rural areas, with majority 
being individual, 46-60 minutes, and consisting of CBT. Only notable 
fluctuation was rise and subsequent fall of use of copayment. While Better 
Access has been well utilised, there has not been a commensurate decrease 
in the number of sessions provided through the ATAPS component, except 
for a small early drop in the number of sessions provided in urban projects, 
which has now levelled out. In outcomes, the projects were shown to be 
achieving positive outcomes of large or medium magnitude. 
 
Table 21: Divisions of GP utilisation of Demand Management Strategies in Better 
Outcomes ATAPS program (based on 159). 
STRATEGY 
 
WAYS IN WHICH STRATEGY MIGHT BE OPERATIONALISED 
 
Regions 
Utilising 
(%) 
Most 
useful 
(%) 
Restrict intake criteria 
 
Develop specific inclusion/exclusion guidelines (e.g., target patients who have 
particular diagnoses, are on low incomes, and/or have not accessed or are 
unable to access other mental health services) 
50 13 
Monitor and limit  
referrals 
 
Track and cap number of referrals per GP per period (e.g., allocate set number 
of vouchers per GP per month/quarter) 
Track and redistribute unused referrals (e.g., recall and reallocate unused or 
partially used vouchers) 
61 29 
Prioritise referrals Establish and maintain a waiting list or a triage system 41 6 
Optimise session  
delivery 
 
Encourage group sessions (e.g., offer group session referral options to GPs, 
provide incentives for allied health professionals to provide group sessions, 
and/or encourage patients to attend groups sessions) 
Limit number of sessions available to patients 
Monitor session attendance and reallocate unused sessions 
53 7 
Seek co-payments Establish and maintain a co-payment system 37 0 
Inform/train GPs 
 
Provide training to equip GPs with skills to manage some patients themselves. 
Identify and promote other referral pathways to GPs 
Inform GPs of the need to limit services 
Promote GP provision of psychological support 
82 6 
Match allied health 
workforce to demand 
Ensure appropriate numbers and time fractions of allied health professionals to 
whom referrals can be made 
50 3 
Put in place systems 
and/or administrative 
procedures 
Centralise administration to implement and monitor and enforce demand 
management Strategies 
76 24 
Encourage  
partnerships/ 
collaboration 
Encourage GPs and allied health professionals to monitor referral levels 
together 
Encourage collaboration of professional groups 
55 6 
Develop strategic  
funding arrangements 
 
Review/monitor overall expenditure (e.g., introduce quarterly billing system) 
Allocate services by geographical region 
Develop demand management-specific formulae 
43 6 
Note: Regions can endorse use of multiple strategies (adds to >100%), but can only report one strategy as most useful. 
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APPENDIX 8. ADDITIONAL DETAILS REGARDING COST-EFFECTIVENESS 
OF PSYCHOLOGICAL TREATMENTS 
Table 22: Cost-effectiveness of Allied Health Provision of Psychological Treatments 
 
Study Disorder (patient description) Intervention Comparator 
Study Type and 
setting Costs and Outcomes Results Q
1 
Antonuccio, Thomas 
et al, (1997)(106) 
 
Unipolar depression 
(using several 
studies) 
CBT (15 sessions 
with unspecified 
professional + 5 
booster sessions) 
and group CBT  
Pharmacotherapy 
(prozac) 
Modeled 
Not really modeled to 
a particular setting 
(especially NOT PC) – 
stated aim is to do 
with managed care in 
US.  
Direct pat costs (inc HC provider, 
medication, lost wages, travel costs, co-
morbidity costs. Indirect costs 
(multiplier effect, reduced taxes, 
reduced community service work). 
Indirect costs (lost productivity, 
multiplier effect, reduced taxes, lost 
income due to suicide). Outcomes not 
modeled (but come in via probability of 
success) 
CBT cheaper than drugs (+33%) 
and combination (+23%) 
3 
Bower, Byford et al. 
2000 (117) 
 
Depression (with 
and without anxiety 
as a co-morbidity) 
CBT and non-
directive counseling 
by therapists (up to 
12 sessions) 
Usual GP care Prospective 
randomised trial 
UK study - relatively 
transferable to Aust 
Costs: Health care services (primary and 
secondary services, drugs and private 
health services. Non-treatment costs 
included travel and childcare. Lost 
production due to lost work time 
through illness. 
Outcomes: BDI and EQ 5D 
Both psychotherapies reduced 
depressive symptoms with no diff 
between the 2 (as at 4 months) 
However by 12 months all groups 
had equivalent outcomes. No 
differences on the EuroQoL were 
observed There were no 
significant differences between 
the costs at 4 or 12 months  
8 
Browne, Steiner et 
al. 2002 (80) 
 
Dysthymia disorder 
(DSM-IV) – 
screened in PC 
(using the UN-
CIDI) and then if 
screened positive 
were formally 
assessed using the 
SCID-P 
Setraline alone or 
interpersonal 
therapy (by 
‘counsellors’) (time 
limited therapy of 
12 sessions [with 
an average of 10 
attended]) alone or 
Combination of 
both 
All three 
treatments were 
compared to 
each other – NO 
control group 
Single blind RCT 6 
month and 2 year 
f’up 
 
Canada specifically in 
primary care setting. 
Costs: Therapist time, drug costs, 
primary care (not sure how defined), 
emergency room, specialists, 
hospitalisation, lab services. Plus OOP 
for meds and services, and production 
losses (time off work, cash transfer 
effects of illness. 
Outcomes: Montgomery Asberg Primary 
measure: Depression Rating Scale. 
Secondary measures Social Adjustment 
Scale, McMaster Family Asse4ssment 
device, CES-D and VAS to also measure 
depression 
At 6 months, significant 
differences observed for all 
combinations (compared to 
baseline however at 2 years all 3 
Treatment effective but setraline 
or combination more effective 
than IPT alone. 
No diffs between groups on QoL 
(SAS scale) 
There was also a sig difference in 
costs – with IPT alone having the 
lowest costs – combination plus 
drug alone showed no diffs. 
Unfortunately no incremental 
analysis was undertaken 
8 
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1 
(Chisholm, 
Sanderson et al. 
2004 (118) 
 
Depression (not 
differentiated by 
co-morbidities .) – 
ICD with dysthymia 
excluded 
Older anti-
depressant; newer 
antidepressants; 
brief 
psychotherapy 
(including CBT and 
problem solving); 
older 
antidepressant plus 
brief 
psychotherapy; 
newer anti-
depressants plus 
brief 
psychotherapy; 
proactive 
collaborative care 
with older 
antidepressants; 
and, proactive 
collaborative care 
w newer 
antidepressants. All 
interventions 
modeled for 10 
years.; ** not sure 
what proactive care 
is 
The null (natural 
course of 
depression). Plus 
incremental 
analysis of the 
different 
Treatment 
options 
Modeled using WHO-
Choice Generalised 
Cost-Effectiveness 
Analysis  
4 episub-regions of 
the world. Includes 
Australia as part of 
the Western pacific A 
cluster (with Japan). 
Costs: individual (including drug and 
therapy costs (6-8 sessions); primary 
care (3-6 visits) case management (4-6 
contacts), outpatient care and inpatient 
care.; and programme level (including 
provisions for training GPs and case 
managers + central admin 
Outcomes: :DALYs modeled from 
published studies using popmed 
(Markov model)  
Proactive collaborative care 
strategies had the best population 
wide health gain. Most C/E was 
pharmacotherapy with older anti-
depressants. Proactive 
collaborative care with older 
antidepressants was the most C/E 
combined care. For the region 
Aust falls in adding psychotherapy 
to existing drug regimes resulted 
in acceptable C/E ratios – though 
adding ‘proactive care’ was more 
CE that psychotherapy. 
10 
Croghan et al (1999) 
(135) 
 
Depression  Combining 
psychotherapy with 
drug care in order 
to increase 
likelihood of 
therapeutic 
guideline 
adherence 
Current practice 
(for these 
patients enrolled 
Quasi-experimental 
retro design (6 
months prior 
Treatment and 12 
months post 
Treatment) 
USA 
Costs: Data from insurance claims forms 
– drugs and therapy costs 
Outcomes: continuity of antidepressant 
meds  
Patients who received secondary 
specialist care more likely to 
maintain Treatment 
0 
Gould, Otto et al. 
1995  
Panic CBT (psychologist) 
+ drug Treatment 
Compared to 
each other 
Meta-analysis 
USA 
Costs- psychology consults 
Outcomes-effect size  
CBT as effective than drugs and 
group CBT though was cheaper 
1 
AUSTRALIAN PRIMARY HEALTH CARE RESEARCH INSTITUTE 
 
 
101 
__________________________________________________________________________________________________________________________________ 
  
 
Study Disorder (patient description) Intervention Comparator 
Study Type and 
setting Costs and Outcomes Results Q
1 
Haby, Tonge et al. 
2004 (112) 
 
Major depression in 
children and 
adolescents (using 
DSM-IV criteria)  
CBT (defined as 12 
sessions) by 
different types of 
professionals and 
SSRIs 
Current 
Australian 
practice (people 
accessing 
services who do 
not receive 
effective 
treatments 
Modeled using best 
available evidence 
Australia – GP 
referral to others 
Costs: Health sector (drugs, therapist, 
GPs 
Outcomes: DALY (modeled from existing 
literature and the NSMHWB) 
CBT by a publicly financed 
psychologist are the most C/E – 
SSRIs and other therapists 
providing CBT (public and private 
psychiatrists as well as private 
psychologists) all fall below the 
threshold of $50,000/DALY 
10 
Heuzenroeder, 
Donnelly et al. 2004 
(113) 
8 
Generalised anxiety 
disorder and panic 
disorder (using 
DSM-IV criteria) 
CBT and SNRIs Current 
Australian 
practice (people 
accessing 
services who do 
not receive 
effective 
treatments 
Modeled using best 
available evidence 
Australia – GP 
referral to others 
Costs: Health sector (drugs, therapist, 
GPs and OOP) 
Outcomes: DALY (modeled from existing 
literature and the NSMHWB) 
CBT by a publicly financed 
psychologist are the most C/E –
CBT delivered by various 
therapists are all more CE than 
pharmacotherapy. 
10 
Issakidis, Sanderson 
et al. 2004 (114) 
 
Anxiety disorders 
differentiated by 
severity 
Study looked @ c/E 
of current care and 
optimal care 
Mild anx: 10% via 
self-help, 60% CBT 
and remainder 
drugs. Mod-severe: 
CBT mainly (70%) 
– with a proportion 
also using drugs. 
The remaining 
30% would be 
Treatment with 
meds as a 1st line 
therapy-managed 
by a GP 
Current 
Australian 
practice and the 
null 
Modeled using best 
available evidence 
 
Australia 
Costs: Govt and health service 
perspective (including medical, 
pharmaceutical and self-help materials) 
Outcomes: YLD (as in the DALY) 
All modeled interventions appear 
cost-effective – finally if we 
swapped from current care to 
optimal care the costs would 
remain roughly similar but the 
health gains would be markedly 
increased (to <$20,000/DALY 
averted 
10 
Kaltenthaler, Brazier 
et al. 2006 (107) 
anxiety, 
depression, 
phobias, panic and 
obsessive-
compulsive 
behaviour (OCD) 
Computerised CBT 
(4 different 
products 
considered) – HTA 
review 
Treatment as 
usual 
Modeled (based on 
sponsor data) 
 
UK – National Health 
Service 
Outcome – depression treated 
(classified into minimal, mild, moderate 
and severe based on the BDI scores 
from the trials (data submitted by 
sponsors) 
Costs: Intervention including license 
fees, computer hardware, screening, 
clinical support, capital overheads + 
other costs from personal 
communication from McCrone 
Beating the Blues - 
£1801perQALY pounds and 
86.8% (threshold of £30,000 per 
QALY), for Cope £7139 and 
62.6% and for Overcoming 
Depression £5391 and 54.4%. For 
phobia/panic software, the 
ICER/QALY of FF over relaxation 
was £2380. Its position compared 
with TCBT is less clear. When 
modeling OCD packages, the CE 
was highly influenced by the 
assumptions made around 
licensing  
10 
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Study Disorder (patient description) Intervention Comparator 
Study Type and 
setting Costs and Outcomes Results Q
1 
King, Sibbald et al. 
2000 (120) 
 
464 subjects with 
either depression 
or mixed 
depression with 
anxiety (scored 
14+ on the BDI) 
*Non-directive 
counseling 
(provided by 
counselors) 
*CBT (provided by 
clinical 
psychologists) 
 
Both types of 
therapy had to be 
provided over 6-12 
sessions 
Usual GP care – 
discussions with 
patients and 
prescriptions of 
medication (GPs 
asked not to 
refer to 
specialists for at 
least 4 months 
(preferably 12) 
RCT – 4 and 12 
month f’up (not total) 
however included 
provisions for patient 
preferences 
 
24 general practices 
in the UK 
Costs: Health professional consults, 
medication and time off work. Health 
records (recording service utilisation) 
from each of the practices were also 
assessed for 12 months prior to study 
entry and 
Outcomes: BDI, Clinical Interview 
Schedule (ICD-10 Diagnosis), Brief 
symptom Inventory, modified social 
adjustment Scale, Satisfaction 
questionnaire, EuroQoL 
At 4 months both psych therapies 
had reduced depressive 
symptoms significantly (a clinically 
sig difference). These differences 
were not observed in other 
measures of outcome. By 12 
months all differences had 
disappeared (all groups had 
improved but the GP group had 
improved the most (not between 
this time period GPs could refer to 
specialists). At 12 months the 
non-directive group was sig more 
satisfied than the others No sig 
differences in costs were found. 
Overall conclusion was that psych 
therapy more C/E in the short-
term only. 
9 
Lave, Frank et al. 
1998 (110) 
 
 Major Depression 
(n=276) 
*Pharmacotherapy 
(nortriptyline 
hydrochloride) – 
administered by 
GPs and internists 
following a strict 
schedule with 
designated visit 
times . 
*Interpersonal 
psychotherapy – 
delivered by a 
psychiatrist or 
psychologist 
including 16 weekly 
sessions followed 
by 4 monthly 
continuation 
sessions 
Usual care – GPs 
told pat has 
depression only. 
RCT – with up to 12 
months follow-up 
 
USA 
Costs: Trial costs of interventions, 
health service use (including physician 
visits,, prescriptions, emergency 
department and hospitalisations – via 
administrative data sets, other services 
by outside providers via questionnaire. 
Indirect costs were also included 
transportation and time costs 
Outcomes: depression free days 
(measured by the HAM-D), BDI and 
quality adjusted days (using a 
conversion methodology from previous 
research 
Pharmacotherapy pats did slightly 
better than those assigned to 
interpersonal psychotherapy (of 
both economic costs and quality-
of-life outcomes). Both were more 
effective than usual care, cost 
more. The ICER for 
pharmacotherapy relative to usual 
care ranges from US$12.66 to 
$16.87 which translates to direct 
cost per quality-adjusted year 
gained from $11270 to $19510 
8 
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Study Disorder (patient description) Intervention Comparator 
Study Type and 
setting Costs and Outcomes Results Q
1 
McCrone, Knapp et 
al. 2004 (108) 
 
Anxiety and 
depression (n=274) 
Computer delivered 
CBT – described in 
the paper 
Usual care – 
including full 
range of 
Treatment 
available to the 
GP 
RCT – various f’up 
points up to 12 
months 
 
General practices in 
England 
Costs: mental health care – including 
psychiatrists, psychologists, CMHN, 
counselors and other therapists) primary 
care staff (GPS, practice nurses, district 
nurses and health visitors) hospital use 
(including o/p care, day surgery and 
ED), home help, meds, other services 
(e.g. chiropractors, physiotherapists and 
dieticians. Lost productivity also 
measured 
Outcomes: BDI, BAI, Work and Social 
Adjustment Scale – depression free days 
using the BDI, estimations method 
based on previous literature (same 
method as Lave) was used to estimate 
QALYs 
Main eco results presented as net 
benefit (where the clinical 
outcome is multiplied by some 
shadow-price “λ”. 
Regarding costs the CBT group 
was a bit higher but this was NS 
after controlling for trial based 
costs. Though the CBT group had 
significantly lower prod costs. The 
CBT group had sig better 
outcomes on the key measures. 
The QALY gains were however 
quite small. Therefore 
intervention was more expensive 
but more effective compared to 
usual practice  
10 
Mihalopoulos, 
Kiropoulos et al. 200 
(59) 
 
Depression and 
anxiety 
Panic online 
(internet based 
therapy for panic 
disorder) supported 
by either a GP or a 
psychologist and 
PEP (GP training in 
CBT) 
Usual care in PC Modeled and 
Threshold analysis 
 
Australia 
Costs: Health sector (derived from 
published literature 
Outcomes: Modeled DALYs using 
interpolation 
PEP is likely to be quite C/E – 
though evidence is based on 
other published trials. PEP type 
interventions are also likely to be 
cost-effective even with moderate 
effect sizes (in the vicinity of 0.1) 
9 
Revicki, Siddique et 
al. 2005 (121) 
 
Major depression in 
267 low income 
minority member 
*Pharmacotherapy 
– managed by 
primary care 
nurses supervised 
by psychiatrists 
*CBT – delivered 
by 
psychotherapists 
supervised by a 
clinical psychologist 
Community 
referral – 
educated on 
depression and 
then referred to 
community 
providers (don’t 
know who these 
providers are) 
RCT (12 months f’up) 
 
USA – recruitment 
was from PC but 
interventions were 
not necessarily PC 
based 
Costs: intervention costs, medical costs, 
hospitalisations, ED, outpatient visits to 
physicians and other health sector 
providers and all meds – only direct 
med costs included as the study 
adopted a largely payer perspective 
Outcomes: Depression free days 
measured by the HAM-D (DFD were also 
used to estimate QALYs, SF-36,  
Both intervention groups had 
significantly lower adjusted mean 
Hammers (and therefore DFDs) 
scores. The cost per additional 
dep 
-free day was USD 24.65 for 
pharmacotherapy and USD 27.04 
for CBT compared with 
community referral. Small initial 
diffs on the SF-36 not maintained 
@ f’up. 
8 
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Study Disorder (patient description) Intervention Comparator 
Study Type and 
setting Costs and Outcomes Results Q
1 
Richards, Barkham et 
al. 2003 (109) 
 
139 people with 
mild-moderate 
anxiety and 
depression in PC 
(GHQ used to 
detect caseness) 
Cognitive 
behavioural based 
self-help package 
facilitated by 
practice nurses 
including 3 
appointments 
Usual care by 
GPs 
RCT (up to 3 month 
follow-up) 
 
PC teams in the UK 
Costs: GPs, practice nurses, medication, 
counselling, mental health worker, 
outpatient psychologist, outpatient 
psychiatrist, self-help (booklet) 
Outcomes: CORE-OM, EuroQol-5D, 
consultation satisfaction questionnaire 
Patients Treatment with CBT 
attained similar clinical outcomes 
for similar costs and were more 
satisfied than patients Treatment 
in usual care. On-treatment 
analysis showed patients CBT 
were more likely to be below 
clinical threshold at 1 month. This 
difference was less well marked at 
3 months (OR = 1.36, 95% CI = 
0.52 to 3.56). 
6 
Sanderson, Andrews 
et al. 2003) (115) 
 
Depression, 
dysthymia and 
bipolar disorder 
(from the 
NSMHWB) 
*Current mental 
health services in 
Aust (derived from 
the NSMHWB) 
*Evidence based 
medicine 
(medication, 
psychological 
therapies –CBT, 
family therapy, 
specific counselling 
[including problem 
solving] and 
manualised self-
help 
Do nothing  Modeled 
 
Australia 
Costs: 
Outcome: YLD (modeled by best 
available literature) 
Current direct mental health-
related health averted just under 
30,000 YLDs giving a cost-
effectiveness ratio of 20,633 
dollars per YLD. Outcome could 
be increased by nearly 50% at 
similar cost with implementation 
of an evidence-based package of 
optimal treatment, halving the 
cost-effectiveness ratio to 10,737 
dollars per YLD. 
10 
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Study Type and 
setting Costs and Outcomes Results Q
1 
Schoenbaum, 
Unützer et al. 2001 
(111) 
 
1356 pats with 
Depression 
(measured by 
telephone CIDI) 
2 quality 
improvement (QI) 
interventions 
QI meds – nurse 
specialists trained 
to support med 
adherence through 
monthly telephone 
contacts or visits 
QI therapy- 
practice therapists 
were trained to 
provide CBT 
therapy. Though 
pats in all trial 
arms could have 
therapy or meds 
however the extra 
resources in each 
of the trial arms 
made it easier to 
get the appropriate 
med or therapy 
Usual care Group level RCT 
(where 
randomisation 
occurred at the 
practice level). F’up 
up to 2 years 
46 PC clinics in 6 
Managed care 
organisations 
Costs: intervention costs including 
training,, ED, medical and mental health 
care visits, meds, (no hospital costs 
included) employment, time costs 
(separately measured) 
Outcomes :SF-12, QALYs (using the SF-
12), days with depression burden 
Compared to usual care, average 
health care costs increased $419 
in QI-meds and $485 in QI-
therapy. Patients had 25 and 47 
fewer days with depression 
burden and were employed 17.9 
and 20.9 more days during the 
study period. QI-therapy may 
have a better overall value in 
terms of cost per QALY than QI-
meds, therefore value to 
improving access to structured 
psychotherapy for depressed 
primary care patients. 
7 
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1 
Scott and Freeman 
1992 (69) 
Depression meeting 
DSM-III criteria on 
a structured clinical 
interview (n=121) 
Amitryptiline 
prescribed by a 
psychiatrist (seen 
weekly for first 2 
weeks and then 
fortnightly or 
monthly as 
required), CBT by a 
clinical psychologist 
(number of 
sessions not 
specified except 
that they were 
weekly to start with 
but sessions lasted 
50 minutes), case 
work by a social 
worker (sessions 
numbers not 
specified but 
weekly to start 
with) 
Routine care by 
a GP (could 
include referral 
to another 
agency) 
RCT with 16 weeks of 
follow-up (ratings at 
0, 4 and 16 weeks) 
 
14 UK primary care 
practices 
Standard observer rating of depression 
(HAM-D) at outset and after four and 16 
weeks. Numbers of patients recovered 
at four and 16 weeks. Structured 
evaluation of treatment by patients at 
16 weeks. 
Costs: Total length and cost of therapist 
contact plus drug costs only – no stated 
perspective.  
Marked improvement in 
depressive symptoms occurred in 
all treatment groups over 16 
weeks. Any clinical advantages of 
specialist treatments over routine 
general practitioner care were 
small, but specialist treatment 
involved at least four times as 
much therapist contact and cost 
at least twice as much as routine 
general practitioner care. 
Psychological treatments, 
especially social work counselling, 
were most positively evaluated by 
patients. 
6 
Shapiro, Sank et al. 
1982 (122) 
 
44 outpatient 
subjects enrolled in 
a HMO diagnosed 
with anxiety or 
depression 
CBT group 
Individual CBT 
administered by a 
mental health 
specialist 
 
Traditional 
process-
orientated 
interpersonal 
group. 
 
RCT pre and post 
Treatment (average 
of 24 days) 
USA - HMO 
Costs: Only of the interventions – very 
roughly calculated 
Outcomes: BDI, Stait-Trait Anxiety, 
Adult self expression scale 
All three experimental groups 
improved and no diffs in outcome 
found Group CBT cheaper than 
individual 
2 
Vos, Corry et al. 
2005 (123) 
 
Depression – from 
NSMHWB 
Bibliotherapy 
CBT (individual and 
group delivered by 
psychologists and 
psychiatrists) 
Pharmacotherapy 
 
Usual care (from 
NSMHWB) – 
largely non-
evidence based 
medicine (EBM) 
options (i.e. 
transferring 
current people 
not receiving 
EBM to EBM 
options) 
Modeled 
 
Australia 
Costs: health sector (medical - GPs and 
specialists, psychologists, meds, OOP) 
all modeled from a private and public 
sector provision perspective 
Outcomes: DALYs (using effect size 
translations from previous literature 
All interventions for MD have 
favourable ICERs under Australian 
health service conditions. 
Bibliotherapy, group CBT, 
individual CBT by a psychologist 
on a public salary and tricyclic 
antidepressants are very cost-
effective, falling below 10,000 
Australian dollars per 
Maintenance Treatment with 
SSRIs is the most expensive 
option (ranging from $17,000 -
20,000 per DALY).  
10 
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1 
Katon, Schoenbaum 
et al. 2005 (138) 
 
Depression and 
dysthymic disorder 
(DSM – IV) in 60+ 
year olds 
Improving mood 
promoting Access 
to Collaborative 
Treatment 
(IMPACT). 1 year 
stepped 
collaborative plan 
including either a 
psychologist or 
nurse supporting 
the PC physician. 
Treatment involved 
either an anti-
depressant or 
problem solving 
Treatment 
Usual primary 
care were the 
physician was 
notified of the 
diagnosis and 
could then offer 
usual care which 
included both 
antidepressant 
medication 
and/or 
supportive 
counselling 
RCT with added EE – 
up to 2 year F’up 
18 primary care clinic 
in USA  
Costs: Payer perspective of outpatient 
costs including meds, specialty mental 
health care (PC and specialists, lab 
tests, emergency dept and the cost of 
the intervention (salary + OH). 
Inpatient costs were also included  
Outcomes: Depression free days 
(measured by the 20 item Hopkins 
Symptom checklist) and QALYs – using 
a rudimentary method of an increase in 
weights of between 0.2-0.4 for 
depression remission. 
Incremental outpatient cost per 
QALY US$2,519. Bootstrapping 
suggested that in 25% of 
iterations the intervention is 
dominant 
5 
Katon, Russo et al. 
2006 (136) 
 
Panic Disorder 
(DSM-IV) – N=232 
CBT (up to 6 
sessions modified 
for the PC setting) 
and up to 6 phone 
calls by a mental 
health specialist 
and 
pharmacotherapy 
(usually SSRIs) 
usually managed 
by the PC physician 
Usual primary 
care could 
include 
medication 
and/or referral to 
a mental health 
professional 
RCT – 12 month f’up 
 
6 PC clinics in USA 
Costs: Outpatient costs – payer 
perspective including code for 
psychotherapy; mental health, primary 
care and emergency room visits and 
hospitalisation plus medications 
Outcomes: Anxiety free days (measured 
by the anxiety severity index, ) 
depression also measured by the Center 
for epidemiological survey depression 
scale, QALYs measured by interpolation 
from previous studies which used the 
SF-12 Brazier weights 
Intervention sig more effective – 
incremental analysis shows 
US$14,158-$24,776 per QALY 
9 
Von Korff, Katon et 
al. 1998 (137) 
 
Depressive illness 
1 RCT 217 
2 RCT 153. 
Diagnosed by IDS 
using DSM-IIIR  
Collaborative care 
– brief cognitive 
behavioural 
therapy and 
enhanced patient 
education – 
provided mainly by 
psychologists 
Usual care – not 
sure exactly 
what this 
consists of 
2 RCTs 
1) about enhanced 
management of 
pharmacotherapy 
and brief 
psychoeducation 
2)collaborative care 
F’up – 12 months 
 
USA 
Costs: medical, psychology, meds, 
ambulatory care (GP visits for things 
other than depression, medical 
specialty, lad and radiology,, emergency 
room, hospital and ancillary services 
such as physical therapy 
Outcomes: % of patients achieving a 
reduction of n50% on the SCL-90 4 
months after randomisation 
Collaborative Care increased the 
costs. There was a modest cost 
offset due to reduced use of 
specialty mental health services, 
but costs of ambulatory medical 
care services did not differ b/w 
the intervention and cont groups. 
For major dep there was a 
modest increase in cost-
effectiveness (due to lower costs 
for CC cf. UC. For pats with minor 
dep CC was more costly 
(therefore less C/E). 
9 
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APPENDIX 9. REVIEWS FOR ECONOMICS ARTICLES 
1. Barrett et al. (160) – A systematic review of published economic evaluations of interventions 
for depression. Fifty-eight papers met the criteria for inclusion 
2. Bower et al. (161) – A systematic review of self-help treatments for anxiety and depression in 
primary care. 
3. Bower et al. (162) – A Cochrane review. 
4. Bower et al. (163) – A meta-analysis on costs from clinical trials  
5. Gould et al. (119) – A meta-analysis of treatment of outcome for panic disorder 
6. Hunsley (164) – A review of cost issues of psychological interventions (not a systematic 
review) – aim of paper was to acquaint psychologists with costing issues. 
7. Kalenthaler et al. (107) – A HTA review of computerised CBT for anxiety – 1 economic 
evaluation cited (McCrone et al., 2004) 
8. Myhr and Payne (165) – A review regarding the cost-effectiveness of CBT for the treatment 
of mental disorders (not necessarily in a primary care setting). 
9. Otto et al. (166) – A review of CBT versus pharmacotherapy for panic disorder. 
10. Schulberg et al. (167) – A review of the use of psychotherapy to treat depression in primary 
care practice – also reviews the economic evaluation literature available up to the time of the 
review. 
11. Vos et al. (116) – Looks at all ACE-MH studies and provides advice to policy advisors 
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APPENDIX 10. QUALITY RATING PROFORMA FOR 
ECONOMIC EVALUATION ARTICLES 
 
Drummond criteria checklist: Study:_____________________________________________ 
 
1. Was a well-defined question posed in answerable form? 
1.1. Did the study examine both costs and effects of the service(s) or programme(s)? 
1.2. Did the study involve a comparison of alternatives? 
1.3. Was a viewpoint for the analysis stated and was the study placed in any particular decision making context? 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
2. Was a comprehensive description of the competing alternatives given (i.e. can you tell who did that to 
whom, where, and how often)? 
2.1. Were any important alternative omitted? 
2.2. Was (Should) a do-nothing alternative (be) considered? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
3. Was the effectiveness of the programmes or service established? 
3.1. Was this done through a randomised, controlled clinical trial? If so, did the trial protocol reflect what would happen in regular practice? 
3.2. Was effectiveness established through an overview of clinical studies? 
3.3. Were observational data or assumptions used to establish effectiveness? If so, what are the potential biases in results? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
4. Were all the important and relevant costs and consequences for each alternative method identified? 
4.1 Was the range wide enough for the research question at hand? 
4.2 Did it cover all relevant viewpoints?  
4.3 Were capital costs, as well as operating costs, included? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
5. Were costs and consequences measured accurately in appropriate physical units? 
5.1 Were any of the identified items omitted from measurement? If so, does this mean that they carried no weight in the subsequent 
analysis? 
5.2 Were there any special circumstances that made measurement difficult?  
  
1. YES     2. NO     3. Partially     4. Can’t tell   
 
6. Were any costs and consequences valued credibly? 
6.1 Were the resources of all values clearly identified? 
6.2 Were market values employed for changes involving resources gained or depleted? 
6.3 Were market values absent, or market values did not reflect actual values, were adjustments made to approximate market values? 
6.4 Was the valuation of consequences appropriate for the question posed? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
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7. Were costs and consequences adjusted for differential timing? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
8. Was an incremental analysis of costs and consequences of alternatives performed? 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
9. Was allowance made for uncertainty in the estimates of costs and consequences? 
9.1 If data on costs or consequences were stochastic, were appropriate statistical analysis is performed? 
9.2 If a sensitivity analysis was employed, was justification provided for the ranges of values (for key study parameters)? 
  
1. YES     2. NO     3. Partially     4. Can’t tell   
 
10. Did the presentation and discussion of study results include all issues of concern to users? 
10.1 Were the conclusions of the analysis based on some overall index or ratio of costs to consequences? If so, was the index interpreted 
intelligently or in a mechanistic fashion? 
10.2 Did the study results compared with those of others who have investigated the same question? If so, were allowances made for potential 
differences in study methodology? 
10.3 Did the study discuss the generalisability of the results to other settings and patient/client groups? 
10.5 Did the study discuss issues of implementation, such as the feasibility of adopting the ‘preferred’ programme given existing financial or 
other constraints, and whether any freed resources could be redeployed to other worthwhile programmes? 
 
1. YES     2. NO     3. Partially     4. Can’t tell   
 
 
 
 
 
